tsawon wane lokaci ne wadannan alamun suka fara bayyana?
Kuma duk wani ciwo a cikin kirji dole ne a bi da shi ta wannan hanyar musamman a wannan lokacin da kuke
Kuma da zazzabi.
kuma za a gwada hawan jini da kuma yawan cholesterol da ke jikinka
Kuma kana da zazzabi a yanzu?
Kuma shin kana jin wannan ciwo a kirjinka a yanzu?
kuma shin kana da wahalar numfashi?
kuma za ki iya gaya mani wani irin ciwo ko rashin lafiya da ki ke da shi?
Kuma yaushe zafin jikinka ya kai?
Ni ma na yi amai
Ina da wata 'yar sanyi da kuma tari.
Ina jin zafi a kirji a yau
Kuma wannan shine lokacin da ake samun cutar sankara a hanci
Kuma ka ga wata irin ciwo a kirji.
Ina kuma jin kamar ina da zazzabi.
Kuma ina son ka bayyana inda ka kirji zafi
Kuma suna da zazzabi.
da kuma tarihin ciwon sukari
Kuma ka san, ƙirjina yana jin kamar za a murƙushe shi
Kuma ka san, mutane suna yawan yin amai a kaina
kuma kuna jin ciwon kirji
kuma ka ce akwai matsa lamba a kan kirji
kowa a cikin iyalin da ke da matsalar zuciya, ciwon zuciya, bugun zuciya, hawan jini, hawan jini
Shin akwai wata alama ko matsala da kuka lura tare da ciwon tsoka?
Shin akwai wani a cikin gidanku da ke da irin wannan ciwo?
Shin kana jin wasu alamun?
Shin kun taɓa samun ƙarancin numfashi?
Shin har yanzu kuna jin ciwon kirji?
saboda wannan lokacin ne na zazzabin mura
Amma kuma ba za mu iya ware ciwon kirji da ke fitowa daga zuciya ba
Amma abin da ya fi damuna a yanzu shi ne wannan ciwon kirji.
Kuma ina jin wahalar numfashi.
amma na san mutane da yawa coughing a gare ni
Amma muna bukatar mu ɗauki kowane ciwo a ƙirjinmu da muhimmanci.
Amma yanzu kana iya numfashi da kyau?
Na manta da ainihin dalilin ciwon kirji
Shin yana jin kamar wani yana matse ƙirjinka?
Har yanzu yana jin kamar yana da numfashi
Shin suna da alamun rashin lafiya iri daya?
Shin kuna da wani ciwo mai tsanani kamar hawan jini ko wani abu?
Kuna da wata cuta ko wata cuta mai tsanani kamar ciwon sukari?
Shin kana jin karancin numfashi tare da ciwon kirjin?
kana da cutar hawan jini?
Shin kuna jin ƙarancin numfashi tare da alamun cutar?
Ka san irin alamun da take da shi?
Shin kun ga hoton?
Na sha ruwa da yawa a yau.
Amma na yi gwajin ciwon sukari
Amma yana da wasu alamun da na ke da su
Yaya zafin jikinka yake?
Yaya karfin jininka?
idan zazzabin ya ci gaba
idan zafin jikinka ya kai 100 ko sama da haka
idan ka lura da wata alama ko matsala kana bukatar a yi maka ƙarin bincike
Ina da zazzabi a jiya
Ina da ɗan zazzaɓi.
Ina da zazzabi a jiya
Ina jin zafi a nan, a cikin kirji
Ni ma na kasa yin numfashi
Zan aika da hoton zuwa gare ku
Ina jin ciwon kirji a yau
Ina da ciwon kai da zazzaɓi a yau
A ganina, wannan mura ce
A ganina, wannan ɗan mura ne
Shin yana jin kamar akwai wani mai nauyi a ƙirjinka?
duk ya fara ne daga ciwon kai da zazzabi a kusan lokaci guda
Ina jin zafi a tsakiyar kirji na
matsi kamar ciwon kirji
a cikin ƙirjina
a tsakiyar kirji na
a tsakiyar kirji
Ina jin ciwon a kirji
Ina matukar damuwa game da wannan ciwon kirji
Ina son ka bayyana mini wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kamar daidai a tsakiyar kirji
Don zazzabin za ka iya shan tachipirina mai zaki
Mary, kwana nawa ne ka ke fama da wannan cutar?
Ka ce kana jin zafi a cikin kirji
Wani lokaci ina jin ciwo a ƙirjina
To, akwai wata alama tare da wannan alamar banda ciwo
Ko wani yana zaune a kirjinka?
Wannan yana da kusan daidai da zazzabi, tari, ciwon kai, da kuma ciwon tsoka
daidai a tsakiyar kirji na
Ka nuna mini inda kake jin ciwo a hoton nan
saboda kana da zazzabi
To, shin, kuna ganin wasu daga cikin wadannan alamun na iya zama masu alaka da ciki?
To, yaranka suna da wasu irin wannan alamun?
Ka gaya mini game da ciwon kirjinka
zazzabi ya tashi da dare
Na yi kwana biyu ina jin zazzabin
zazzabin ya tashi a daren jiya
Dr. Porter ne a cikin cibiyar bincike na asibiti a cikin dakin gaggawa.
Za a iya gaya mana game da ciwon da ke cikin kirji?
Ina jin zafi a gaba na, a nan, a kirji
Na ji ciwo mai tsanani a kirji
"Sa'ad da na ji irin wannan ciwo a kirjina,
"Abin da irin zafi kuke ji a cikin kirji?
Yaushe ne wannan ciwon a kirji ya fara?
A ina ne ka ji ciwon a kirji?
A wace bangare ne kake jin ciwon kirji?
Kana jin kamar kana da wata matsala a kirjinka
Ka san ina da ciwon suga da kuma wasu cututtuka?
Ka ce kana jin wannan ciwon kirji
Haɗarin cutar coronavirus (COVID-19) yana ƙaruwa cikin sauri a cikin EU/EEA da United Kingdom, 1 ga Janairu zuwa 15 ga Maris, 2020
Ƙididdigar yawan masu kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen EU/EAEA da United Kingdom wanda ya tabbatar da cewa, duk da bambancin yanayi a kowace ƙasa, annobar COVID-19 tana ci gaba cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, jihohi, asibitoci, da kuma cibiyoyin kula da marasa lafiya masu tsanani ya kamata su kasance a shirye don samun damar yin amfani da su don karuwar masu cutar COVID-19 da za su buƙaci kula da lafiya, musamman kula da marasa lafiya.
A ranar 31 ga Disamba, 2019, an ba da rahoton tarin cututtukan huhu da ba a san asalin su ba a Wuhan, lardin Hubei, China.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta ba da rahoton cewa kwayar cutar ta zama sabon kwayar cutar da yanzu ake kira SARS-CoV-2 coronavirus.
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa ana kiranta da cutar coronavirus (COVID-19).
Shaida ya zuwa yanzu ya nuna cewa kusan kashi 80% na masu cutar COVID-19 suna da cutar mai laushi, wato, kamuwa da cutar huhu tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan sun warke.
A cikin kimanin kashi 14 cikin 100 na masu kamuwa da cutar, COVID-19 ya zama mai tsanani kuma ya buƙaci a kula da su a asibiti, yayin da sauran kashi 6 cikin 100 na masu kamuwa da cutar suka kamu da rashin lafiya mai tsanani wanda ke buƙatar kulawa mai tsanani.
Adadin mutanen da suka mutu daga COVID-19 a asibiti ya kai kusan 4%.
A cikin wannan binciken, mun yi nazarin yanayin yanayin cutar COVID-19 na ƙasashen Tarayyar Turai/EEA da Burtaniya kuma mun gwada su da abin da ya faru a lardin Hubei na China.
Mun kuma kwatanta adadin COVID-19 na yanzu a cikin EU/EEA da UK tare da adadin waɗanda suka kamu da cutar a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Rahoton COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 yana da ƙarin yaduwar ƙasa kuma yanayin COVID-19 a sauran duniya yanzu yana bin yanayin cutar a China.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin Eurosurveillance 2020 na 5 ga Maris, Spiteri et al. sun ba da rahoton mutanen Turai na farko da aka tabbatar da cutar COVID-19 bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon kamuwa da cutar guda uku a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris 2020, an gano COVID-19 a cikin ƙasashe 30 na EU/EEA da United Kingdom (UK), tsakanin 31 ga Disamba 2019 da 15 ga Maris 2020 tare da wannan kwanan wata, akwai rahotanni 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun ƙididdigar tarawa da kuma tara abubuwan da suka faru na COVID-19
A Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin COVID-19 da aka ruwaito ga kowace ƙasa a duniya kowace rana a karfe 8:00 na safe.
Ana amfani da bayanan don tantance yanayin COVID-19 a cikin EU/EEA da UK, da kuma kwatanta su da yanayin Italiya.
A matsayin wakili na yawan masu cutar COVID-19, mun lissafa mafi ƙarancin abin da ya faru a cikin kwanaki 14, don haka ya haɗa da yanayin tafiya na COVID-19, a kowace ƙasa ta EU/EEA da Burtaniya, a cikin lokacin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadin adadin da aka sanar da kowace ƙasa har zuwa 15 ga Maris 2020 a karfe 8:00 idan aka kwatanta da na Italiya a cikin lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Matsakaicin abin da ya faru na kwanaki 14 na ƙarshe na COVID-19 a cikin EU/EEA da UK gabaɗaya ya bi yanayin lardin Hubei (Cina) (Hotuna 1).
Ga EU/EEA da UK gabaɗaya, yawan abubuwan da ke tattare da COVID-19 ya fara tashi a kusan 21 ga Fabrairu, sannan ya tashi sosai a kusan 28 ga Fabrairu 2020 (Karin bayani).
Wannan yanayin yana da yawa saboda saurin karuwar adadin da aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da UK suna nuna irin wannan yanayin na karuwar cutar COVID-19 (Sakamakon bincike).
Hoto na 2 ya nuna adadin masu cutar COVID-19 a cikin EU/EEA da UK idan aka kwatanta da adadin masu cutar a Italiya a lokacin 31 ga Janairu-15 ga Maris 2020.
Bayanan sun nuna cewa, ya zuwa 15 ga Maris da karfe 8:00, sauran ƙasashen EU/EEA 15 da UK sun ba da rahoton adadin adadin da ya yi daidai da na Italiya a makonni uku da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin wadanda suka kamu da COVID-19 da aka ruwaito ya karu cikin sauri a cikin EU/EEA da UK.
Abubuwan da aka lura a cikin abubuwan da suka faru na COVID-19 sun nuna cewa cutar tana ƙaruwa a irin wannan saurin a duk ƙasashe.
Wannan ya kasance ba tare da la'akari da bambancin matakan da ƙasashe ke fuskanta ba, bambancin martanin lafiyar jama'a, da kuma yiwuwar bambancin ma'anar shari'a tsakanin ƙasashe da bambancin ladabi don zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, wanda ya haɗa da gwajin bi da bi.
A farkon Maris 2020, likitoci a yankunan Italiya da ke fama da cutar sun bayyana cewa kimanin kashi 10% na masu cutar COVID-19 suna buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai tsanani a yankin sun kai iyakar ƙarfin su.
A halin yanzu, ana samun bayanan karɓar COVID-19 a asibiti da/ko naúrar kulawa mai tsanani a matakin EU/EEA don kashi 6% da 1% na shari'o'in (ba a nuna bayanai ba).
Duk da haka, ana buƙatar tattara bayanai a cikin tsari don haɓaka bayanan sa ido na yanzu wanda ke mai da hankali kan adadin shari'o'in da aka ruwaito da kuma mutuwar.
Nazarin da aka gudanar a 2010-2011 ya nuna bambanci mai yawa dangane da samun gadaje na kulawa da kulawa da kulawa a Turai, wanda ya kai daga 29.2 a Jamus zuwa 4.2 a kowace 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye da ko ƙasa da Italiya (12,5 na kula da lafiya da gadaje na kulawa da juna a kowace 100,000 na jama'a a cikin 2010-2011).
Halin da aka tsara game da wadatar ƙarfin kiwon lafiya, tare da ƙididdigar yawan cutar COVID-19 na asibiti ga kowane ƙasashen EU/EEA da UK waɗanda ke da haɗarin > 90% na wuce ƙarfin ƙarfin gado na ICU, an bayar da su a cikin sabuntawa na shida na ECDC na saurin kimanta haɗarin COVID-19.
Saboda har yanzu ana clustering lamura a wasu yankuna a cikin EU/EEA da UK, kuma asibitoci da kuma ICUs yawanci suna ba da sabis na yanki na yanki, ya kamata a samar da bayanai game da lamura da wuraren kula da lafiya a matakin Sunan Yankin yanki don ƙididdiga 2 (NUTS-2).
Kwarewar Italiya da yanayin da ake ciki a wasu ƙasashe sun nuna cewa cutar COVID-19 tana tasowa cikin sauri a cikin EU/EEA da UK.
Saboda haka, jihohi, asibitoci, da kuma dakunan kula da marasa lafiya na bukatar su shirya don yanayin yaduwar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin masu cutar COVID-19 da ke bukatar kula da lafiya, musamman kula da marasa lafiya na musamman, kamar yadda ya faru a yankunan da abin ya shafa a Italiya.
Kamar yadda aka nuna a cikin sabon saurin binciken haɗarin ECDC, hanzari, aiki, da kuma cikakken tsarin yana da mahimmanci don rage yaduwar SARS-CoV-2, tare da sauyawa daga tsarin hanawa zuwa tsarin ragewa, saboda saurin karuwar adadin lamura, kamar yadda aka zata, bazai ba masu yanke shawara da asibitoci isasshen lokaci ba don fahimta, yarda, da daidaitawa da amsa mai kyau idan ba a yi amfani da shi ba a baya.
Wannan saurin tantance haɗarin ya kuma ba da shawarar matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai karancin lokaci a lokacin da kasashe za su iya ƙara yawan matakan da suke dauka na rage yaduwar SARS-CoV-2 da kuma rage matsin lamba a kan kula da lafiya.
Idan ba haka ba, sauran tsarin kiwon lafiya na EU/EEA na iya fuskantar hauhawar marasa lafiya da ke bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19), wacce ake samu sakamakon cutar sankarar bargo mai saurin tashi 2 (SARS-CoV-2), ya zuwa yanzu ya hallaka sama da mutane 3,000 kuma ya harbi sama da mutane 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'i ga mutane.
Kamar dai kwayar cutar SARS-CoV, wacce ta haifar da cutar SARS a cikin dubban mutane a shekara ta 2003, SARS-CoV-2 na iya zama ana watsa shi ne daga jemage kuma yana haifar da alamomi iri ɗaya ta hanyar irin wannan hanyar.
Duk da haka, COVID-19 yana da ƙananan ƙarancin cuta da mutuwa fiye da SARS, amma ya fi kamuwa da kuma ya shafi tsofaffi fiye da matasa, da kuma maza fiye da mata.
A cikin martani ga yawan wallafe-wallafe da ke ƙaruwa da sauri game da wannan sabuwar cuta, wannan labarin yayi ƙoƙari ya ba da cikakken bayani game da batun bincike mai saurin ci gaba.
Za mu tattauna abubuwan da suka shafi cututtuka, da kuma yadda ake kamuwa da su.
Ko da yake har yanzu akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan binciken zai taimaka wajen fahimtar da kuma kawar da wannan mummunar cuta.
Bikin bazara a ranar 25 ga Janairu 2020 ya zama abin tunawa da ba a taɓa yin irinsa ba kuma ba za a iya mantawa da shi ba ga duk Sinawa waɗanda aka umarce su da su zauna a gida a lokacin hutun da kuma makonni bayan haka saboda barkewar sabuwar cutar ta kwayar cutar.
Kwayar cutar tana da kamanni sosai da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar ta SARS a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta ba da sunan SARS-CoV-2 a ranar 11 ga Fabrairu 2020, kuma cutar da take haifarwa ana kiranta Cutar COVID-19 (COVID-19).
An fara bullar cutar ne a Wuhan, China, kuma da sauri ta bazu a kasar nan da kuma kusan kasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, cutar ta haifar da mutane 80,000 da aka tabbatar da suna da cutar COVID-19, tare da sama da mutane 40,000 da suka warke da kuma 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 shine "magabcin jama'a na lamba 1" kuma yana da damar yin barna fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu tun daga rahoton farko a ranar 7 ga Janairu 2020 wanda ya ƙaddamar da jerin ƙwayoyin ƙwayoyin cuta da aka ware daga wasu marasa lafiya, sama da takardu 200 aka buga akan COVID-19, wanda ya haɗa da kwayar cutar, cututtukan cuta, ilimin cututtukan, ganewar asali, da magani.
Wannan bita yana ƙoƙari ya tattara ci gaban bincike a cikin wannan sabon yanayin da ke ci gaba cikin sauri.
A duk inda za mu iya, za mu gwada gwada COVID-19 da SARS da kuma sauran cututtukan da ke haifar da CoVs, wato cututtukan da ke haifar da cututtukan numfashi na gabas ta tsakiya (MERS, ya barke a 2012).
Za mu kuma tattauna abin da aka koya game da yadda za a hana cutar da kuma yadda za a iya sanin cutar da kuma wasu tambayoyi da ba a amsa ba.
A al'adance, ana ɗaukar CoV a matsayin mai cutarwa ga ɗan adam, musamman yana haifar da kusan kashi 15% na sanyi 4.
Duk da haka, a cikin wannan karni, mun ga CoVs masu saurin kamuwa da cutar mutum sau biyu, wato SARS-CoV da MERS-CoV, kowannensu ya haifar da barkewar cutar da ta fara a China a 2003 da Saudi Arabiya a 2012, kuma nan da nan ya bazu zuwa wasu ƙasashe da yawa tare da mummunar cuta da mutuwa.
Saboda haka, COVID-19 na yanzu shine annoba ta uku na CoV a cikin tarihin ɗan adam.
Kamar yadda aka nuna a Hoto na 1.1, an fara samun rahoton clusters na cutar huhu da ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Kiwon Lafiya ta Jamhuriyar Jama'ar Sin.
Bayan kwana bakwai, an sake fitar da kwayar cutar.
A ranar 15 ga Janairun 2020, an ba da rahoton mutuwar mutum na farko daga Wuhan.
A halin yanzu, annobar ta yaɗu da sauri a birane, larduna, da kuma ƙasashe da suke kewaye da ita.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da cutar mai ba da lafiya, wanda ke nuna cewa yiwuwar watsa mutum-zuwa-mutum na iya faruwa.
A ranar 23 ga watan Janairu, an sanya dokar kulle a cikin garin Wuhan kuma an dakatar da duk zirga-zirgar jama'a.
A ranar 24 ga watan Janairu, binciken asibiti na farko game da cutar ya ba da rahoton cewa, daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulda kai tsaye da kasuwar abincin teku ta Wuhan da aka ɗauka a matsayin wurin da cutar ta fara daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar a matsayin matsalar gaggawa ta duniya.
A lokacin da aka rubuta wannan rahoto, cutar ta riga ta yadu zuwa duk ƙasar Sin da kusan wasu ƙasashe 50 a duniya (Fig. 2).2).
Saboda yanayin yana ci gaba da sauri, ba a san iyakar cutar ba.
A ranar 11 ga Fabrairu, 2020, wani binciken da aka yi a kan mutane 8,866, wanda ya haɗa da mutane 4,021 da aka tabbatar da cewa suna da COVID-19, ya ba da ƙarin bayani game da cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da mutane a kowane zamani, amma musamman a tsakanin shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekara 50, kaɗan ne ke ƙasa da shekara 20, kuma mutane 14 ne kawai suka kamu da cutar da ke ƙasa da shekara 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 yana yaduwa a cikin gungu, musamman a ciki da wajen Hubei.
COVID-19 yana ɗaukar kimanin kwanaki 5 (2-9) daga kamuwa da cutar zuwa ganewa.
Matsakaicin lokacin kwanciya shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin daga haihuwar zuwa mutuwa shine 9.5 (4,8-13) kwanaki.
Halin da ake ciki na asali (R0) shine 3.77 (95% CI: 3.51-4.05) da kuma R0 daidai da 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin jigilar jama'a kafin bikin bazara a China.
Mutuwar marasa lafiya tare da tabbataccen lamari ya kasance 1.44% (95% CI: 1.10-1.86%) da kuma daidaitaccen mutuwa ga duk marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku masu haɗarin COVID-19 sune jinsi (namiji), shekaru (≥60 shekara), da kuma cutar huhu mai tsanani.
CoVs babban rukuni ne na ƙwayoyin cuta masu ƙwayoyin cuta waɗanda ke ɗauke da RNA mai ma'ana guda ɗaya.
CoVs za a iya raba su zuwa jinsi huɗu, wato alpha, beta, gamma, da delta, tare da alpha- da beta-CoV da aka sani suna cutar da mutane.
Glycoprotein na spike ko spike (S) murfin yana ɗaure ga mai karɓar kwayar, angiotensin-switching enzyme 2 (ACE 2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan haɗuwa ta membrane ta faru.
An saki kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan kwayar kwayar ta kwayar cutar ta kwayar cuta, RNA na kwayar cuta tare da glycoprotein mai rufi da kwayar nucleocapsid sun kafa wani kwayar cuta mai dauke da virion, wanda daga baya ya haɗu da membrane na plasma don sakin kwayar cutar.
An fara rahoton jerin kwayoyin SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 sabon nau'in beta-CoV ne tare da daidaiton kwayar halitta sama da kashi 99.98% a cikin samfurori 10 da aka tsara; an samo samfurin ne daga wurin da cutar ta fara, Huanan Seafood Market a Wuhan.
A cikin kwayoyin halitta, SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar watsa kwayar electron microscopy, an gano SARS-CoV-2 a cikin wani ɓangaren epithelium na hanyoyin numfashi na mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 kamar SARS-CoV.
Duk da haka, sunadarin S na SARS-CoV-2 yana ɗaure da ACE2 na ɗan adam ya fi ƙarfin ɗaurewar da yake da shi ga sunadarin S na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta ba kamar kamuwa da SARS-CoV a cikin marasa lafiya ba.
SARS-CoV-2 na iya samar da sabon gajeren furotin wanda aka sanya shi da lambar orf3b da kuma furotin da aka sanya shi da lambar orf8.
Furotin na SARS-CoV-2 orf3b na iya taka rawa a cikin cutar cutar da kuma hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani sanannen yanki ko motsi.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton cikakken tsarin ACE2 na mutum mai ƙirar ƙira a ƙuduri na 2.9 Å a cikin hadaddun tare da jigilar amino acid B0AT1.
Sun gano cewa hadaddun, wanda ke da buɗewa da rufewa, an tsara su don yin dimers kuma hadadden ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ya zama hujja don ganewa da kamuwa da CoV.
B0AT1 na iya zama wata manufa ta magani a cikin ƙirar magunguna don hana kamuwa da cutar SARS-CoV-2.
Inang na asali da kuma na tsakiya
An san SARS-CoV da MERS-CoV sun samo asali ne daga ƙuda kuma kowannensu ya watsa zuwa ga mutane ta hanyar bison daji da raƙumi.
Ta hanyar kwatanta kwayar halitta ta SARS-CoV-2 da sauran CoVs, ana ɗaukar ƙwanƙwasa a matsayin asalin SARS-CoV-2 saboda sabon kwayar cutar ta kasance daidai da kashi 96% na CoVs masu kama da SARS na ƙwanƙwasawa guda biyu da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san irin matsakaiciyar mai watsawa da ke taimaka wa kwayar cutar ta tsallaka shingen jinsin don ya kamu da mutane ba, kuma ba a bayyana hanyar watsawa ba.
Ji, et al. sun ba da shawarar cewa maciji ne mai ɗaukar kwayar cutar daga bat zuwa ga mutum wanda ya ƙunshi sake haɗuwa da homologs a cikin S-protein.
A cewar wani binciken, masu bincike a Guangzhou, China, sun ba da shawarar cewa larvae, tsintsiya mai tsintsiya mai tsintsiya mai tsinkaye wanda ake amfani da shi a cikin maganin gargajiya na kasar Sin, yana da damar zama mai ɗaukar SARS-CoV-2 na tsaka-tsakin lokaci bisa ga kashi 99% na kwayar halitta a cikin kwayar cutar da aka samo a larvae da SARS-CoV-2.
Duk da haka, bambancin 1% da aka yada a cikin dukan kwayoyin halittar har yanzu babban bambanci ne; saboda haka, sakamakon ƙarshe a matsayin hujja mai ƙarfi bai riga ya kasance ba (Fig. 3).
Ba a san yawancin halayen physiochemical na SARS-CoV-2 ba.
In vitro, SARS-CoV da MERS-CoV na iya rayuwa har tsawon sa'o'i 48 a cikin yanayi mai bushewa kuma har zuwa kwanaki 5 a 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan halayen.
An bayar da rahoton cewa SARS-CoV-2 yana da ƙwarewa ga ultraviolet da zafi a 56 °C na minti 30; ether, 75% ethanol, disinfectant wanda ya ƙunshi chlorine, peroxyacetic acid, chloroform, da sauran mai narkewa mai narkewa, amma ba chlorhexidine ba, yana da tasiri wajen kashe kwayar cutar.
Gabaɗaya, duk mutanen duniya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da wannan sabuwar kwayar cutar.
A halin yanzu, babu wani cikakken bincike da ya ba da rahoto game da maganin rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi a baya kan sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. 4).
Gabaɗaya, bayan mamaye mai gida, kwayar cutar tana ganewa ta hanyar tsarin rigakafin da ke cikin jiki ta hanyar karɓar karɓar karɓa (PRR), wanda ya haɗa da C-type lectin-like receptor, Toll-like receptor (TLR), NOD-like receptor (NLR), da kuma RIG-I-like receptor (RLR).
Ta hanyoyi daban-daban, ƙwayoyin cuta suna haifar da bayyanar abubuwan ƙwayoyin cuta, ƙwayoyin dendritic cell, da kuma nau'in I (IFN) na ƙwayoyin cuta wanda ke iyakance yaduwar ƙwayar cuta da kuma hanzarta fashewar ƙwayoyin cuta na ƙwayoyin cuta ta hanyar macrophages.
Duk da haka, furotin N a SARS-CoV na iya taimakawa ƙwayoyin cuta su guji amsawar garkuwar jiki.
Ba da daɗewa ba, ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwayar cuta.
Kwayoyin T, waɗanda suka haɗa da CD4+ da CD8+ suna da muhimmiyar rawa a wannan kāriya.
Kwayoyin T CD4+ suna motsa ƙwayoyin B don samar da ƙwayoyin cuta na ƙwayoyin cuta, kuma ƙwayoyin T CD8+ suna kashe ƙwayoyin cuta da suka kamu da cutar kai tsaye.
Kwayoyin T masu taimako suna samar da sinadarin cytokines wanda ke hana kumburi kuma yana taimakawa wajen kare sel.
Koyaya, CoV na iya hana aikin T-cell ta hanyar haifar da apoptosis na T-cell.
Har ila yau, rigakafin humoral, wanda ya haɗa da kari, kamar C3a da C5a, da kuma rigakafi suna da mahimmanci wajen yaƙi da kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka ware daga marasa lafiya da suka warke sun kawar da MERS-CoV.
A wani ɓangare kuma, yawan yadda tsarin na garkuwar jiki yake amsawa yana haifar da yawan adadin ƙwayoyin halittun da ke cikin gida, wanda hakan zai iya haifar da mummunar lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayi, ƙwayoyin jiki na iya kasawa har ma da mutuwa.
Cutar SARS-CoV-2 da ke nuna cluster na cututtuka, ya fi yawa a kan tsofaffi da masu ciwo da mata masu juna biyu.
A mafi yawan lokuta, mutanen da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda aka raunana garinsu suna da damar kamuwa da cutar fiye da sauran mutane.
An kiyasta matsakaicin lokacin kwanciyar SARS-CoV-2 ya kasance kwanaki 1-14, mafi yawa kwanaki 3-7 bisa ga nazarin 425 na farko a Wuhan.
Amma, wani bincike na 1,099 ya nuna cewa matsakaicin lokacin da ake yi wa cutar ne na kwana 3 kuma yana daga 0 zuwa 24.
Nazarin da aka yi kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin incubation na kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866 na shari'ar.
Yana da muhimmanci hukumomin lafiya su daidaita lokacin da ake bukatar a keɓe mutane don ya dace da lokacin da cutar ta fara kamawa don hana mutanen da ke da cutar, amma ba su da alamun cutar, su yaɗa cutar ga wasu.
A matsayina na al'ada, mutanen da suka kamu da cutar ko kuma suka kamu da cutar ana bukatar su killace kansu na tsawon kwanaki 14.
Ya kamata a tsawaita lokacin killacewar zuwa kwanaki 24?
Zazzabi yana da alamun farko da na farko na COVID-19, tare da ko ba tare da alamun bayyanar ba kamar tari mai bushewa, ƙarancin numfashi, ciwon tsoka, ciwon makogwaro, ciwon kai, ciwon makogwaro, ƙonewa, ciwon kirji, zawo, tashin zuciya, da amai.
Wasu marasa lafiya suna fuskantar rashin barci da/ko rashin jini a mako guda bayan sun kamu da cutar.
A cikin mafi munin yanayi, cututtukan marasa lafiya suna ci gaba da sauri zuwa cututtukan cututtukan cututtukan cututtukan cututtuka, damuwa mai tsanani, asidosis na rayuwa, da kuma coagulopathy.
Marasa lafiya da ke da zazzabi da/ko alamun numfashi da zazzabi mai tsanani, ko da ba tare da wata cuta ta hoto ba, ya kamata a gwada su don gano cutar da wuri.
Nazarin yanayin jama'a a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar ya kai kashi 98% na zazzaɓi, 76% na tari mai bushewa, 55% na dyspnea, da 3% na zawo; 8% na marasa lafiya suna buƙatar tallafin ventilator.
An samu irin wannan sakamakon a wasu bincike biyu da aka yi kwanan nan, wato bincike a kan iyali da kuma wanda aka yi a kan mutane da ba su da lafiya.
A kwatankwacin haka, nazarin alƙalumma a cikin 2012 ya nuna cewa marasa lafiya na MERS-CoV suma suna da zazzaɓi (98%), tari mai bushewa (47%), da kuma dyspnea (55%) a matsayin manyan alamun.
Duk da haka, kashi 80% na marasa lafiya suna buƙatar tallafin iska, fiye da marasa lafiya na COVID-19 kuma ya dace da yawan mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da kuma ciwon makogwaro (21%) a cikin marasa lafiya MERS.
A cikin marasa lafiya na SARS, zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), da ciwon makogwaro (13-25%) an nuna su a matsayin manyan alamun kuma ana buƙatar tallafin iska don kusan 14%-20% na marasa lafiya.
Ya zuwa ranar 14 ga Fabrairu, yawan mutuwar daga COVID-19 ya kai kashi 2 cikin ɗari, kuma adadin mutanen da aka tabbatar da sun kamu da cutar ya kai 66,576 a duniya.
A cikin watan Nuwamba 2002, mutuwar SARS ta kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
Ga MERS, bisa ga binciken alƙaluma a watan Yuni 2012, mutuwar ta kai kashi 37% na mutane 2,494 da aka tabbatar da cutar.
Nazarin da ya gabata ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da tazarar amincewa (CI) na 95% na 5.71-7.23, yayin da R0 na SARS-CoV ya kai 2 zuwa 4 kawai.
An kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamun bayyanar, mace-mace, da R0 a cikin Table 1.
Waɗannan lambobin sun nuna cewa SARS-CoV-2 yana da saurin yaduwa fiye da MERS-CoV da SARS-CoV, amma ba kamar MERS-CoV da SARS-CoV ba.
Saboda haka, ƙalubalen da ke tattare da cutar SARS-CoV-2 ya fi na MERS-CoV da SARS-CoV.
Sau da yawa ana samun garkuwa a cikin iyali ko kuma a cikin ƙungiya ko a cikin abin hawa kamar jirgin ruwa.
Marasa lafiya sau da yawa suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da abin ya shafa ko hulɗa da mutanen da ke da cutar ko marasa lafiya a cikin makonni biyu da suka gabata kafin kamuwa da cutar.
Koyaya, an bayar da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba fiye da makonni biyu kuma marasa lafiya da aka sallama daga asibiti na iya ɗaukar kwayar cutar. Wannan ya haifar da taka tsantsan don ƙara lokacin keɓewa.
A farkon, marasa lafiya suna da ƙarancin ƙwayoyin farin jini na jijiyoyin jini (musamman lymphocytes) na al'ada ko raguwa.
Misali, an gano lymphopenia tare da adadin ƙwayoyin farin jini < 4×109/L, wanda ya haɗa da adadin lymphocytes < 1×109/L, da kuma aspartate aminotransferase da kuma ƙimar cutar viremia a cikin marasa lafiya 1,099 na COVID-19.
Halin enzymes na hanta da tsoka da kuma myoglobin sun karu a cikin jinin wasu marasa lafiya, kuma sun karu da C-reactive protein da kuma yawan jinin jini a yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, D-dimer ya karu, wanda shine samfurin da ke lalata fibrin da ke cikin jini, kuma adadin lymphocytes ya ragu a hankali.
An gano rashin lafiyar photo-thorax a cikin mafi yawan marasa lafiya na COVID-19 kuma an nuna shi da hasken girgije na biyu ko gilashin gilashi a cikin huhu.
Marasa lafiya sukan kamu da cutar huhu, ciwon huhu mai tsanani, da kuma ciwon rashin numfashi mai tsanani (ARDS).
A lokacin da cutar ta ARDS ta auku, kumburi da ba a iya shawo kansa ba, da kuma ruwan da ke taruwa, da kuma ci gaba da ciwon ƙwayar cuta suna sa gas ya zama marar kyau.
Rashin aiki na ƙwayoyin cuta na I da II yana rage yawan matakan surfact kuma yana ƙaruwa da matsa lamba wanda ke rage ƙarfin huhu don haɓaka kuma yana ƙaruwa haɗarin ƙwayar huhu.
Saboda haka, mafi munin sakamakon hoton thoracic sau da yawa yana daidai da mafi munin cutar.
A ranar 18 ga Fabrairun 2020, bincike na farko na ilimin cututtukan COVID-19 ya nuna ƙarancin ƙwayoyin huhu, ƙirar membrane na hialin, da kuma shigar da lymphocytes na interstitial, da kuma ƙwayoyin sinadirai masu yawa a cikin huhu na marasa lafiya da suka mutu daga cutar, daidai da ilimin cututtukan cututtukan kwayar cuta da ARDS da kuma kama da nazarin cututtukan marasa lafiya na SARS da MERS.
An yi amfani da RNA na SARS-CoV-2 ta hanyar jujjuyawar transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don tantance COVID-19.
Duk da haka, saboda yawan adadin karyar karyar, wanda zai iya saurin cutar, an fara amfani da bayyanar asibiti don ganewar asali (wanda ba zai sake dogara da RT-PCR ba) a China a ranar 13 ga Fabrairu, 2020.
Haka kuma ya faru da ganewar cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwajin gwaji, da binciken radiology yana da mahimmanci kuma dole ne don yin ingantaccen ganewar asali.
A ranar 14 ga Fabrairu 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniyar amfani da dabarun SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafin kowace microliter na shigar) ta amfani da sandar tsomawa a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Da fatan, wannan sabuwar fasaha za ta iya inganta ƙwarewa da sauƙi idan an tabbatar da ita a gwaji.
Saboda rashin gogewa da sabon CoV, likitoci sun fi bayar da kulawa mai kyau ga marasa lafiya COVID-19, yayin da suke gwada magungunan da aka riga aka yi amfani da su ko aka gabatar da su don maganin sauran CoVs, kamar SARS-CoV, MERS-CoV, da sauran cututtukan ƙwayoyin cuta (Table 2).2).
Wannan ya haɗa da maganin da ake da shi yanzu da kuma wanda za a iya yi da magungunan rigakafi, maganin hana rigakafi, steroids, plasma daga marasa lafiya da suka warke, maganin gargajiya na kasar Sin, da kuma tallafi na tunani.
Har ma an ba da shawarar yin amfani da jini daga cikin waɗanda suka warke don a yi amfani da shi a magani.
Kamfanonin ƙwayoyi sun yi tsere don su samar da rigakafi da allurar da za su iya yaƙi da cutar.
A farkon matakin, SARS-CoV-2 ya fi kai wa huhu kuma yana iya kai wa ga wasu gabobin da ke nuna ACE2 a ƙananan matakan, kamar tsarin gastrointestinal da koda.
Duk da haka, rashin aiki da kuma rashin iskar na numfashi sune manyan barazanar da ke fuskantar marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun bayyanar cututtuka da ceton rayuka, wanda ya haɗa da maganin oxygen na yau da kullun, babban iskar oxygen, ba da iska mai ƙarfi, da kuma iska mai ƙarfi, gwargwadon tsananin cutar.
Marasa lafiya da ke da alamun cututtukan numfashi mai tsanani ya kamata a tallafa musu da maganin oxygenation na membrane na extracorporeal (ECMO), wata hanyar da aka gyara na bugun zuciya da ake amfani da ita don magance rashin zuciya ko kuma rashin numfashi mai barazana.
Bugu da ƙari, kula da daidaiton electrolyte, rigakafin da kula da cututtukan na biyu da na shanyewar jiki, da kuma kare ayyukan ƙwayoyin jiki suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa yawan karfin garkuwar jiki ya haifar da hadarin cytokine a cikin marasa lafiya na SARS da MERS.
Guguwar cytokine wani nau'i ne na amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines, wanda ya haɗa da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna sa kwayoyin rigakafi su saki manyan adadin 'yanci na' yanci wanda shine babban dalilin ARDS da kuma gazawar kwayoyin halitta.
Rashin rigakafi yana da mahimmanci a cikin kula da hadari na cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da Tocilizumab, wani anti-IL6 monoclonal antibody, don magance hadari na cytokine.
Sauran hanyoyin magance immunosuppression na cytocine cyclone sun haɗa da gyaran ƙwayar T-cell da aka tsara na rigakafi; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; 4 siginar siginar; da kuma masu hana HDAC.
Ana amfani da magungunan steroid, masu hana garkuwar jiki, a maganin SARS don rage tsananin cutar.
Duk da haka, steroid a babban allurai ba zai iya taimakawa ga mummunar raunin huhu a cikin SARS da COVID-19 marasa lafiya.
Akasin haka, steroids na iya haifar da mummunan sakamako masu illa, musamman osteonecrosis, wanda ke shafar yanayin.
Duk da haka, an ba da shawarar bayar da gajeren lokaci na ƙananan kashi na corticosteroids a hankali ga marasa lafiya masu COVID-19 marasa lafiya.
A lokacin wannan bita, babu ingantaccen maganin rigakafin da aka tabbatar.
Duk da haka, an gano cewa yin amfani da intravenous remdesivir, wani kwayar halitta mai kama da nucleotide, yana da tasiri a cikin wani Ba'amurke da ke fama da cutar COVID-19.
Remdesivir wani sabon maganin rigakafi ne wanda Gilead ta samar, wanda aka fara amfani da shi don maganin cututtukan da suka shafi kwayar cutar Ebola da Marlburg.
Daga baya, remdesivir ya nuna hanawa ga wasu ƙwayoyin RNA guda ɗaya, ciki har da MERS da SARS.
A sakamakon haka, Gilead ya ba da wannan fili ga kasar Sin don gudanar da jerin gwaje-gwaje a kan mutanen da ke da SARS-CoV-2 da ke fama da cutar, kuma ana sa ran sakamakon zai yi kyau.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su a matsayin yiwuwar magani ga marasa lafiya da ke da alamun cututtukan numfashi.
Za a iya samun zawo, tashin zuciya, amai, lalacewar hanta, da sauran cututtukan bayan an yi amfani da maganin lopinavir/ ritonavir.
Dole ne a lura da hulɗar wannan maganin tare da sauran magungunan da mai haƙuri ke amfani da su.
An yi amfani da jini daga marasa lafiya da aka warkar da su don yin rigakafin cutar
Akwai tarihi mai tsawo na karɓan jinin waɗanda suka warke daga cuta don a yi wa wasu da suke da irin wannan cuta magani ko kuma a hana wasu samun cutar.
Hakika, mutanen da suka warke daga ciwon sukan sami ƙwayoyin rigakafi da yawa a cikin jininsu.
Antibodies sune immunoglobulins (Ig) da B-lymphocytes ke samarwa don yaƙi da pathogens da sauran abubuwan da baƙi, gano kwayoyin da ke da alaƙa da pathogens, da kuma hana su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wani rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 allurar.
Alamar ta inganta cikin sa'o'i 24, tare da rage kumburi da nauyin kwayar cuta da kuma kara yawan iskar oxygen a cikin jini.
Duk da haka, ana bukatar tabbatarwa da kuma bayani don gabatar da irin wannan hanyar don amfani da ita a manyan matakan kafin a samar da takamaiman magani.
Ƙari ga haka, ban da tasirin warkarwa, wasu rashin amfani da jini yake da shi ya kamata a yi la'akari da su sosai.
Alal misali, ƙwayoyin rigakafi suna iya sa mutum ya yi tsayayya da rigakafinsa kuma ya kamu da cuta mai saurin kai, wadda za ta iya zama barazana ga rayuwar mutum.
Yawan kwayoyin cutar a cikin jini yawanci ba shi da yawa kuma ana bukatar adadi mai yawa na kwayoyin cutar a cikin jini don kula da marasa lafiya masu tsanani.
Samun da kuma samar da takamaiman maganin rigakafi da sauri don yaƙi da cutar a duniya yana da wuya.
Saboda haka, yana da muhimmanci kuma yana da amfani a ware kwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayoyin halitta da ke nuna kwayar cutar ko kuma tace kwayar cutar da ke da muhimmanci ga kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da kwayoyin cutar da sauƙi.
An yi amfani da TCM wajen magance cututtuka dabam dabam a ƙasar Sin shekaru dubbai da suka shige.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban-daban a cikin dabara.
Yawancin abubuwan da ke da tasiri ba a san su ba ko kuma ba su da kyau saboda yana da wuya a cire ko tabbatar da su ko kuma mafi kyawun haɗuwa.
A halin yanzu, saboda babu ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya tare da alamu masu sauƙi zuwa matsakaici ko ga mutanen da ke murmurewa daga mummunan cuta.
Misali, Shu Feng Jie Du capsule da Lian Hua Qing Wen capsule sun sami tasiri don maganin COVID-19.
An sami mafi girman dawo da lafiya a cikin jinyar COVID-19 a cikin lardunan China da ke amfani da TCM a cikin 87% na marasa lafiya, wanda ya haɗa da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM kawai a cikin kusan 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin warkewa (13%).
Amma, wannan kwatanci yana da wuyan gaske domin akwai wasu abubuwa da yawa da za a yi la'akari da su, kamar su yawan marasa lafiya da kuma yadda suke da tsanani.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun wallafa wani bincike wanda ya kwatanta maganin WM kadai da maganin WM da TCM.
Sun gano cewa lokacin da ake bukata don farfadowa da zafin jiki, bayyanar cututtuka, da kuma asibiti ya fi guntu a cikin rukunin WM + TCM fiye da na WM kadai.
Abin da ya fi ban sha'awa, yawan bayyanar cututtuka (mai sauƙi zuwa mai tsanani) ya fi ƙasa ga ƙungiyar WM + TCM idan aka kwatanta da ƙungiyar WM kawai (7.4% vs. 46.2%) da ƙananan mutuwa a cikin ƙungiyar WM + TCM idan aka kwatanta da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, inganci da amincin TCM na jiran gwaji mafi kyau a kan mafi girma da kuma a cikin cibiyoyin bincike.
Wani abu mai ban sha'awa shine a nuna tsarin aiki da kuma bayyana abubuwan da ke da tasiri a cikin maganin TCM ko haɗuwa, idan ya yiwu.
Yawancin marasa lafiya da ake zargi ko aka tabbatar da su da COVID-19 suna jin tsoron wannan cuta mai saurin yaduwa da kuma kisa, kuma mutanen da ke cikin killace ma suna jin haushi, kadaici, da fushi.
Bugu da ƙari, cututtukan cututtukan cututtuka kamar zazzabi, hypoxia, da tari da kuma cututtukan cututtuka kamar rashin barci da corticosteroids ke haifar da zai iya haifar da damuwa da damuwa.
A farkon barkewar cutar SARS, an samu rahotanni na cututtukan kwakwalwa da suka hada da bakin ciki, damuwa, tashin hankali, rikicewar motsin jiki, bayyanar cututtuka na kwakwalwa, raunin hankali, har ma da rashin lafiya.
Binciken tuntuɓar da keɓaɓɓu da kuma keɓewa, a matsayin wani ɓangare na maganin lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su ƙara damuwa da jin laifi game da tasirin watsawa, keɓewa, da kuma zargi game da dangi da abokai.
Don haka, ya kamata a samar da kulawar lafiyar hankali ga masu cutar COVID-19, wadanda ake zargi da wadanda suka yi mu'amala da su, da kuma jama'a da ke cikin bukata.
Tallafin ilimin halin dan adam ya kamata ya hada da kafa ƙungiyar kiwon lafiyar kwakwalwa ta fannoni daban-daban, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma daidai game da barkewar SARS-CoV-2, da shirin jiyya da kuma amfani da na'urori da aikace-aikacen lantarki na ƙwararru don kauce wa kusanci da juna.
Ana bukatar allurar rigakafi mai inganci don yanke sarkar watsawa daga matattarar dabbobi da mutane masu kamuwa da cutar zuwa ga masu karamin karfi kuma sau da yawa yana da mahimmanci ga maganin rigakafi don sarrafa annobar da cutar ta haifar.
An yi ƙoƙari don haɓaka allurar rigakafi ta S, wanda ke da tasiri mai ɗorewa da kuma tasiri don samar da rigakafin rigakafin rigakafi da/ko rigakafin rigakafin SARS-CoV.
Don SARS, an gwada rigakafin da aka raunana a cikin dabbobi.
Koyaya, ingancin in vivo na wannan rigakafin rigakafi a cikin tsofaffi da samfuran ƙalubalen ƙwayoyin cuta da kariya daga kamuwa da kwayar cutar zoonotic ya kasance a ƙayyade kafin a fara nazarin asibiti.
Wannan na iya zama saboda SARS ya ragu shekaru 17 da suka wuce kuma babu wani sabon labarin da aka bayar tun daga lokacin.
Akasin haka, lokuta na yau da kullun da na MERS na ci gaba da faruwa a Gabas ta Tsakiya kuma ya bazu zuwa wasu yankuna saboda ci gaba da samun tushen zoonotic a yankunan da ke da rauni.
An tsara dabarun alurar riga-kafi don MERS ta amfani da ƙwayoyin cuta da aka kashe, DNA plasmid, ƙwayoyin cuta, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta, da kuma ƙwayoyin sunadarai masu haɗuwa kuma an kimanta wasu a cikin dabbobi.
Ci gaban allurar rigakafin SARS-CoV-2 mai aminci da tasiri ga mutanen da ba su da rigakafi aiki ne mai matukar gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, wannan matsala ba ta da sauƙi saboda tsayin lokacin haɓaka allurar rigakafi (na watanni 18 a matsakaita) da kuma bambancin CoV mai ƙarfi.
A matsayin sabuwar cuta, COVID-19 ya fara nuna cikakken hanyarsa ta asibiti ga dubban marasa lafiya.
A yawancin yanayi, marasa lafiya suna samun sauƙi ba tare da wani sakamako ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da babban yanayin rashin lafiya da mutuwa a cikin marasa lafiya masu rauni.
Saboda haka, ƙirar ƙirar cutar cutar tana da mahimmanci ga hukumomin kiwon lafiya don fifita ayyukanta, musamman a yankuna da ƙarancin albarkatu.
Dangane da binciken binciken asibiti da aka ruwaito ya zuwa yanzu, abubuwan da ke gaba na iya tasiri ko alaƙa da tsinkayen marasa lafiya na COVID-19 (Table 3):
Shekaru: Shekaru shine mafi mahimmancin mahimmanci don hangen nesa na SARS, wanda ya shafi COVID-19.
COVID-19 ya fi faruwa ne a tsakanin shekaru 30-65 tare da kashi 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken da ke dauke da lamura 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai zurfi suna da haɗarin haɗari da haɗari kuma sun fi tsufa fiye da marasa lafiya da ba sa buƙatar kulawa mai zurfi (tsakanin shekaru 66 da 51), wanda ya nuna cewa shekaru yana da mahimmanci a cikin sakamakon COVID-19.
Jinsinsu: SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka bayyana a sama.
Cutar da ke tattare da cutar da ke tattare da ita da kuma rikitarwa: Masu fama da cutar COVID-19 da ke buƙatar kulawa mai tsanani suna da damar samun rauni na zuciya da kuma rashin lafiya.
Cutar zuciya ta zama babbar hanyar mutuwa ga masu cutar SARS.
An kuma bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da colangiocytes tare da ACE2-mai kyau, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya na COVID-19.
Yana da kyau a lura cewa shekaru da kuma cututtuka da ke tattare da shi suna da alaƙa da juna kuma suna iya shafan juna.
Abubuwan da aka gano na yau da kullun: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin da aka samu kuma an ba da shawarar a matsayin mai yuwuwar hangen nesa don cutar, amsawa ga magani, da kuma dawo da ƙarshe.
Hakanan an ba da shawarar daidaituwa tsakanin matakan CRP da tsananin da tsinkayen COVID-19.
Bugu da ƙari, ƙaruwar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango ƙarshen sakamako.
Ana nuna waɗannan enzymes sosai a cikin gabobin jiki, musamman a cikin zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, wadannan enzymes sune alamun gargajiya na rashin aiki na zuciya da hanta.
Babban alamun asibiti: Hoton thoracic da ci gaban alamun asibiti na lokaci ya kamata a yi la'akari da su tare da sauran abubuwa don yin hasashen ƙarshen sakamako da rikice-rikice na COVID-19.
Amfani da steroid: Kamar yadda aka bayyana a sama, steroids sune immunosuppressants da aka fi amfani dasu a matsayin maganin tallafi don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Saboda yawan amfani da allurar rigakafi a cikin marasa lafiya da ke fama da cutar SARS, mutane da yawa da suka tsira daga cutar sun kamu da cutar ta osteonecrosis tare da nakasa na tsawon rayuwa da kuma rayuwa mai kyau.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroid a ƙananan kashi da kuma gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsayi na tunani: Kamar yadda aka bayyana a sama, yayin annobar COVID-19, yawancin marasa lafiya sun sha wahala daga matsanancin damuwa saboda tsananin rashin tabbas da kuma tsananin rashin tabbas da kuma ganin mutuwar dangi da abokan asibiti.
Dole ne a ba da shawara na tunani da kuma goyon baya na dogon lokaci don a taimaki wannan mai haƙuri ya warke daga damuwa kuma ya koma rayuwa ta al'ada.
Dangane da nazarin yanayin alƙaluma har zuwa yanzu, COVID-19 yana da bambancin yanayin cutar da SARS.
Baya ga yin kwayar cutar a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwayar cutar sosai a cikin hanyoyin numfashi na sama kuma yana haifar da alamu mai sauƙi ko mara alama a farkon farkon kamuwa da cuta, kamar yadda sauran CoVs ke haifar da sanyi.
Saboda haka, a farkon lokaci ko lokacin da ake yin maganin, marasa lafiya da suka kamu da cutar na iya samar da kwayar cutar da yawa a yayin ayyukan yau da kullun, wanda ke haifar da babban matsala wajen sarrafa annobar.
Koyaya, ana tsammanin SARS-CoV na iya yaduwa yayin da mai cutar ya kamu da cutar kuma galibi ba a farkon matakin ba.
Saboda haka, cutar COVID-19 ta yanzu ta fi tsanani da kuma wahalar sarrafawa fiye da cutar SARS.
A halin yanzu, ana gudanar da babban ƙoƙari a cikin China, wanda ya haɗa da keɓewa na yankin Wuhan da biranen da ke kewaye da shi da kuma keɓe kusan dukkanin jama'a a cikin fatan dakatar da watsa SARS-CoV-2.
Duk da cewa wannan mataki ya yi matukar illa ga tattalin arzikin kasar da kuma sauran bangarorin, yawan sabbin marasa lafiya ya ragu, wanda ke nuna cewa annobar ta ragu.
A mafi yawan kimantawa, cutar za ta ƙare a watan Maris kuma za ta yi ta raguwa na tsawon watanni uku zuwa huɗu.
Amma wasu masana ba su da wannan ra'ayin.
Paul Hunter et al. sun yi hasashen cewa COVID-19, wanda ya bayyana ya fi yaduwa fiye da SARS, ba zai ƙare ba a shekara ta 2020.
Ira Longini, et al. sun kirkiro wani samfurin don yin hasashen sakamakon cutar kuma sun bayyana cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Kungiyar masu bincike na Kanada sun ba da rahoton cewa an gano SARS-CoV-2 a cikin tsokar tsakiya da kuma makogwaro na marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata. Wannan ya nuna cewa kwayar cutar da aka gano za ta iya sake zama wani abu mai kama da na mura.
Ko da yake, akwai alamun da ke nuna cewa kasar Sin tana fuskantar koma bayanin sabbin kamuwa da cutar, wanda ke nuna cewa dabarun da ake bi a yanzu na iya yin tasiri.
An yi hasashen cewa cutar Ebola za ta haifar da mutane miliyan daya da rabi da za su mutu.
Duk da haka, da keɓewa da kuma warewa, an iya sarrafa cutar.
Hakanan, kamar SARS-CoV, SARS-CoV-2 na iya zama mai saurin kamuwa da cuta kuma a ƙarshe ya ɓace ko ya zama ƙwayoyin cuta marasa cutarwa waɗanda ke iya zama tare da mutane.
Kwatanta cutar COVID-19 da SARS da MERS an nuna a kasa (Fig. 5).
SARS-CoV-2 ana iya samunsa ta hanyar tari ko tari, kuma yana iya samunsa ta hanyar hulɗa kai tsaye da abubuwan da ke da cutar.
An kuma gano wannan kwayar cutar a cikin farji, wanda ya kawo sabuwar hanyar watsawa, wato farji-da-bakin ciki.
Wani bincike na baya-bayan nan kan mutane 138 ya ba da rahoton cewa kashi 41% na masu cutar na iya zama masu kamuwa da cutar, wanda ya haɗa da marasa lafiya 17 da suka kamu da wata cuta da kuma masu kula da lafiya 40.
Don haka, ya zama wajibi a dauki matakan kariya don kare mutane, musamman ma masu ba da kiwon lafiya, ma'aikatan jin kai, 'yan uwa, abokan aiki, har ma da mutanen da suka yi hulda da marasa lafiya ko kuma mutanen da suka kamu da cutar.
Layin farko na kariya da za a iya amfani da shi don rage haɗarin kamuwa da cuta shine ta hanyar amfani da abin rufe fuska, ko dai abin rufe fuska na N95 (series na 1860s) na taimakawa wajen hana yaduwar cutar.
Mashin rufe fuska yana hana kumfar da za ta iya kamuwa da cutar ta shiga iska ko kuma ta tsaya a kan wani abu, inda za a iya yada ta ga wasu.
Koyaya, abin rufe fuska na N95 (lambar lamba ta 1860s) ne kawai zai iya karewa daga inhalation na virions masu girman 10 zuwa 80 nm, tare da kashi 5% na virions na iya shiga cikin su; SARS-CoV-2 yayi kama da SARS-CoV dangane da girman, duka biyun suna da girman 85 nm.
Saboda ƙwayoyin za su iya shiga har ma da masks masu tiyata guda biyar da aka ɗora a ɗaya, masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa N95 (lambar lamba ta 1860s) maimakon masks na tiyata.
Baya ga abin rufe fuska, masu kula da lafiya dole ne su sa rigunan keɓewa masu dacewa don ƙara rage hulɗa da kwayar cutar.
Ƙwayoyin cuta kuma za su iya kama mutum ta idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta hanyar kumburin ido.
Saboda haka, masu kula da lafiya dole ne su sa abin rufe fuska ko tabarau yayin da suke aiki da marasa lafiya.
Ga jama'a a yankunan da aka shafa ko kuma za a iya shafawa, yana da kyau a shawarci kowa ya wanke hannunsa da sabulu mai kashe ƙwayoyin cuta sau da yawa, a yi ƙoƙarin zama a gida don keɓewa, kuma a guji hulɗa da mutanen da ke iya kamuwa da cutar.
An yi imani cewa yin nesa da juna na tsawon kafa uku zai taimaka wajen nisanta mutum daga mai cutar.
Waɗannan matakan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 sabon kwayar cutar ce ga ɗan adam, babban kamannin ta da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama babban abin tunawa ga China wanda ke da ƙwaƙƙwaran ƙwaƙwalwar ƙwaƙwalwar ƙwayar SARS a 2003.
Duk da haka, a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankulan jama'a ta hanyar cewa sabon kwayar cutar tana da ƙananan yaduwa da iyakancewar iyawar haifuwa daga mutum zuwa mutum kuma hanawa da kuma hana cutar ba matsala ba ce.
Wannan sakon ya kwantar da hankalin jama'a, musamman ma a lokacin da kasar ke shirin bikin bazara, wanda ya yi latti a wannan lokacin da ake buƙatar magance cutar a cikin Wuhan.
Hukumar kula da cututtuka a kasar Sin za ta iya koyan darasi daga wannan kuma ta yi gagarumin gyara a nan gaba.
Misali, ya kamata (1) ya zama mai hankali a yayin da yake sanar da jama'a saboda kowane kalma yana da tasiri a kan mutane kuma yana iya canza halayensu da yanke shawara; (2) ya zama mai hankali da kuma amsawa ga bayanan da ba na al'ada ba daga asibiti maimakon jiran rahoton likita ko jami'in da ke da izini; (3) ya zama mai ƙuntatawa don hana yiwuwar barkewar cutar a farkon matakan, maimakon ƙoƙarin kwantar da hankalin jama'a; kuma (4) ya fi yawan fitar da takamaiman horo da tasiri don haɓaka wayar da kan jama'a game da cututtukan cututtuka da kuma gwadawa da haɓaka tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 ta samo asali ne daga sabon kwayar cutar SARS-CoV-2 wanda ya fara yaduwa a ƙarshen Disamba 2019.
A cikin kasa da watanni 2, annobar ta bazu zuwa duk kasar Sin da kuma kasashe 50 a duniya a lokacin da aka rubuta wannan bita.
Tun da yake wannan kwayar cuta ta yi kama da SARS-CoV kuma alamomin COVID-19 da SARS suna kama, barkewar COVID-19 ta yi kama da barkewar SARS.
Duk da haka, akwai wasu bambance-bambance masu kyau tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don dakatar da annoba da kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa kuma ya fi shafar maza fiye da mata, kuma yawan mutuwar ya fi girma a cikin tsofaffi fiye da matasa.
Mutuwar SARS ya fi na COVID-19 (10.91% zuwa 1.44%).
Masu cutar COVID-19 suna yada kwayar cutar koda lokacin da ba su da alamun cutar, yayin da masu cutar SARS galibi suna yada kwayar cutar yayin da suke cikin mawuyacin hali. Wannan ya sa ya zama da wahala a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wasu daga cikin dalilan da ya sa SARS-CoV-2 ke yaduwa da sauri da kuma a wurare da yawa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don bincika SARS-CoV-2 na iya haifar da sakamako mara kyau a cikin wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya da suka warke na iya sake samun sakamako mai kyau a gwajin kwayar cutar.
Wannan ya kara hadarin yaduwar cutar.
Tare da saurin da bincike na COVID-19 ke ci gaba, akwai wasu mahimman batutuwa da za a warware, waɗanda sune:
Daga ina ne SARS-CoV-2 ya fito?
Duk da cewa an gano cewa akwai alamun kwayar halitta da ya kai kashi 96 cikin dari tsakanin SARS-CoV-2 da kwayar cutar SARS-like CoVs guda biyu na kwari, har yanzu ba a kammala cewa SARS-CoV-2 ya samo asali ne daga kwari ba.
Waɗanne dabbobi ne suka yi aiki a matsayin masu watsa kwayar cutar daga gida mai kama da ƙuda, kamar dai wani ɗan kwari, zuwa ga mutane?
Idan ba mu san amsoshi na 1 da 2 ba, ba za mu iya hana yaduwar cutar ba kuma za ta iya sake barkewa a kowane lokaci.
Ko da yake ƙirar kwayoyin da ƙididdigar ƙwayoyin halitta sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya daidai cutar ta shiga cikin ƙwayoyin jijiyoyin jiki kuma ta haifar da canje-canje na gaba?
Shin kwayar cutar ta kuma yi abota da kwayoyin da ke nuna ACE2 a wasu gabobin?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin, ba za mu iya sanin ainihin cutar da kuma yadda za mu magance ta ba.
Har yaushe ne wannan annoba za ta ci gaba?
Ta yaya kwayar cutar ke samun ci gaba a tsarin halittar jini yayin da take yaduwa tsakanin mutane?
Shin wannan cutar za ta zama ta duniya baki daya, ta ƙare kamar SARS, ko kuma za ta sake dawowa kamar yadda za a yi da cutar mura?
Amsoshin waɗannan tambayoyin da kuma wasu masu muhimmanci suna da muhimmanci sosai, amma zai ɗauki lokaci kafin a san su.
Duk da haka, ko ta yaya, ba mu da wani zabi sai dai mu kawo karshen wannan annoba da wuri-wuri don mu koma ga rayuwa ta yau da kullum.
Asalin zoonotic na kwayar cutar corona ta mutum
A cikin dubban shekaru, maye gurbi da kuma daidaitawa sun haifar da co-evolutions na coronaviruses (CoVs) da masu karɓar su, gami da mutane.
Kafin 2003, an san CoVs na mutum guda biyu (HCoVs) da ke haifar da cututtuka masu saukin kai, kamar sanyi.
Cutar cutar sankarar barnar numfashi mai tsanani (SARS) da cutar sankarar barnar numfashi ta Gabas ta Tsakiya (MERS) sun sake juyawa kuma sun nuna yadda cutar HCoVs ke iya zama mai cutarwa da barazanar rai.
Bayyanuwar SARS-CoV-2 a tsakiyar kasar Sin a ƙarshen 2019 ya sa CoV ta sake zama a cikin hasken rana kuma ta ba mu mamaki tare da yawan watsawa, amma tare da ƙananan pathogenicity fiye da ɗan'uwanta, SARS-CoV.
HCoVs na da ƙwayar halittar dabbobi, saboda haka fahimtar asalin halittar dabbobi na HCoVs zai taimaka mana.
Mafi yawan HCoVs sun samo asali ne daga kwari.
An kuma gano wasu HCoVs masu daukar nauyin matsakaici.
Gano dabbobi masu gida yana da tasiri kai tsaye a cikin rigakafin cutar ɗan adam.
Binciken hulɗar CoV-host a cikin dabbobi na iya ba da mahimman bayanai game da kwayar cutar CoV a cikin mutane.
A cikin wannan bita, mun gabatar da wani bayyani na halin yanzu na ilimin game da HCoV guda bakwai, tare da mai da hankali kan tarihin gano su da asalin zoonotic da watsawa tsakanin jinsuna.
Abu mai mahimmanci, mun kwatanta da kuma bambanta waɗannan HCoVs daga juyin halitta da kuma sake haɗawa da kwayoyin halitta.
Ana tattauna cutar ta COVID-19 a cikin wannan mahallin.
Bugu da kari, an kuma nuna bukatun samun nasarar sauya sheka da kuma tasirin juyin halitta na kwayar cutar kan tsananin cutar.
Cutar korona (CoV) ta fito ne daga dangin Coronaviridae, wanda ya kunshi wasu nau'ikan kwayar cutar RNA mai ɗauke da kwayar cutar, mai ɗauke da kwayar cutar, da kwayar cutar guda.
Wannan kwayar cutar tana da mafi girman kwayar halitta mai girman kilobase 26 zuwa 32 a cikin kwayar RNA da ake kira "CoV", saboda yanayin halittarta mai kama da kambi a ƙarƙashin na'urar daukar hoto ta lantarki.
Bisa ga tsarinsa, kwayar cutar tana da kwayar halittar da ba ta da kashi biyu, wanda ke da tsari iri ɗaya.
Kusan kashi biyu cikin uku na kwayoyin halitta sun ƙunshi manyan manyan sarkar buɗewa guda biyu (ORF1a da ORF1b) waɗanda suka haɗu.
Ana kara sarrafa polyprotein don samar da sunadarai 16 masu zaman kansu, wanda ake kira nsp1~16.
Sauran kwayoyin halitta sun ƙunshi tsarin buɗewa (ORF) don furotin na tsarin, wanda ya haɗa da spike (S), envelope (E), membrane (M), da nucleoprotein (N).
Wasu sunadarai masu mahimmanci na musamman ga wasu layin suna ƙunshe da wasu layin CoV.
Dangane da bambancin jerin sunayen sunadarai, an rarraba CoVs zuwa jinsuna huɗu (alfa-CoV, beta-CoV, gamma-CoV, da delta-CoV); daga cikin jinsunan huɗu, beta-CoVs suna da HCoV mafi yawa kuma an sake rarraba su zuwa layin jinsi huɗu (A, B, C, da D).
Bayanai na phylogenetic sun nuna cewa bats da rodents sune tushen yawancin kwayoyin alfa-CoV da beta-CoV, yayin da kaji shine babban wurin ajiye gamma-CoV da delta-CoV.
A cikin shekaru dubbai, CoVs sun ci gaba da ƙetare ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-ƙetare-
A halin yanzu, akwai sanannun mutum bakwai na CoVs (HCoVs).
Daga cikin waɗannan ƙwayoyin cuta guda bakwai, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoV guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63 galibi suna haifar da bayyanar cututtuka masu laushi, kamar sanyi da/ko zawo.
Akasin haka, SARS-CoV, MERS-CoV, da SARS-CoV-2 suna da halayyar cutar sosai, suna haifar da cututtukan ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa kuma suna da damar da za su iya haɓaka cikin cututtukan cututtukan numfashi na gaggawa (ARDS) da bayyanar a waje da ƙwayoyin huhu.
An ware nau'in HCoV-229E na farko, B814, daga cikin masu cutar mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an ƙara samun ilimi ta hanyar zurfin nazarin HCoV-229E da HCoV-OC43, waɗanda duka ke haifar da alamun bayyanar da kansu.
A zahiri, an yarda da ra'ayin cewa kamuwa da HCoVs ba shi da haɗari, har sai barkewar SARS.
Cutar SARS da ta auku a 2003 na ɗaya daga cikin cututtukan da suka fi muni a tarihin zamani, inda ta kamu mutane fiye da 8,000 kuma ta kashe kusan kashi 10 cikin ɗari.
Shekaru goma bayan haka, cutar MERS ta haifar da barkewar annoba a yankin Larabawa tare da yaduwa zuwa wasu sassan duniya.
Sabuwar HCoV 2019 (2019-nCoV), wanda daga baya aka kira SARS-CoV-2, shi ne mai haifar da cutar ta kwayar cutar 2019 (COVID-19), wanda ya kashe mutane fiye da 3,120 kuma ya kamu da mutane fiye da 91,000 har zuwa 3 ga Maris, 2020.
An yi gargadi kuma dole ne duniya ta shirya don cutar SARS-CoV-2 da ke tafe.
Dukkanin HCoV guda bakwai suna da asalin zoonotic daga bat, bera, ko dabbobi.
A cikin bats, CoVs suna da kyau kuma ba su da wata cuta, amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da ƙalubalen likita, kimiyya, zamantakewa, da ɗabi'a ga China da duniya baki ɗaya.
Binciken asalin zoonotic na HCoVs yana ba da tsarin don fahimtar tarihin halitta, motsawa, da kuma abubuwan da ke iyakance yiwuwar motsi tsakanin nau'in.
Wannan binciken na iya jagorantar ko sauƙaƙe binciken dabba don gano wurin ajiya, matsakaici, da kuma ƙara ƙarfin SARS-CoV-2, wanda ke da mahimman abubuwan da ke tattare da hana yaduwar cutar a nan gaba.
A cikin wannan bita, mun ba da cikakken bayani game da asalin zoonotic, watsawar nau'in, da kuma pathogenesis na HCoVs.
Mun fi maida hankali musamman kan batun da ke kan gaba cewa kwayar cutar HCoV ba ta haifar da cutar a cikin yanayin ta na halitta, amma tana haifar da cutar bayan an watsa ta tsakanin jinsin zuwa wani sabon mai karɓa.
Mun kuma tattauna yanayin HCoV na juyin halitta cewa yawanci ana samun karuwar iyawar watsawa tare da raguwar cutar.
An kuma tattauna ƙarshen cutar SARS-CoV-2 a cikin wannan mahallin.
An san dabbobin CoV tun daga ƙarshen 1930s.
Kafin ware HCoV-229E nau'in B814 na farko daga hanjin marasa lafiya da ke fama da mura, an ware CoV daban-daban daga dabbobi da yawa da ke fama da cutar, wanda ya haɗa da turkey, beraye, shanu, aladu, kuliyoyi, da karnuka.
A cikin 'yan shekarun da suka gabata, an gano HCoV bakwai.
Takaitaccen tarihin gano HCoVs a cikin jerin abubuwan da suka faru (Jerin 1) ya zama abin da ke ba da bayani.
An fara keɓe HCoV-229E daga hanyoyin numfashi na marasa lafiya da ke fama da cutar numfashi a cikin 1966, wanda daga baya aka daidaita shi don haɓaka a cikin layin WI-38 na huhu.
Marasa lafiya da ke kamuwa da HCoV-229E suna nuna alamun mura, wanda ya haɗa da ciwon kai, saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin sa.
Daga baya a 1967, an ware HCoV-OC43 daga kwayar halitta da kuma hanyar da aka tsara a cikin kwakwalwar jariri mai shayarwa.
Hoton asibiti na kamuwa da HCoV-OC43 ya yi kama da kamuwa da cutar da HCoV-229E ya haifar, wanda ba a iya rarrabe shi da sauran cututtukan cututtukan cututtukan numfashi kamar su influenza A da rhinoviruses.
HCoV-229E da HCoV-OC43 sun bazu a duniya kuma ana iya watsa su sosai a lokacin hunturu a yankuna masu matsakaiciyar yanayi.
Yawanci, lokacin da ake kamuwa da waɗannan ƙwayoyin cuta guda biyu ba ya wuce mako guda ba kuma ana bin su da lokacin rashin lafiya na kusan makonni biyu.
Dangane da binciken kan masu sa kai, lafiyayyun mutane da ke da cutar HCoV-229E sun kamu da mura.
Wasu marasa lafiya da ke da tsarin garkuwar jiki da ya raunana ne kawai suka nuna cewa suna da wata cuta mai tsanani a cikin ƙananan hanyoyin numfashi.
SARS, wanda aka fi sani da " pneumonia atypical ", shi ne cutar HCoV na farko da aka rubuta sosai a tarihin ɗan adam kuma mai cutar SARS-CoV, wanda shine HCoV na uku da aka gano.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na ƙasar Sin.
Cutar SARS ta haifar da kamuwa da cutar 8.096 tare da mutuwar 774, wanda ya bazu a cikin ƙasashe da nahiyoyi da yawa.
Ban da super-contagion, kowane hali ana tsammanin zai iya haifar da kusan shari'o'i biyu, tare da lokacin kwanciyar hankali na kwanaki 4 zuwa 7 kuma ana ganin ƙwanƙolin kwayar cutar a ranar 10 na cutar.
Marasa lafiya da ke fama da SARS-CoV sun fara fama da ciwon kai, ciwon kai, zazzabi, zazzabi, da jin tsoro, wanda ke biyo bayan rashin ƙarfi, tari, da rashin numfashi a matsayin ci gaba.
Lymphopenia, gwajin aikin hanta na yau da kullun, da haɓaka haɓaka na kinase na halitta sune abubuwan da ke faruwa a cikin SARS.
Rashin yaduwar alveolar, yaduwar kwayar epithelial, da kuma karuwar macrophages an kuma lura da su a cikin marasa lafiya na SARS.
Daga baya, kusan kashi 20 zuwa 30 cikin 100 na marasa lafiya za su bukaci kula da su sosai da kuma samun iska mai kyau.
Baya ga ƙananan hanyoyin numfashi, wasu gabobin da suka haɗa da gastrointestinal, hanta, da ƙwayoyin cuta na iya kamuwa da cuta a cikin lokuta masu tsanani, yawanci tare da hadari na cytokine, wanda zai iya zama mai mutuwa, musamman a cikin marasa lafiya marasa lafiya.
An fara ware kwayar cutar ne daga wani dangi da aka yi wa gwajin huhu wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an sadaukar da ƙoƙari sosai don binciken HCoVs.
An ware HCoV-NL63 daga wani jariri dan wata 7 daga Netherlands a ƙarshen 2004.
Wannan kwayar cutar ta fara yaduwa ne a tsakanin yara, tsofaffi, da kuma marasa lafiya masu rauni da ke fama da cututtukan numfashi.
Bayanan hoto: Coryza, conjunctivitis, mura, da kuma bronchiolitis suna da yawa a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike kuma mai zaman kansa ya bayyana keɓewar irin wannan kwayar cutar daga samfurin hanci na wani ɗan shekara 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma ya yaɗu a duniya.
An kiyasta cewa HCoV-NL63 yana wakiltar kusan kashi 4.7% na cututtukan cututtukan numfashi na yau da kullun kuma yawanci yakan faru ne a farkon lokacin bazara, bazara, da kuma hunturu.
HCoV-NL63 yana da alaƙa da cututtukan ƙwayar ƙwayar ƙwayar cuta, wanda ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti saboda ciwon huhu da kuma bronchiolitis a Hong Kong.
Baya ga cututtukan huhu da kuma cututtukan huhu, an ce HCoV-HKU1 yana da alaƙa da saurin cutar asma.
Hakazalika da HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 ana samun su a duk duniya, suna haifar da cutar numfashi mai sauƙi.
Duk da cewa waɗannan HCoVs huɗu na al'umma sun daidaita ga mutane kuma gabaɗaya suna da ƙarancin yiwuwar canzawa zuwa cutar mai saurin kamuwa da cuta. Duk da haka, lokuta na musamman sun faru ne saboda dalilai da ba a sani ba, kamar yadda lamarin ya faru da wani nau'in HCoV-NL63 wanda ya fi saurin cutar da aka ruwaito kwanan nan yana haifar da cututtukan ƙananan hanyoyin numfashi a cikin China.
A cikin al'amuran da suka shafi mutane, yawanci, yayin da suka sami damar yin amfani da shi a cikin mutane, cutar da cutar HCoV ta ragu.
An fara gano MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da cutar huhu mai tsanani da kuma rashin lafiya a Saudi Arabia.
Kodayake yawancin lokuta da aka tabbatar da su daga cikin yankin Gabas ta Tsakiya, an ba da rahoton wasu lokuta da ake shigo da su daga wasu ƙasashen Turai da Tunisia.
Wani sabon barkewar cutar a Koriya ta Kudu a 2015 tare da tabbatar da mutane 186 da suka kamu da cutar.
Bayyanar asibiti na MERS yayi kama da bayyanar asibiti na SARS, wanda aka bayyana da ci gaba mai ci gaba na cutar huhu.
Ba kamar SARS ba, yawancin masu cutar MERS suna fama da rashin ƙwayoyin koda, wanda a yanzu haka MERS ne kawai ke fama da cutar ta HCoV.
Fiye da kashi 30 cikin 100 na marasa lafiya suna da alamun cututtukan gastrointestinal, kamar zawo da amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, an ba da rahoton fiye da 2500 da aka tabbatar da lab tare da babban mutuwar cutar, wanda ya kai 34.4%, yana mai da MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi ban tsoro da aka sani ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano clusters na marasa lafiya na huhu waɗanda aka danganta su da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa barkewar cutar ta SARS-CoV-2 a cikin ƙananan hanyoyin numfashi a matsayin Babban Matsalar Kiwon Lafiya na Duniya kuma ta sanya wa cutar suna COVID-19.
Ya zuwa 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duniya, tare da mutuwar cutar ta hanyar cutar da kashi 3.4%.
A takaice, mutuwar cutar a Hubei, China, ya kai kashi 4.2%, yayin da mutuwar cutar a wajen Hubei ya kai kashi 1.2%.
SARS-CoV-2 na haifar da cututtukan cututtukan numfashi kamar SARS-CoV da MERS-CoV tare da bayyanar zazzabi, tari, da rashin iskar numfashi.
An kuma samu cutar gudawa a wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin cututtuka mafi tsanani kuma yana iya saurin zama cututtukan cututtukan numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda babban nau'in tsarin nucleotide, wanda ya kai kashi 82%, dukansu suna cikin rassan bishiyar phylogenetic daban-daban.
SARS-CoV-2 ba shi da wata illa, amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An ba da rahoton mutane da suka kamu da SARS-CoV-2 ba tare da bayyanar cututtuka ba kuma suna iya taka rawa a cikin saurin yaduwar SARS-CoV-2 a duniya.
Kwatanta da bambancin SARS-CoV-2 da sauran HCoVs guda shida sun nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Da farko, lokacin kwanciya da tsawon lokacin cutar HCoVs suna da kama sosai.
A wannan batun, SARS-CoV-2 ya bi al'ada na sauran HCoVs shida.
Na biyu, tsananin COVID-19 ya kasance tsakanin SARS-CoV da sauran HCoVs hudu na al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna hoton da aka fi gani a cikin kamuwa da HCoV na al'umma, wanda ya haɗa da hoton alamun rashin bayyanar cututtuka masu sauƙi ko ma marasa bayyanar cututtuka.
A gefe guda, ƙananan ƙananan lokuta na COVID-19 na iya kama da kamuwa da cutar SARS-CoV ko da yake a ƙananan ƙananan.
Na uku, yaduwar SARS-CoV-2 kuma tana nuna halaye masu ban sha'awa, suna da kamanceceniya da HCoVs na al'umma da SARS-CoV.
A gefe guda, SARS-CoV-2 yana da ƙwarewar watsawa kamar yadda HCoVs na al'umma suke.
A gefe guda, rashin yiwuwar watsa SARS-CoV-2 bayan wasu hanyoyin da mutane ke bi har yanzu ba a tabbatar da su ba, kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 daga samfurin ƙwayoyin cuta.
"Ko watsawar SARS-CoV-2 ta hanjin-bakin-baki na da muhimmiyar rawa, kamar yadda yake a yayin watsa SARS-CoV, aƙalla a wasu yanayi, ya rage binciken da ya biyo baya ya fayyace".
Hakanan yana da mahimmanci a san ko SARS-CoV-2 na yanayi ne kamar na HCoV na al'umma.
Koyaya, hoton SARS-CoV-2, wanda ya haɗa da iya watsawa, cututtukan cututtuka, da ci gaba da yaduwa ta hanyoyi da yawa a cikin mutane, zai yi tasiri sosai ga ƙarshen ƙarshen annobar COVID-19 da ke gudana.
HCoVs hudu na al'umma da ke haifar da alamu masu laushi duk sun dace da mutane.
A wani bangaren kuma, ana iya cewa mutane sun saba da wadannan HCoVs guda hudu.
A wasu kalmomin, HCoV da mutane na iya zama nau'in da suka tsira daga cutar HCoV na zamanin da.
HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutanen da ke fama da cutar HCoVs masu tsanani an kawar da su.
Don haka, HCoVs dole ne su yi kwafi a cikin mutane da yawa don ba da damar haɗuwa da maye gurbi don yaƙi da abubuwan da ke iyakance mai karɓar bakuncin.
Saboda haka, tsawon lokacin da SARS-CoV-2 ya kasance kuma yawancin mutanen da suka kamu da cutar, hakanan akwai yiwuwar cutar ta zama cikakkiyar cuta ga mutane.
Idan kwayar cutar ta daidaita, zai yi wuya a dakatar da yaduwar cutar a cikin mutane ta hanyar keɓewa ko kuma wasu matakan hana kamuwa da cuta.
A cikin shekaru, akwai CoVs guda huɗu da ke yawo a cikin yawan mutane kuma suna haifar da mura a cikin mutane masu ƙoshin lafiya.
Ba ya bukatar wani wurin da dabbobi suke.
Akasin haka, SARS-CoV da MERS-CoV masu saurin kamuwa da cuta ba su saba da mutane ba kuma ba za a iya hana su ba.
Dukansu dole ne su kiyaye kansu kuma suyi haifuwa a cikin wuraren ajiyar zoonotic kuma su nemi damar da za su yada zuwa ga maƙasudin ɗan adam mai saurin kamuwa, mai yiwuwa ta hanyar ɗaya ko fiye da matsakaici da haɓakawa.
SARS-CoV-2 yana da kamannin kamannin SARS-CoV/MERS-CoV da HCoVs guda huɗu na al'umma.
SARS-CoV-2 yana da saurin watsawa kamar HCoV na al'umma, aƙalla a halin yanzu.
Koyaya, SARS-CoV-2 ya fi cutar cutar fiye da HCoVs na al'umma kuma ba shi da cutar SARS-CoV ko MERS-CoV.
Har yanzu ana jira a ga ko SARS-CoV-2 zai iya zama cikakke ga mutane kuma ya zagaya cikin mutane ba tare da wani matattarar dabba ko matsakaici ba.
Kafin tattauna asalin dabba na HCoV, muna buƙatar tattauna ma'anar da halayen mahaɗan juyin halitta, na halitta, na ajiya, na tsaka-tsaki, da na haɓaka HCoV.
Dabbobi suna aiki a matsayin HCoV mai karɓar juyin halitta idan suna da dangin dangi kuma suna da babban haɗin kai a cikin jerin abubuwan da ke tattare da nucleotides.
Kwayar cutar ta kakanninmu tana da kyau kuma ba ta da wata cuta a cikin wannan gidan.
Hakanan, masu ɗaukar bakuna suna ɗaukar HCoVs a ci gaba kuma na dogon lokaci.
A cikin waɗannan lokuta guda biyu, an kamu da shi ta hanyar halitta kuma shine mai karɓar HCoV ko kuma uwar garke.
A wani bangaren kuma, idan sabon HCoV ya shiga cikin wani mai masaukin baki kafin ko kuma a lokacin da kwayar cutar ta shiga cikin mutane, kwayar cutar ba ta saba da sabon mai karɓa ba kuma sau da yawa tana da cutarwa.
Wannan matsakaiciyar uwargijiyar na iya zama tushen tushen zoonotic na kamuwa da cutar mutum kuma tana aiki a matsayin mai karfafawa ta hanyar ba da damar kwayar cutar ta ɗan lokaci, sannan ta watsa ta zuwa ga mutane don haɓaka sikelin kamuwa da cutar mutum.
HCoVs na iya samun kamuwa da cuta ta hanyar mutuƙar cuta idan ba za su iya ci gaba da watsawa a cikin mai watsawa ba.
A gefe guda, HCoVs kuma suna iya dacewa da matsakaiciyar mai karɓar bakuncin har ma da haifar da dogon lokaci.
A wannan yanayin, mahaɗan da ke tsakanin mahaɗan ya zama mahaɗan da ke cikin maɓuɓɓugar halitta.
Bayanin cututtukan da aka samu ya nuna cewa babu wanda ya kamu da SARS da ya taɓa cin zarafin dabbobi.
Binciken da aka yi a kan masu sayar da dabbobi ya nuna cewa masu sayar da dabbobi suna da yawan IgG anti-SARS-CoV fiye da sauran mutane.
An gano farkon da aka gano a cikin kasuwar dabbobi masu cin ganyayyaki da ke dauke da kwayar cutar SARS-CoV da ke da alaƙa da SARS-CoV.
A takaice dai, wannan yana da alaƙa da cewa babu wani rahoton SARS da aka ruwaito tun lokacin da aka kashe duk wani katantanwa a kasuwar.
Koyaya, an ba da rahoton cewa ɓarkewar ɓarkewar wata daga cikin daji ko gonaki waɗanda ba a fallasa su ga kasuwannin dabbobi masu rai sun ba da mummunan sakamako ga SARS-CoV. Wannan yana nuna cewa ɓarkewar wataƙila tana aiki ne kawai a matsayin mai watsa shiri na matsakaici, amma ba a matsayin mai ɗaukar SARS-CoV ba.
Ya kamata a lura, saboda kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da rigakafin anti-SARS-CoV, ba za a iya yin watsi da yiwuwar cewa yawancin ƙananan nau'in dabbobi masu shayarwa suma suna aiki a matsayin matsakaiciyar matsakaiciyar matsakaiciyar SARS-CoV ba.
Duk waɗannan suna kama da SARS-CoV.
Binciken dabbobin da ke neman SARS-CoVs ya gano CoVs na bat da ke da alaƙa da juna, wanda ake kira CoVs na Rhinolopus-SARS HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin batunan da ke cikin kasar Sin.
Wannan kunkuru ya ba da sakamako mai kyau ga anti-SARS-CoV antibodies da kuma SARSr-Rh-BatCoV HKU3 genome sequence.
Wannan da sauran CoVs na bat suna da daidaitattun daidaitattun daidaitattun daidaitattun daidaito na 88-92% tare da SARS-CoV.
Wannan binciken ya zama tushen sabon ra'ayi cewa bats ne masu karɓar bakuncin sabon kwayar cutar mutum.
An kuma gano wasu CoVs masu kama da SARS (SL-CoV) daga kwari, amma guda ɗaya kawai, wanda aka kira WIV1, za a iya ware shi azaman kwayar cuta mai rai.
An san cewa angiotensin-converting enzyme 2 (ACE2) mai karɓar SARS-CoV ne.
WIV1 da aka samo daga samfurin ɓarnar ɓawon ɓoye an nuna yana amfani da ACE2 na ɓarnar, magungunan, da mutane a matsayin masu karɓa don shiga cikin sel.
Abin sha'awa, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta.
Ya zuwa yanzu, WIV1 ya wakilci mafi kusantar kusanci ga SARS-CoV a cikin beyar, tare da daidaiton kashi 95% na jerin kwayoyin halitta.
Duk da yawan jituwa tsakanin waɗannan ƙwayoyin cuta biyu, galibi ana yarda cewa WIV1 ba ita ce ainihin ƙwayar cuta ta SARS-CoV ba kuma ƙwararrun ba su ne ainihin masu karɓar SARS-CoV ba.
Binciken phylogenetic ya sanya MERS-CoV a cikin rukuni ɗaya tare da bat CoV-HKU4 da bat CoV-HKU5.
CoV-HKU4 na Bat da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓa, dipeptidyl peptidase 4 (DPP4), a matsayin hanyar shiga na kwayar.
Jerin RNA na polymerase-dependent RNA na MERS-CoV ya fi kusa da filogenetically ga takwarorinsa a cikin bat-CoV beta da aka gano daga Turai da Afirka.
A halin yanzu, ba a gano MERS-CoVs masu rai a cikin dabbobin daji ba.
MERS-CoV da danginsa na kusa CoV-HKU25 bat suna da kashi 87% na jerin kwayoyin nucleotide.
Saboda haka, balaguron daji bazai iya zama mai karɓar bakararar MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Arabiya sun yi amfani da kwayoyin cutar da ke kawar da MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suka yi amfani da su a wasu ƙasashen Afirka.
An gano MERS-CoV mai rai wanda ya yi kama da kwayar cutar da aka samu a cikin mutane daga cikin hanjin raƙumi na Arabiya. Wannan ya kara nuna cewa raƙumi shine ainihin mai karɓar bakuncin MERS-CoV.
Hakanan yana da mahimmanci a lura cewa an lura da mummunan lalacewar kwayar cutar tare da alamun bayyanar cututtuka a cikin raƙuman gwaji da ke kamuwa da MERS-CoV.
Ya kamata a lura cewa raƙumi mai kamuwa da cutar yana watsa kwayar cutar ba kawai ta hanyar numfashi ba, har ma ta hanyar hanyar sharar-bakin ciki, wanda shine babbar hanyar watsa kwayar cutar daga bat.
Koyaya, har yanzu akwai tambayoyi da ba a amsa ba saboda yawancin lokuta da aka tabbatar da MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, mai yiwuwa saboda watsawar mutum-zuwa-mutum ko hanyar watsawa da ba a sani ba wanda ya shafi jinsin dabba da ba a sani ba wanda ke ɗauke da MERS-CoV.
SARS-CoV-2 ya raba kashi 96.2% na homology na nucleotide tare da bat RaTG13 CoV da aka ware daga Rhinolophus affinis bat.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 sun yi yawa don kafa dangantaka ta iyaye.
A wasu kalmomin, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararruwar ƙwar ƙwararrun ƙwararruwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararruwar ƙwarru.
Wataƙila, mahaɗan mahaɗan na SARS-CoV-2 yana cikin nau'in namun daji da aka siyar kuma aka kashe a Kasuwar Kayan Kasuwancin Kifi ta Huanan. Yawancin shari'o'in farko na COVID-19 suna da alaƙa da wannan kasuwar, wanda ke nuna yiwuwar watsawar dabbobi zuwa mutum.
Wasu binciken da aka yi kwanan nan dangane da jerin metagenomic sun nuna cewa wata ƙungiyar ƙananan ƙananan dabbobi masu fama da haɗari, da aka sani da ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarƙwarar ƙwarƙwarƙwarar ƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwar
Sabon kwayar kwayar cutar coronavirus ta raba kashi 85-92% na daidaiton jerin nucleotides tare da SARS-CoV-2.
Koyaya, CoVs suna da alaƙa da RaTG13 tare da kusan 90% na daidaituwa a cikin matakan jerin nucleotide.
An rarraba su zuwa rukuni biyu na SARS-CoV-2-kamar ƙwayoyin cuta a cikin bishiyar phylogenetic, ɗayan kuma yana da alaƙa da yankin mai karɓar karɓa (RBD) wanda ya fi kama da SARS-CoV-2, tare da daidaiton jerin amino acid na 97.4%.
Abin sha'awa, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai, kodayake matakin daidaito na jerin kwayoyin halitta ya fi girma.
Binciken da aka yi a baya a kan ƙwayoyin ƙwayoyin cuta ya kuma ba da rahoton gano ƙwayar cuta daga ƙwayar huhu, wanda ya zama mai alaƙa da SARS-CoV-2.
Binciken ya yi amfani da hanyoyi daban-daban na tsarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halittar da ke kunshe da kimanin kashi 86.3% na cikakkiyar kwayar cutar.
Ba za mu iya ware yiwuwar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙ
Koyaya, a halin yanzu babu wata hujja da ke tallafawa SARS-CoV-2 ya samo asali kai tsaye daga tengu saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs dangin SARS-CoV-2 na tengu.
Bugu da kari, nisan tsakanin SARS-CoV-2 da RaTG13 ya fi kusa da nisan tsakanin SARS-CoV-2 da beta-CoVs dangi SARS-CoV-2.
Ba a tantance hanyar juyin halittar SARS-CoV-2 a cikin barkonan ba, kwari, da sauran dabbobi masu shayarwa ba.
Kodayake an sami mafi girman daidaituwa a cikin RBD tsakanin SARS-CoV-2 da beta-CoV dangin SARS-CoV-2 cowl, SARS-CoV-2 da RaTG13 suna da mafi girman daidaituwa a cikin matakan tsari na gaba ɗaya.
Ba za a iya yin hasashe ba idan aka ce babban matakin kama tsakanin beta-CoV RBD-SARS-CoV-2 da SARS-CoV-2 ya haifar da juyin halitta ne wanda aka zaɓa.
Ka'idar da ke nuna cewa akwai yiwuwar sake haɗuwa tsakanin beta-CoVs dangin SARS-CoV-2 da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin mai motsa juyin halitta, sake haɗuwa yana da yawa tsakanin beta-CoVs.
Masu bincike har yanzu ba su yanke shawara game da asalin zoonotic na SARS-CoV-2 ba.
Baya ga HCoV mai saurin kamuwa da cuta, an kuma bincika asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka gano ƙwayoyin HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ba da rahoton cewa CoV bat mai suna ARCoV.2 (Appalachian Ridge CoV) wanda aka gano a cikin bat uku na Arewacin Amurka ya nuna kusanci da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa ta hanyar ƙwayar cuta tare da wani CoV na bat, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, tare da Camelidae wanda ake zargi da zama mai watsa shiri.
Don ƙarin haske, ilimin yanzu game da asalin dabbobi na HCoV da aka sani an taƙaita shi a Hoto 1 da Table 2.
Binciken phylogenetic ya ba da shaidar abubuwan da suka faru na watsawa tsakanin HCoVs a tarihi.
A cikin shekarun 1890, lokacin da HCoV-OC43 ya shiga cikin dabbobi don ya kamuwa da mutane, an sami annobar cutar ta numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna ba shi da haske sosai.
An gano wani kwayar cutar bat-alpha-CoV mai alaƙa da HCoV-229E.
A tsakanin su, akwai alpha-CoV na alpaka.
Wasu shaidu sun goyi bayan cewa kwayar cutar ta yadu daga barkonon zuwa ga mutum.
Na farko, mutane, ba alpaca ba, za su iya yin hulɗa da bat a cikin yanayin da suke da shi.
Akasin haka, mutane suna hulɗa da al'arpan.
Na biyu, alpha-CoV na bat da ke da dangantaka da HCoV-229E ya bambanta kuma ba shi da cutar a cikin bats, yayin da alpha-CoV alpaka ke haifar da barkewar cututtukan numfashi a cikin dabbobin da ke da cutar.
A ƙarshe, ba a gano alpha-CoVs na alpaca a cikin dabbobin daji ba.
Saboda haka, ba za a iya watsi da yiwuwar alpacas sun sami alpha-CoVs dangi-HCoV-229E daga mutane ba.
A gaskiya, ƙudaje ne tushen ƙwayoyin cuta da ke sa mutane rashin lafiya, kamar su ƙwayoyin rabies, Ebola, Nipah, da Hendra.
Saboda haka, ba abin mamaki ba ne cewa kwari na iya watsa HCoV-229E kai tsaye zuwa ga mutane.
A wani yanayi kuma, yayin da alpha-CoV na bat ya zama matattarar kwayar halittar HCoV-229E, alpacas da raƙuman Arabian na iya zama matsakaitan masu watsa kwayar cutar ga mutane, kamar yadda MERS-CoV ya kasance.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga kwari zuwa raƙumi da raƙumi zuwa mutum.
An gano asalin MERS-CoV na bat a farkon ganowar cutar kuma an sake tabbatar da hakan tare da binciken da aka yi.
A bayyane yake cewa, kwari suna da wadataccen kwayar cutar da ke da amfani wajen musayar sassan kwayar halitta tsakanin jinsin da kuma watsawa tsakanin jinsin.
Tsawon rayuwa, da ƙawancen da ke tsakanin ƙwararrun ƙwayoyin halittun, da kuma ƙarfin tashi, duk suna sa ƙwararrun ƙwararrun ƙwayoyin halittun su zama ƙwararrun masu watsa ƙwayoyin cuta.
A wani bangaren kuma, MERS-CoV ya shiga raƙuman Arabiya shekaru da yawa.
Wannan kwayar cutar ta saba da raƙumi wanda ya canza daga matsakaiciyar mai watsawa zuwa mai watsawa mai zaman kanta.
MERS-CoV yana haifar da cutar da ta fi sauƙi kuma yana riƙe da ƙananan ƙananan ƙwayoyin cuta a cikin waɗannan dabbobi.
Halin watsawa na wucin gadi zuwa ga mutane ya faru ne ta hanyar kwatsam kuma mutane sun kasance masu karɓar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsawa ba.
Ba kamar rawar raƙumi a cikin watsa MERS-CoV ba, rawar da ake yi na crayfish, idan akwai, a cikin watsa SARS-CoV-2 ya bambanta.
Mafi mahimmanci, beta-CoVs na ƙwararrun ƙwararrun ƙwararrun ƙwayoyin cuta ne.
Tsuntsu na iya zama mai karɓar bakuncin beta-CoVs na SARS-CoV-2 dangi, kama da weasels a cikin SARS-CoV.
A cikin binciken da ke zuwa, za a yi la'akari da yiwuwar watsa SARS-CoV-2 tsakanin dabbobi zuwa mutane.
Na farko, bat zai iya zama mai karɓar bakuncin ga SARS-CoV-2 wanda ya kusan kama da SARS-CoV-2.
Mutane na iya raba gurbi na muhalli da bat ta hanyar kisan kai ko kuma hakar ma'adanai.
Na biyu, ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon.
Mutane suna samun kwayar cutar ta hanyar kashewa da kuma cin naman da aka farauta.
Wataƙila, yawancin dabbobi masu shayarwa, waɗanda suka haɗa da dabbobin gida, suna da saukin kamuwa da SARS-CoV-2.
Ana bukatar a yi binciken kwayoyin cutar a kan dabbobi da kuma na cikin gida.
Na uku, kamar yadda aka ambata a sama, ana iya samun haɗuwa da daidaitawa na SARS-CoV-2 a cikin nau'ikan nau'ikan nau'ikan da ke hulɗa da duka bat da perch.
Binciken asalin asalin SARS-CoV-2 na dabbobi na ci gaba.
Baya ga nau'ikan nau'ikan dabbobi masu yawa, manyan abubuwa guda uku na ɓangaren kwayar cutar suna da mahimmanci don sauƙaƙa CoVs don ƙetare shingen jinsin.
Na farko, yawan saurin da yake samu a cikin kwayar halitta na RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙimar jujjuyawar CoV za a iya ɗauka  matsakaici zuwa  high tare da matsakaicin canjin canji na ~10-4 a kowace shekara a kowane lokaci, dangane da lokacin daidaitawa na CoV zuwa sabon mai watsa shiri.
CoVs suna da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwayar ƙwaƙwalwar ƙwayar ƙwaƙwalwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Abin sha'awa, an san cewa Remdesivir nucleotide analog yana hana kwayar cutar CoV ta hanyar hana wannan exoribonuclease da RNA-dependent polymerase.
Remdesivir yana daya daga cikin magungunan anti-SARS-CoV-2 da aka fi sa ran za a gwada a gwajin asibiti.
Koyaya, yawan kwayar cutar CoV ta mutan ta fi na mai karɓar ta sau miliyan.
Bugu da ƙari, yawanci ana samun saurin maye gurbin a lokacin da kwayar cutar ba ta saba da mai karɓar ba.
Idan aka kwatanta da SARS-CoV tare da saurin maye gurbi, saurin maye gurbin SARS-CoV-2 a zahiri ya yi ƙasa, yana nuna mafi girman daidaituwa ga mutane.
Aƙalla, SARS-CoV-2 ya dace da sauran masu watsawa waɗanda ke da alaƙa da mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV wanda ya dace da raƙuman Arabiya.
A ka'ida, akwai yiwuwar cewa kwayar halitta mai saurin lalacewa za ta sa allurar rigakafi da kuma maganin rigakafi don SARS-CoV-2 ba su da tasiri.
Na biyu, babban kwayar halittar RNA a cikin CoVs yana ba da ƙarin sassauci a cikin gyaran kwayar halitta, don maye gurbi da sake haɗuwa, don haka yana ƙara yuwuwar haɗin kai tsakanin nau'ikan, wanda ke da kyau ga bayyanar sabon CoVs lokacin da yanayi ya dace.
Wannan yana da goyan bayan yawancin tsarin buɗewa na musamman da aikin furotin da aka tsara zuwa ƙarshen 3 'na kwayoyin halitta.
Na uku, CoVs suna canzawa a cikin tsari yayin da suke yin kwafin RNA ta hanyar zaɓaɓɓen zaɓi na kwafin.
A cikin mahaɗan da ke aiki a matsayin matattarar haɗuwa, sau da yawa sauyawar juzu'i yakan faru yayin fassarar RNA CoV.
Cikakken RNA da kuma subgenomic RNAs masu kama da juna suna iya sake haɗuwa don samar da sabon CoV.
An gano shaidar phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma a cikin CoVs na dabbobi kamar bat SL-CoV da bat CoV-HKU9.
Hadin gwiwar kwayar cuta-kwayar cuta dangane da watsawa
Baya ga abubuwan da aka ambata a sama, hulɗar da ƙwayoyin cuta tare da masu karɓar bakuncin su shine babban abin da ke shafar watsawa tsakanin jinsin.
A nan, an dauki SARS-CoV recombination a matsayin misali na musamman, wanda kuma ya nuna shaidar zaɓi mai kyau yayin faruwar watsa tsakanin jinsin.
Dangane da nazarin kwatancen tsakanin ɓangarorin SARS-CoV na mutum da na mujiya, ana tsammanin SARS-CoV yana da saurin daidaitawa a cikin runduna daban-daban, musamman tare da maye gurbin RBD protein S.
Gabaɗaya, RBD protein S CoV yana hulɗa da masu karɓar kwayar halitta kuma yana da niyya sosai ga amsawar antibody na mai karɓa.
A SARS-CoV, RBD shine amino acid na 318 zuwa 510 a cikin S1 sashi, wanda ke haɗuwa da ACE2 na mutum da masu karɓar sa a matsayin hanyar shiga kwayar cutar.
SARS-CoV RBD yana da ikon gane masu karɓar ACE2 na dabbobi daban-daban, waɗanda suka haɗa da bats, muses, mice, da kuma raccoons, don haka ya ba da damar watsa kwayar cutar tsakanin jinsin.
A gaskiya, 6 ne kawai amino acid residues da aka lura daban tsakanin mutum da fox virus isolates a cikin RBD kuma 4 daga cikinsu suna cikin halayen haɗi na karɓa don hulɗa tare da ACE2 masu karɓa.
CoV SARS-CoV fox yana da maye gurbin K479N da S487T a cikin RBD, wanda zai iya haɓaka alaƙar hulɗar furotin na kumburi tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan maye gurbin amino acid biyu sun kasance da muhimmanci ga kwayar cutar ta daidaita zuwa ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da masu karɓar ƙwayoyin cuta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nuna cewa haɗin haɗin S-protein tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken cryo-EM ya nuna cewa haɗuwar haɗuwa tsakanin ACE2 na mutum da SARS-CoV-2 S protein ya ninka 10 zuwa 20 fiye da haɗuwa tsakanin ACE2 na mutum da SARS-CoV-2 S protein.
Hakanan yana da mahimmanci a san ko akwai wasu masu karɓar ra'ayi waɗanda za a iya buƙatar su don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 shima yana da alaƙa da ACE2, amma tare da wani sashi daban a S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da kuma 9-O-teraseetylated sialic acid don HCoV-OC43.
Wadannan masu karɓar na iya kuma taka rawa a cikin nasarar daidaitawar wannan CoV a cikin mutane bayan watsawa tsakanin jinsin daga dabba mai dabba.
Ban da masu karɓar kwayoyin, sakamakon ƙarshe na watsa HCoVs tsakanin jinsuna kuma yana ƙarƙashin ikon sauran abubuwan dogaro da iyakancewar mai karɓa.
Wannan bambancin sunadarai tsakanin mutum da kuma mahalarta ruwa na halitta, kamar su bat, raƙumi na Arabiya, da kuma dabbobi masu rarrafe na iya zama cikas ga watsawa tsakanin jinsuna.
HCoVs dole ne su karɓi ikon mai karɓar mai karɓa kuma su keta ƙuntataccen mai karɓar mai karɓa don samun nasarar watsawa tsakanin jinsin.
A wannan yanayin, har yanzu ana bukatar ganowa da kuma bayyana muhimman abubuwan da ke tattare da wannan nau'in kwayar cutar.
Binciken cikakkiyar kwayar halitta don ganin abubuwan da suka danganci SARS-CoV-2 da kuma iyakancewar mai amfani da fasahar CRISPR mai mahimmanci na iya zama da amfani.
Haruwan sabon HCoV: komawa zuwa farkon barkewar cutar
Bambancin CoVs na bat yana ba da babbar dama ga sabon HCoVs.
A wannan yanayin, CoVs na bat suna aiki a matsayin HCoV gene loop.
Bugu da ƙari, saurin juyin halitta da kuma sake haɗuwa da kwayoyin halitta suna motsa juyin halittar HCoV kuma suna aiki a matsayin matakai biyu masu muhimmanci a cikin wannan tsari.
Misali, samun ko rasa sabon kwayar halitta mai bayyana sunadarai na iya canza yanayin kwayar cutar sosai.
Daga cikin sunadarai masu amfani da SARS-CoV, ORF8 an yi imanin cewa yana da muhimmiyar rawa wajen daidaitawa ga mutane saboda an gano ƙwayoyin cuta na SARS-CoV-like da aka gano suna ƙin sunadarai daban-daban na ORF8.
SARS-CoV tare da halayyar kawar da nucleotide 29 an samo shi a cikin nau'in da aka ware a farkon annobar mutum.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin yana da maye gurbin mai karɓa wanda ke tallafawa sauyawar mai karɓa.
Bugu da ƙari, SARS-CoV na iya samun tarihin sake haɗuwa tare da layin alpha-CoV da gamma-CoV, tare da gano ƙananan ƙananan ƙananan yankuna a cikin RNA polymerase mai dogaro da RNA.
An kuma gano wuraren da ake yin gyare-gyare a cikin nsp9, mafi yawanci a cikin nsp10, da kuma wasu a cikin nsp14.
Haka kuma, an nuna cewa an samu sake haɗuwa tsakanin zuriya a cikin cutar MERS-CoV, wanda ya faru a cikin raƙuman Arabiya a Saudi Arabia.
Bugu da ƙari, a cikin SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na sake haɗuwa a cikin wasu HCoVs inda HCoVs ke sake haɗuwa da wasu CoVs na dabbobi a cikin ƙwayoyin halittarsu.
Hakanan ya kamata a kula da cewa zaɓin da aka yi na iya taka rawa a cikin canje-canje na bazata a cikin kwayar halitta ta kwayar halitta, mai yiwuwa ya haifar da yaduwar kwayar cutar daga matsin lamba na zaɓin da aka samu, kamar yadda tsarin rigakafin mai karɓa ya yi.
Misalin wannan sakamako shine cikakken asarar ORF4 a cikin nau'in HCoV-229E na asali saboda cirewar nucleotides biyu.
Duk da yake ana iya ganin cikakkiyar ORF4 a cikin ƙwayoyin cuta na bat da na raƙumi waɗanda ke da alaƙa da HCoV-229E, alpha-CoV alpaca yana nuna ƙuƙwalwar nucleotide guda ɗaya wanda ke haifar da sauyawar tsari.
A ƙarshe, juyin halittar HCoVs na yau da kullun yana motsawa ta hanyar matsin lamba na zaɓi a cikin mai karɓar bakinsa.
Ana iya samun alamomi ko rashin alamomi a lokacin da aka kamu da CoV a cikin bats, wanda ke nuna cewa CoV da bats sun daidaita.
An gano cewa bature ya yi daidai da CoV a fannin ilimin halittar jiki da kuma na jiki.
Misali, nakasa a cikin kunnawar amsawar proinflammatory a cikin jemagu zai rage cutar da ke haifar da CoV sosai.
Bugu da ƙari, an hana aikin kwayar halitta a cikin bat saboda ƙaruwar tsarin mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa mai karɓa mai karɓar mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa mai karɓa
Bugu da ƙari, ƙimar yawan nau'in oxygen mai aiki (ROS) na ƙwayoyin cuta na ƙwayoyin cuta na iya hana CoV sake yin kwafi da kuma tasiri ga gyara ta hanyar exoribonuclease don haka yana ba da matsin lamba don ƙirƙirar ƙwayoyin cuta na kwayar cutar da ke da illa sosai yayin shiga cikin sabon mai ba da izini.
Ƙarin ƙwayoyin CoV na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabon furotin ko fasalin furotin don dacewa da mai masauki.
Saboda haka, ba daidaituwa ba ne cewa sababbin HCoVs guda uku sun bayyana a cikin shekaru biyu da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da alamu masu sauƙi a cikin mahalarta, kamar su kwari da raƙumi.
CoVs suna yin kwayar halitta sosai ba tare da haifar da amsawar garkuwar jiki mai ƙarfi ba.
A nan ne sirrin kasancewar marasa cutar da kuma sanadin kamuwa da mutane da yawa.
Alamu sun fi tsanani saboda yawan kunnawar garkuwar jiki da kuma guguwar cytokine, tare da lalacewar huhu da ke da tsanani idan garkuwar jiki ta yi ƙarfi.
Akasin haka, a cikin masu ɗauke da cutar marasa alamar cutar, amsar rigakafi ta kasance ba tare da CoV ba.
Wannan dabarar don yanke alaƙar amsawar garkuwar jiki na iya zama da amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin beyar.
Saboda haka, bayar da interferon na I, aƙalla a farkon lokacin kamuwa da SARS-CoV-2 a cikin mutane, ya kamata ya zama da amfani.
Bugu da ƙari, kunnawar NLRP3 inflammasome a cikin bat yana da lahani.
Saboda wannan dalili, hanawa NLRP3 tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Tashin SARS-CoV-2 ya biyo bayan yanayin SARS-CoV da MERS-CoV.
Yayin da aka gano beta-CoV na bat wanda ke da kashi 95% na kwayar nucleotide tare da SARS-CoV, akwai CoV na bat wanda ke da kashi 96% na kwayar nucleotide tare da SARS-CoV-2.
Duk da cewa an gano cewa kwari da sauran dabbobi a cikin kasuwar suna dauke da kwayar cutar da ke kama da SARS-CoV, ba a gano wani mai watsawa kai tsaye ga SARS-CoV-2 ba.
An gano beta-CoVs na kwari wanda ya yi daidai da SARS-CoV-2, wanda ya nuna cewa kwari na iya zama ɗaya daga cikin masu watsawa ko kuma beta-CoVs na kwari na iya ba da gudummawar ɓangaren kwayar halitta a cikin SARS-CoV-2 na ƙarshe.
Duk da cewa har yanzu ana cikin shakku, babu wata hujja da ta nuna cewa an yi amfani da SARS-CoV-2 a kan mutum ko ta hanyar ganganci ko kuma ba da gangan ba.
CoVs sun dawo cikin al'amuran da suka shafi kwanan nan SARS-CoV-2 ya barke.
Nazarin CoVs a cikin bats da sauran dabbobi sun canza ra'ayinmu game da mahimmancin asalin zoonotic da kuma wuraren ajiyar dabbobi don HCoVs a cikin watsawar ɗan adam.
Akwai shaidu da yawa da ke nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga ƙudaje kuma an watsa su ga mutane ta hanyar matsakaiciyar uwar garke.
Ganin cewa cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da kwari a cikin kasuwar ruwa, watakila rufe kasuwar ruwa da kashe dukkan kwari da ke ciki ya kawo ƙarshen annobar SARS.
A dalilin haka ne ma, yakamata a cire taruna daga kasuwannin da ake sayar da su don hana yaduwar cutar, saboda gano wasu beta-CoVs na taruna da ke da kusanci da SARS-CoV-2.
Duk da haka, gaskiyar da kuma hanyar da SARS-CoV-2 ke watsawa ga mutane ta hanyar ƙuda da sauran dabbobi masu shayarwa har yanzu ana buƙatar a bayyana su a cikin bincike na gaba.
A wani bangaren kuma, MERS-CoV ya dade yana cikin raƙuman Larabawa.
Kamar yadda yake da muhimmanci a wajen sufuri, rakumi ne tushen nama da madara da fata da kuma kayan ulu.
Rakuman Larabawa suna da yawa a dukan Gabas ta Tsakiya da kuma Afirka.
Saboda haka, ba za mu iya kashe dukkan rakuma don mu iya hana MERS ba, kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar MERS, dole ne a ɗauki cikakkiyar hanyar don haɓaka rigakafin don raƙumi wanda zai yi tasiri ga MERS-CoV kuma a haɗe tare da sauran matakan sarrafa kamuwa da cuta.
Kafin mu iya kawar da cutar, sabon nau'in kwayar halittar na iya bayyana kuma ya haifar da cutar.
Akwai nau'ikan CoV na zoonotic da ke yawo a cikin daji.
Musamman, kwayar cutar da ke iya zama ta zoonotic ta bats tana da bambanci sosai.
Akwai yiwuwar da yawa ga wannan CoV na zoonotic don ya samo asali kuma ya sake haɗuwa, wanda ke haifar da sabon CoV wanda zai iya zama mai saurin watsawa da/ko mafi haɗari ga mutane a nan gaba.
Al'adun cin naman daji a wasu wurare a kasar Sin dole ne a yi watsi da su don rage hulda da ba dole ba tsakanin mutane da dabbobi.
Tare da mummunan gogewa da SARS, MERS, da COVID-19, an yi amfani da shirye-shirye da tsare-tsaren magance mafi kyau.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya tun zamanin dā.
Waɗannan ƙwayoyin suna cikin wuraren da suke a yanayi har sai sun sami damar yaduwa.
Kodayake bat yana da halaye masu yawa waɗanda ke taimakawa watsa kwayar cutar, damar da mutane ke da shi na hulɗa da bat da sauran nau'in namun daji za a iya rage idan aka koyar da mutane don nisantar da dabbobi.
Ana buƙatar ci gaba da sa ido kan masu shayarwa don ƙarin fahimtar ilimin halittu na CoV da masu watsawa na halitta, wanda zai zama da amfani wajen hana watsawar dabba-zuwa-mutum da barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar zoonotic ita ce mutane su nisanta kansu daga wuraren da ke da tsabta na muhalli na wuraren da cutar zoonotic take.
Ba a gano wasu sassan asalin zoonotic na SARS-CoV-2 ba.
Na farko, idan bats sun yada kwayar SARS-CoV-2 ga kwari, yanayin da bat da kwari suke da shi a cikin yanayin muhalli yana da mahimmanci a sani.
Na biyu, idan dabbobin daji suna da rawar da za su taka kai tsaye wajen yada cutar ga mutane, za a yi la'akari da yadda mutane ke hulɗa da dabbobin daji.
Na uku, idan akwai dabbobi masu shayarwa na uku da suke aiki a matsayin matsakaiciyar uwar gida, ya kamata a bayyana yadda waɗannan dabbobi suke hulɗa da wasu dabbobi, kamar mutane da dabbobi masu kama da kurciyoyi da kuma dabbobi masu kama da ƙuda.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, ciki har da dabbobin gida na iya zama masu saukin kamuwa da SARS-CoV-2, ya kamata a gudanar da gwaji na kamuwa da cuta da kuma kulawa.
Ko dai kwari, kwaro, ko kuma wani dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kusan kwayar cutar da ta kama da ita za a iya gano ta a cikin halittarta a nan gaba.
Binciken da ake ci gaba a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai game da rigakafin COVID-19 da sarrafa shi a cikin mutane.
Ana buƙatar sabunta ka'idojin bincike na ƙiyas da  tabbataccen  COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta wallafa jagorar shawarwari na sauri don ganewar asali da kuma magance cutar ta 2019 (2019-nCoV) sabon kamuwa da cutar coronavirus.
Ko da yake cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, fahimtarmu da iliminta suna ƙaruwa bisa ga binciken da ake yi da kuma ƙwarewar asibiti; saboda haka, hanyoyin ganowa da kuma magance su ana sabunta su.
A cikin wannan wasika, mun amsa daya daga cikin sharhin da aka yi a cikin jagororinmu kuma mun samar da sabbin ka'idojin bincike don  zargin da ake zargi da  tabbatar da cutar bisa ga Jagorar Ganowa da Kulawa da COVID-19 (siffa ta bakwai) da Hukumar Lafiya ta Jama'ar Sin ta bayar.
A watan Disambar 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da annobar, wanda a halin yanzu ake kira cutar coronavirus 2019 (COVID-19) kuma an ba wa kwayar cutar suna mai suna coronavirus na cututtukan numfashi mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaƙi da kamuwa da SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawarwari na sauri kuma an buga su akan layi a cikin Binciken Likita na Sojoji a ranar 6 ga Fabrairu 2020.
Wannan littafin ya jawo hankali sosai tun lokacin da aka wallafa shi.
Koyaya, yana da kyau a lura cewa COVID-19 sabon cuta ne, kuma wayewar mu da ilimin mu suna haɓaka bisa ga binciken da ake ci gaba da binciken da kuma kwarewar aikin asibiti; saboda haka, hanyoyin bincike da hanyoyin magance su ma ana sabunta su.
Misali, Jagorar Gano da Kulawa don COVID-19 wanda Hukumar Kula da Lafiya ta Jama'ar Jama'ar Sin (http://www.nhc.gov.cn/) ta fitar, tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, hukumar ta fitar da jimlar bugu bakwai tare da wasu mahallin da aka canza sosai.
Jagoranmu ya sami bayani daga Zhou et al., sun gabatar da shawarwari masu sauƙi na ƙididdigar ƙididdiga bisa ga kwarewarsu ta asibiti.
Ayyukan da suka yi sun ba da ƙarin tabbaci ga jagororinmu kuma sun zama abin da za a iya amfani da shi a duniya don magance wannan cutar.
Muna goyon bayan aikinsu mai muhimmanci kuma muna nuna godiyarmu.
Duk da haka, sakamakon aikin su ya buƙaci sabuntawa bisa ga sabon Maganar Kulawa da Kulawa don COVID-19 (juzu'i na bakwai na gwaji) da kuma binciken da aka yi kwanan nan.
Bisa ga fitowa ta bakwai (3 ga Maris 2020), don tabbatar da abin da ake tsammani ana buƙatar haɗuwa da ɗayan tarihin tarihin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka tare da bayyanar cututtukan cututtukan cututtuka guda biyu don yin cikakken bincike, ko kuma ana buƙatar cika bayyanar cututtukan cututtukan cututtuka uku idan babu bayyanannen tarihin cututtukan cututtukan cututtukan cututtuka:
Tarihin cututtukan cututtuka: (1) tarihin tafiya ko zama a cikin Wuhan da kewayen birni, ko wasu al'ummomin da aka ba da rahoton wani cutar COVID-19 a cikin kwanaki 14 kafin bayyanar da bayyanar cututtukan; (2) tarihin hulɗa da wani wanda ke da cutar SARS-CoV-2 (tare da gwajin kwayar nucleic acid mai kyau); (3) tarihin hulda da wani mai cutar da ke da zazzabi ko alamun numfashi daga Wuhan da kewayen birni, ko wasu al'ummomin da aka ba da rahoton wani cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtukan; (4) tarihin hulɗa da tarin tabbatattun mutane (halarta mutane 2 da zazzabi da/ko alamun numfashi a cikin makonni 2 a cikin ƙananan yankuna, kamar gida, ofis, aji, da dai sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) siffofin hoto na COVID-19; (3) jimillar adadin farin jini yana nuna adadin lymphocytes na al'ada, raguwa, ko ragewa a farkon farkon.
Ganowa da aka tabbatar da shari'ar ya kamata ya kasance ne bisa ga shari'ar da ake zargi da daya daga cikin wadannan cututtukan cututtuka ko kuma na kwayoyin halitta: (1) gwajin PCR na ainihi-lokaci na SARS-CoV-2; (2) jerin dukkanin kwayar cutar ta nuna babban daidaituwa ga sabon kwayar cutar; (3) tabbatacce ga takamaiman IgM antibodies da IgG antibodies ga SARS-CoV-2 a cikin magani; ko sauyawar gwajin IgG-SARS-CoV-2 takamaiman antibodies daga mara kyau zuwa mai kyau, ko kuma ninki na ninki ≥4 a lokacin dawowa sama da matakin a lokacin da yake cikin yanayin mai tsanani.
Muna iya ganin cewa an ƙara gwajin PCR na ainihin lokacin nucleic acid a cikin samfurin numfashi ko jini a cikin bugu na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara gano pathogenic a cikin samfurin jini a cikin na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan, an ƙara hujja ta serological a cikin na bakwai.
Wannan gyare-gyare ya dogara ne akan ci gaba da bincike na masu bincike don neman mafi kyawun kayan gano kwayar nucleic acid don saurin ganewar asali, da kuma samfurin na numfashi ciki har da ɗaukar jini, wanda ke haɓaka wadatar samfura daban-daban, da kuma tallafawa shigar da wasu ƙwayoyin rigakafi masu kyau cikin ƙa'idodin tabbatarwa.
Ƙari ga haka, akwai ƙarin tabbaci da ya kamata mu yi amfani da shi wajen kula da marasa lafiya masu rashin lafiyan jiki da marasa lafiya marasa lafiya.
Saboda haka, Zhou et al. sun sabunta jadawalin da suka tsara mutanen da ba su da alamun cutar a matsayin "rashin haɗari".
Hakanan tsarin ƙididdiga yana buƙatar tabbatarwa a cikin aikin da kuma nazarin asibiti na gaba.
A ƙarshe, muna sa ran ƙarin tabbaci na kai tsaye za su bayyana kuma za mu nemi masu karatu su yi tsokaci.
Don ganewar " yanayin da ake tsammani " da " tabbataccen lamari ", muna ba da shawarar bin da bin sababbin ƙa'idodi a cikin ƙasashe.
Haka kuma, ƙungiyarmu za ta riƙa sabunta littattafanmu a kai a kai don su taimaka.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, wanda shi ne mafi yawan adadin mutuwar yau da kullun
A jiya, Bangladesh ta tabbatar da mutuwar mutane biyar daga COVID-19 a ranar.
Wannan shi ne adadi mafi girma na mutuwar da cutar ta yi a rana guda.
A ranar Litinin, Cibiyar Kula da Cututtuka da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin adadin wadanda suka kamu da cutar ya hada da 114 da suka kamu da cutar da kuma 33 da suka warke daga cutar.
An samu jimillar mutane 17 da suka mutu.
A wani taron manema labarai na yanar gizo, darektan IEDCR, Dr Meerjady Sabrina Flora, ta ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr. Meerjady, mutum biyu sun haura shekara 60, biyu sun haura shekara 51 zuwa 60, kuma daya ya haura shekara 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu 'yan Dhaka ne.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke kwance a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani sanarwar bidiyo ta yanar gizo, Ministan Sufuri na tituna da gadoji, Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a ne tun daga ranar 26 ga watan Maris kuma an shirya kammala shi a ranar Asabar, 4 ga watan Afrilu.
Har ila yau, an ba da izinin jigilar kayayyakin masarufi - magani, man fetur, da abinci.
An fara samun masu cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗaya daga cikinsu.
A ranar 19 ga Maris, an warkar da su duka uku.
SARS-CoV-2 ya halaka mutane fiye da miliyan a duniya
A ranar Alhamis, adadin wadanda suka kamu da kwayar cutar SARS-CoV-2 ya zarce miliyan daya a duniya, a cewar bayanan Jami'ar Johns Hopkins.
An danganta mutuwar mutane 52,000 da COVID-19, cutar da kwayar cutar corona ke haifarwa.
Wannan ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko da kuma Zambia ta kamu da cutar ta farko.
Koriya ta Arewa ta yi ikirarin cewa, a ranar Alhamis, tana ɗaya daga cikin ƙananan ƙasashe da ba a kamu da cutar coronavirus ba.
Ya zuwa jiya, Hukumar Lafiya ta Duniya (WHO) ta ba da rahoton 1,051,635 da aka tabbatar da cutar, ciki har da 79,332 a cikin sa'o'i ashirin da huɗu tun daga 10 na safe agogon Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar, wanda ya yi sanadiyyar mutuwar mutane 5,900.
Kamfanin dillancin labaran CBS ya ruwaito, yana mai da martani kan bayanan da jami'ar Johns Hopkins ta bayar, cewa fiye da mutum 1,000 ne suka mutu a Amurka sakamakon kamuwa da kwayar cutar korona.
A duk faɗin duniya, ƙasashe sun sanar da ƙarin matakan da za su ɗauka don hana yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow, ya tsawaita dokar kebe yankin har zuwa 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya ce za a ci gaba da biyan 'yan kasar Rasha albashi ba tare da sun je aiki ba har sai 30 ga watan Afrilu.
Majalisar dokokin Portugal ta yi kuri'a don tsawaita dokar ta'addancin na tsawon kwanaki 15; kuri'ar ta wuce da kuri'u 215 a goyan baya, goma sun yi baya, kuma daya ya ki.
Saudiyya ta tsawaita dokar hana fita a biranen Makka da Madina zuwa tsawon yini; a baya, dokar ta kasance tsakanin karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin aiwatar da dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta tsawaita dokar zaman gida har zuwa ranar 1 ga Mayu.
Shagunan Australiya sun rage adadin da suke sayen tawul a kowane sayayya
A ranar Lahadi da Asabar da yamma, Woolworth da Coles na Australia sun rage adadin sayen tawul din bayan gida zuwa biyu da kuma fakitin daya a duk shagunan da ke cikin kasar.
ALDI kuma ta yi amfani da iyakar ma'aikata guda daya a ranar Litinin.
An sanar da wannan takunkumin ne a matsayin wani sako a ofishin ta na banki da kuma shafin Facebook na cibiyar sadarwar.
An bayar da rahoton cewa masu siye da kaya sun tara kayan saboda tsoron COVID-19 ko kuma jama'a su yi zaman kansu.
A ranar Laraba, Woolworths kuma ya ƙuntata sayen tawul ɗin bayan gida zuwa fakiti ɗaya a kowane oda.
Wannan canjin ya biyo bayan ƙuntatawa na fakiti huɗu a kowace ma'amala wanda Woolworths da Coles suka yi a baya a ranar 4 da 5 ga Maris.
A cikin sanarwar da ta fitar a ranar 8 ga Maris, Coles ta ba da rahoton cewa tare da aiwatar da wannan takunkumin na fakiti huɗu, "duka-duka da yawa sun ƙare cikin sa'o'i ɗaya na jigilar kayayyaki", kuma ya kira wannan buƙatar "ba a taɓa gani ba", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira shi "ba a tsammani".
"Kasuwancin ya yi tashin gwauron zabi a makon da ya gabata", in ji wani mai magana da yawun Woolworths.
Shagunan Costco a Canberra sun kuma ƙayyade adadin da aka ba su izini zuwa fakiti biyu a makon da ya gabata.
Don kauce wa ƙarancin, Coles ya yi odar manyan kunshe daga masu kaya kuma ya ƙara yawan jigilar kayayyaki, Woolworths ya yi odar ƙarin kayan, yayin da ALDI ke yin tanadi don ayyukan tallatawa na musamman na Laraba da aka samu a farkon.
Russell Zimmerman, babban daraktan kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna kokarin kara yawan kayayyaki, amma takunkumin hukumar gwamnati ta yankin kan lokacin isar da motocin sun yi wuya.
Ya yi hasashen farashin kayayyaki zai ƙaru, yayin da masu samarwa za su yi ƙoƙari su biya bukatar, kuma za a rage tallace-tallace na musamman.
A ranar Talata, ALDI ta sanar da cewa saboda an fitar da kayan da wuri, wasu shaguna ba za su iya yin wani abu na musamman na ranar Laraba ba.
A wani rahoto da News.com.au ya wallafa, Dokta Gary Mortimer, wani masanin kasuwanci daga jami'ar fasaha ta Queensland, ya ce, shagunan suna cika kayayyaki da dare.
Ya nanata cewa, takalman wankin na da yawa, saboda haka ba a da isassun takalman, kuma idan an sayar da su, sai a bar ɗakunan da yawa a kan shiryayyu, saboda haka, ana ƙara ƙarancin kayayyaki.
Coles da Woolworths sun yi jayayya [cewa] idan akwai abubuwa da yawa a kan shiryayye, idan kayayyaki kamar su tawul din bayan gida da kuma masu shayarwa za su iya [saya] kuma suna cikin adadi mai yawa, ana iya rage fargaba, in ji Russel Zimmerman ta ABC News.
Kamfanin da ke kera kayan wanki mai suna Who Gives a Crap ya ce a ranar Laraba da ta gabata sun kasa samar da kayayyaki.
Kimberly-Clark, wanda ke yin Tissue Tissue Kleenex, da Solaris Paper, wanda ke yin Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye wadatar, a cewar rahoton News.com.au.
Shafin yanar gizo na Domain.com, ya ruwaito cewa wasu masu sayar da gidaje sun ba da takardar shara kyauta ga masu siyar da gwanjo a Melbourne, yayin da ake yin karamin gwanjo saboda masu siyarwa sun yi hutu a karshen mako na ranar ma'aikata.
Littafin NT News na ranar Alhamis, wata jarida da ake bugawa a Darwin, ta haɗa da shafuffuka takwas da aka yi niyya a yanka domin a yi amfani da su a matsayin tawul.
Shagunan da ke da ƙin yin amfani da takunkumin, a cewar rahoton ABC Australia na ranar 3 ga Maris, sun ce ba su da shirin yin amfani da takunkumin sayan.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna cikin babban bukatar, ciki har da masks, tanning, abinci mai bushewa, sabulu don wanke hannu, da gari.
Haka kuma a wajen Australia, a ranar Lahadi da yamma, an ga wani babban shagon intanet na Birtaniya mai suna Ocado ya takaita sayen tawul din Andres zuwa fakiti biyu da suka kunshi kwai 12.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin cutar sankara
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 mai ci gaba - cutar da ke haifar da kwayar cutar SARS-CoV-2 - a matsayin annoba.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu, ba yadda cutar take da muni ba, WHO ta lura da bukatar karfafawa gwamnatoci gwiwa su dauki mataki:
Duk da haka, akwai abubuwa da yawa da za su iya sauya a wannan annoba.
Idan wata kasa ta gano, ta gwada, ta yi maganin, ta ware, ta kuma sakewa al'ummarta, za a iya samun amsa, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna da matukar damuwa game da yadda cutar ta yadu da kuma yadda take da tsanani da kuma yadda ake jinkirin daukar matakan da suka dace.
A cewar Dokta Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka ta Amirka, wannan annoba "ba ta taɓa faruwa ba".
Ya ce, a cikin wani rahoto da CNN ta wallafa a watan Fabrairu, "ban da mura, babu wata kwayar cutar da ke kamuwa da cututtukan numfashi da aka gano tun daga lokacin da ta fara zuwa yanzu da ta ci gaba da yaduwa a duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "ba mu taba ganin irin wannan cutar da kwayar cutar coronavirus ta haifar ba".
Ya ci gaba da cewa, "kuma ba mu taɓa ganin cutar da za a iya shawo kanta a lokaci guda ba".
Sabon yanayin annobar ya biyo bayan shawarar da WHO ta yi a watan Janairu cewa cutar ta zama gaggawa ta lafiyar jama'a da ke damun duniya.
Darakta Anthony Fauci, darektan Cibiyar Kula da Ciwon Jari ta Amirka, ya ce game da wannan annobar, "ainihin abin da ke faruwa shi ne, za ta ƙara yin muni".
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya yi sanadiyar mutuwar sama da mutane 4,600.
Cutar annobar coronavirus ta 2019-2020 annoba ce ta cutar coronavirus ta 2019 (COVID-19) wanda ke gudana kuma cutar ta haifar da cutar ta SARS-CoV-2 (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disambar 2019, an ayyana ta a matsayin Cutar Lafiyar Jama'a ta Duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an sami kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a cikin ƙasashe da yankuna 210, wanda ya haifar da kusan mutuwar 97,000.
An warkar da mutane 364,000.
Adadin mutuwar cutar ya kai kimanin kashi 4 cikin dari a China, yayin da a duniya ya kai daga 13.04% zuwa 0.08 cikin ɗari a New Zealand.
Alamun da ake yawan gani a ciki su ne zazzaɓi, tari, da kuma numfashi na ɗan ciwo.
Matsaloli na iya haɗawa da ciwon huhu da kuma ciwon huhu.
Lokacin bayyanar cututtuka a cikin al'ada kusan kwanaki biyar ne, amma zai iya kaiwa daga kwana biyu zuwa goma sha huɗu.
Har yanzu babu wani maganin rigakafi ko maganin rigakafin cutar.
Babban magani shine maganin alamun bayyanar cututtuka da tallafi. Ayyukan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin yin tari, nisantar da wasu mutane, da kuma sa ido da keɓewa ga waɗanda ake zargi da kamuwa da cutar.
Hukumomi a duniya sun amsa ta hanyar hana tafiye-tafiye, takunkumi, dokar hana fita, sarrafa haɗarin wurin aiki, da rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikice na zamantakewar duniya da tattalin arziki, jinkiri ko soke ayyukan al'adu, siyasa, addini, wasanni, da kuma karancin kayayyaki da yawa da ke ƙara lalacewa ta hanyar sayayya.
An rufe makarantu da jami'o'i a matakin kasa da na gida a kasashe 193, wanda ya shafi kashi 99.4 cikin dari na yawan ɗalibai a duniya.
Labarin karya game da cutar ya bazu a yanar gizo kuma akwai al'amuran nuna ƙiyayya da nuna bambanci ga Sinawa, mutanen da ke da asalin Asiya ta Gabas da Kudu maso gabas da kuma waɗanda suka fito daga yankunan da cutar ta kamu da cutar.
Sakamakon rage tafiye-tafiye da kuma rufe manyan masana'antu, gurbataccen iska da iskar carbon sun ragu.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei), sun ba da rahoton cluster na cututtukan huhu da ba a san dalilin su ba a ranar 31 ga Disamba, 2019 kuma an gudanar da bincike a farkon watan Janairun 2020.
Yawancin waɗannan cututtuka sun danganci Kasuwar Kasuwancin Kayan Kayan Kayan Kayan Huanan kuma saboda haka ana zargin cewa kwayar cutar ta zoonotic ne.
Kwayar cutar da ke haifar da barkewar cutar ana kiranta SARS-CoV-2, sabuwar kwayar cutar da aka gano da ke da alaƙa da coronavirus bat, coronavirus dengue, da SARS-CoV. Mutumin da aka fara kamuwa da cutar ya kamu da cutar ne a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da alamar kasuwar da aka ambata a baya.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun sami alaƙa da wannan kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya yi hasashen cewa wani abin da za a iya ganowa zuwa ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, mai yiwuwa shine na farko.A ranar 26 ga Fabrairun, 2020, WHO ta ba da rahoton cewa, tare da rahoton sabon al'amuran da ke raguwa a China, amma ba zato ba tsammani a Italiya, Iran, da Koriya ta Kudu, yawan sabbin al'amuran da ke faruwa a wajen China ya zarce na cikin China a karon farko.
Wataƙila akwai adadin marasa lafiya da ba a ba da rahoto ba, musamman a tsakanin mutanen da ba su da alamun cutar sosai.
Ya zuwa 26 ga Fabrairu, an sami karancin adadin masu cutar a tsakanin matasa, wadanda shekarunsu 19 da ke ƙasa sun kai kashi 2.4% na masu cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya yi kiyasin cewa kashi 60% na mutanen Burtaniya suna buƙatar kamuwa da cutar kafin a sami rigakafin garkensu.
Lamarin ya shafi yawan mutanen da aka gwada su don COVID-19 kuma an tabbatar da sakamakon gwajin ya tabbata kamar yadda aka tsara.
Har zuwa ranar 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da 3% na yawan jama'arta, kuma ƙasashe da yawa sun kafa manufofin hukuma don ƙin gwada mutane da ke da alamun rashin lafiya, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga Maris ya gano cewa a China, har zuwa ranar 23 ga Janairu, an kiyasta cewa kashi 86% na cutar COVID-19 ba a gano ba, kuma wannan cutar da ba a tantance ba ita ce tushen kamuwa da cutar ga kashi 79% na wadanda aka tantance.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya yi hasashen cewa adadin masu kamuwa da cutar a Italiya ya fi na waɗanda aka ruwaito.
Farkon ƙididdigar ƙididdigar yawan haifuwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da aka wallafa a jaridar U.S. Centers for Disease Control and Prevention ya nuna cewa adadin zai iya kaiwa 5.7.
Yawancin mutanen da ke da COVID-19 sun warke.
Ga wadanda ba su warke ba, lokacin da aka fara nuna alamun cutar da kuma mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, mafi yawan kwanaki 14.
Tun daga ranar 10 ga Afrilu, 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, har zuwa ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun faru ne a cikin mutane sama da shekaru 60 kuma kashi 75% suna da matsalolin kiwon lafiya, waɗanda suka haɗa da cututtukan zuciya da ciwon suga.
Adadin mutanen da suka mutu daga COVID-19 zai iya zama mafi yawa, saboda ƙididdigar hukuma ba ta haɗa da mutanen da suka mutu ba tare da an gwada su ba, misali, a gida, a gidajen kulawa, da sauransu.
Data na Italiya ya gano cewa yawan adadin mutuwar da aka yi a lokacin annobar ya ninka adadin mutuwar da aka yi a sakamakon COVID da sau 4-5.
Wata mata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta yarda, "Mun san [adadin mutuwar da aka sanar] ya fi na gaskiya", in ji wata sanarwa da aka karfafa ta da rahotannin marasa ilimi game da ƙididdigar ƙasa da ƙasa a Amurka. Ƙididdigar ƙasa da ƙasa sau da yawa yakan fito a cikin annoba, kamar a cikin annobar cutar alade H1N1 ta 2009.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga Fabrairu a Filifin, kuma mutuwar farko a wajen Asiya ita ce a Faransa a ranar 14 ga Fabrairu.
Ya zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an yi rahoton mutuwar mutane fiye da goma sha biyu a Iran, Koriya ta Kudu, da kuma Italiya.
A ranar 13 ga Maris, fiye da kasashe arba'in da yankuna sun ba da rahoton mutuwar, a kowace nahiya, ban da Antarctica.
Wannan adadi ya bambanta bisa ga yanki da kuma tsawon lokaci, kuma ana rinjayar shi ta yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan kulawa, lokacin da ya fara barkewar farko, da halayen alƙaluma kamar shekaru, jinsi, da kuma lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar cutar a duniya ya kai 6.0% (97.039/1.617.204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta daga yanki zuwa yanki.
A kasar Sin, kimanin mutuwar mutum zuwa kashi ya ragu daga 17.3% (ga mutanen da ke da alamun cutar 1-10 ga Janairu 2020) zuwa 0.7% (ga mutanen da ke da alamun cutar bayan 1 ga Fabrairu 2020). Sauran ma'auni sun hada da yawan mace-mace (CFR), wanda ke nuna yawan adadin mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cutar (IFR), wanda ke nuna yawan adadin mutanen da aka kamu da cutar (wanda aka gano da wanda ba a gano ba) sun mutu daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna bin wani ƙayyadadden alƙaluma daga kamuwa da cuta zuwa warwarewar shari'ar.
Wasu masana kimiyya sun yi ƙoƙarin ƙididdige waɗannan adadi don ƙayyadaddun mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta yi kiyasin cewa yawan mutuwar da cutar ke haifarwa a lokacin annobar na iya kaiwa tsakanin kashi 0.1% da kashi 0.39%.
Wannan iyakar ƙididdigar ta dace da sakamakon gwajin bazuwar farko na COVID-19 a Jamus da kuma nazarin ƙididdiga wanda ke nazarin tasirin gwaji akan ƙididdigar CFR.
Hukumar ta WHO ta ce ana iya shawo kan cutar.
Ba a san lokacin da cutar ta yi tsanani ba kuma ba a san lokacin da za ta ƙare ba.
Maciej Boni na Jami'ar Jihar Penn ya ce: "Idan ba a kula da cutar ba, za ta ci gaba da yaduwa kuma za ta soma raguwa idan babu mai kula da ita.
Amma, ba za mu iya sanin ainihin lokacin da hakan zai faru ba".
Babban mai ba da shawara ga gwamnatin kasar Sin Zhong Nanshan ya yi amannar cewa " za a iya kawo karshen cutar a watan Yuni " idan aka gama hada kan al'umma don bin shawarar da WHO ta bayar kan matakan da za a dauka don dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Gishiri ta London ya ce SRS-CoV-2 "zai ci gaba da yaduwa, mai yiwuwa na shekara ɗaya ko biyu".
A cewar wani binciken da aka yi a Kwalejin Imperial wanda Neil Ferguson ya ja-gora, za a bukaci a takaita jiki da kuma wasu matakan "har sai an samu allurar rigakafin (watakila watanni 18 ko fiye da haka)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa ba zai yiwu ba cewa wannan kwayar cutar, saboda yadda take yaduwa sosai, ta iya bace gaba daya" kuma cutar "na iya zama wata cuta ta yanayi, wacce ke dawowa kowace shekara".
Yawan kwayar cutar zai dogara ne akan rigakafin da ke cikin garke da kuma yawan kwayar cutar.
Alamun COVID-19 na iya zama ba na musamman ba kuma wanda ya kamu ba zai iya nuna alamun cutar ba.
Abubuwa biyu da suka fi faruwa sune zazzabi (88%) da kuma tari mai tsami (68%).
Ba a yawan samun alamun cutar kamar gajiya, zubar da numfashi (phlegm), rashin jin ƙanshi, ƙarancin numfashi, ciwo a cikin gaɓa da tsoka, ciwon makogwaro, ciwon kai, farfaɗi, amai, diarrhea, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana ciwo mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa sun haɗa da wahalar numfashi, bugun kirji ko ciwo a cikin kirji, rikicewar kwatsam, wahalar tafiya, da kuma launin shuɗi a fuska da lebe; an ba da shawarar kula da likita nan da nan idan waɗannan alamun suka bayyana.
Wasu mutane da suka kamu da cutar na iya zama marasa lafiya, wato ba tare da alamun cutar ba, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, saboda haka, masu bincike sun ba da shawarar cewa duk wanda ya yi kusa da wanda aka tabbatar da kamuwa da cutar ya kamata a kula da shi sosai kuma a bincika shi don tabbatar da rashin kamuwa da cutar.
Sinawa sun kimanta cewa asymptomatic ratios sun kasance daga wasu zuwa 44%.
Lokacin incubation (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) yawanci yakan kasance tsakanin 1 zuwa 14 days, mafi yawan lokuta 5 days.
Ana ci gaba da bincike a kan yadda cutar take yaɗuwa.
An yi imanin cewa COVID-19 ya fi yaduwa a lokacin da aka yi kusa da juna kuma ta hanyar ƙananan ɗigo da aka yi yayin yin tari, yin hanci, ko magana; kusa da juna shine saduwa tsakanin mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya gano cewa tari da ba a rufe ba zai iya sa a tura ɗigon ruwa daga kafa 15 zuwa kafa 27 (mita 8.2).
Wasu masu bincike sun yi hasashen cewa ana iya yada cutar ta hanyar kananan ruwa da ake samu a lokacin da ake magana. Ana kuma iya samun sautin numfashi a lokacin da ake fitar da numfashi, ciki har da lokacin magana, ko da yake cutar ba ta yaduwa ta hanyar iska.
Sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an, sa'an nan, sa'an nan, sa'an nan, sa'an, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan, sa'an nan
Wasu hanyoyin jinya, kamar su intubation da kuma resuscitation na zuciya da huhu (RJP), suna iya sa ɓarkewar numfashi ta zama aerosols da za su iya yaduwa ta hanyar iska.
Haka kuma yaduwar cutar na iya faruwa ne idan mutum ya taɓa wani abu da ke da cutar, kamar fata, idanunsu, hancinsu, da kuma bakinsu.
Duk da cewa akwai damuwa cewa kwayar cutar na iya yaduwa ta hanyar feshin, an yi imanin cewa wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2 ta hanyar shayarwa. Cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar da alamun cutar, kodayake yaduwa na iya faruwa kafin bayyanar da alamun cutar da kuma a cikin wani mataki na ciwo.
Mutane suna ba da gwaji mai kyau har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna yiwuwar watsawa kafin bayyanar cututtuka.
Akwai 'yan rahotanni kaɗan na tabbatar da cutar a cikin dakin gwaje-gwaje, amma an gano wasu ƙasashe a yayin binciken bincike.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, mutum daya yakan kamu da wasu mutane biyu zuwa uku.
Musamman, an gano cewa kwayar cutar za ta iya ganowa har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe 304, kwana ɗaya a kan kwali, da sama da awanni huɗu a kan tagulla.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun gwada tabbatacce na COVID-19.
Babu wata shaida da ke nuna cewa dabbobi na iya yada cutar ga mutane, duk da haka hukumomin Burtaniya sun ba da shawarar wanke hannu bayan saduwa da dabbobi, kamar bayan saduwa da saman da mai cutar ya taɓa.
Coronavirus na cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan 2 (SARS-CoV-2) wani sabon kwayar cutar ne, wanda aka fara warewa daga mutane uku da suka kamu da cutar huhu da ke da alaƙa da tarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka a Wuhan.
Dukkanin alamomin sabon kwayar cutar SARS-CoV-2 suna da alaƙa da coronaviruses a cikin yanayi. A waje da jikin mutum, kwayar cutar na iya lalacewa ta hanyar sabulun gida, wanda ke narkar da ambulafons ɗin da ke kare ta. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
Ana tsammanin kwayar cutar ta zoonotic ne.
Binciken kwayar halitta ya bayyana cewa kwayar cutar ta kwayar halitta ta haɗu da Betacoronavirus, a cikin Sarbecovirus subgenus (B lineage) tare da wasu nau'ikan bat biyu.
Kwayar cutar tana da kusan kashi 96% na kama da juna a matakin kwayoyin halitta tare da samfurin wani bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya a wasu sassan tsarin kwayoyin halittar tsakanin kwayar cutar dengue da ta mutum.
A halin yanzu, kwatancen dukkan kwayoyin halitta ya gano kusan kashi 92% na kayan kwayar halitta tsakanin coronavirus na tengil da SARS-CoV-2, bai isa ya tabbatar da cewa tengil shine matsakaiciyar mai watsa SARS-CoV-2 ba.
Ana iya gane cutar ta kwayar cuta ta hanyar bayyanar cututtuka na ɗan lokaci, amma a ƙarshe ana tabbatar da ita ta hanyar yin amfani da jerin jerin polymerase (rRT-PCR) a cikin ɓoye mai cutar ko kuma ta hanyar ɗaukar hoto na CT.
Wani bincike da aka yi a Wuhan da ya kwatanta PCR da CT ya nuna cewa CT tana da hankali sosai fiye da PCR, amma ba ta da takamaiman bayani, saboda yawan hotunan da ake yi a kan cutar huhu da sauran cututtukan da ke tattare da cutar.
A watan Maris na 2020, Kwalejin Ilimin Radiology ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don rarrabawa ko a matsayin gwajin farko a cikin gano COVID-19".
WHO ta wallafa wasu ka'idojin gwajin RNA na SARS-CoV-2, wanda aka fara rarrabawa a ranar 17 ga Janairu.
An yi amfani da gwajin ta amfani da real-time reverse transcriptase polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin a kan samfurin numfashi ko jini.
Sakamakon yawanci ana samunsa cikin sa'o'i kadan zuwa kwanaki kadan.
Yawancin lokaci, ana yin wannan gwajin ne a cikin nasopharynx, amma ana iya amfani da murhun makogwaro. Da yawa daga cikin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serological wanda ke gano ƙwayoyin cuta.
A ranar 6 ga Afrilu 2020, babu ɗayan waɗannan gwaje-gwajen serological da aka tabbatar da cewa suna da isasshen daidaito don yarda da amfani da su a ko'ina.
A Amurka, gwajin serological da Cellex ya haɓaka an yarda da shi don amfani na gaggawa, kawai ta hanyar dakunan gwaje-gwaje masu takaddama.
Abubuwan da ke nuna hotunan hotunan hoto na CT da na X-ray a cikin mutane masu alamomi sun haɗa da rashin daidaituwa na gilashin ƙasa da kuma rashin zubar da jini.
Ƙungiyar Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun
Saboda haɗuwa da sauran cututtuka kamar adenovirus, hotunan PCR ba tare da tabbatarwa ba yana da iyakance takamaiman a cikin gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa duk da cewa ba shi da takamaiman kamuwa da cuta, hoton ya fi sauri kuma ya fi dacewa da shi don a yi la'akari da shi azaman kayan bincike a cikin wuraren annoba.
An haɓaka hanyoyin sadarwa na neural na tushen AI don gano fasalin hoto na kwayar cutar ta hanyar radiography da CT.
Dabarun hana yaduwar cutar sun hada da tsaftace jiki, wanke hannu, gujewa taba idanu, hanci, ko baki kafin wanke hannu, amfani da tawul lokacin da kake yin tari ko tari, da kuma zubar da tawul a cikin kwandon shara.
Ana ba da shawara ga mutanen da suka kamu da cutar su sanya abin rufe fuska a wuraren da ake yawan jama'a.
An kuma bada shawarar yin amfani da matakan hana jiki don hana yaduwar cutar. Gwamnatoci a yankuna daban-daban sun takaita ko kuma sun yi kira da a dakatar da duk wata tafiya da ba ta da muhimmanci zuwa ko daga kasashen da cutar ta shafa da yankuna.
Amma, cutar ta kai matakin yaduwa a cikin al'umma a yawancin sassan duniya.
Wannan yana nufin cewa cutar ta yadu a cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawara ga masu kula da kiwon lafiya da ke kula da mutanen da ke iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullun, matakan hana saduwa, da kuma kariya ga idanu. Binciken tuntuɓa yana da mahimmanci ga hukumomin kiwon lafiya don tantance tushen kamuwa da cuta da kuma hana ƙarin watsawa.
Amfani da bayanan wuri na wayar salula da gwamnatoci ke yi don wannan dalili ya jawo damuwa game da tsare sirri, tare da sanarwar da Amnesty International da wasu kungiyoyi sama da 100 suka fitar suna kira da a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko kuma an ba da shawarar yin amfani da su ta hanyar son rai, kuma a ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi goma sha biyu masu ƙwarewa suna aiki a kan hanyoyin magance sirri, kamar amfani da Bluetooth don yin rikodin kusancin mai amfani da wani waya.
Bugu da ƙari, masu amfani za su sami saƙo idan sun kasance kusa da wani wanda ya gwada tabbatacce ga COVID-19.Rashin fahimta game da yadda za a hana kamuwa da cuta; misali, wanke hanci da kuma yin amfani da maganin sauro ba su da tasiri.
Babu rigakafin COVID-19 ko dai, kodayake kungiyoyi da dama na aiki don samar da su.
Ana bada shawarar wanke hannu don hana yaduwar cuta.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kai a kai aƙalla na tsawon dakika ashirin, musamman bayan sun yi amfani da bayan gida ko kuma idan hannayensu sun yi datti; kafin cin abinci; da kuma bayan an hura hanci, an yi amai, ko an yi hanci.
Wannan ya faru ne saboda, a waje da jikin mutum, sabulun gida yana kashe kwayar cutar ta hanyar lalata garkuwar ta.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da maganin hana yaduwar giya wanda ya ƙunshi aƙalla kashi 60% na giya bisa ga girma lokacin da sabulu da ruwa ba su samuwa.
WHO ta ba da shawarar cewa mutane su guji taɓa idanunsu, hanci, ko bakinsu kafin su wanke hannayensu.
Za'a iya wanke farfajiyar ta amfani da wasu magunguna (a cikin minti ɗaya na bayyanar da maganin kashe cuta ga farfajiyar bakin karfe), gami da ethanol 6271%, isopropanol 50100%, sodium hypochlorite 0.1%, hydrogen peroxide 0.5%, da povidone-iodine 0.27.5%.
Sauran maganin, kamar su benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai wani abin da ake zargi ko tabbatar da cutar COVID-19 a cikin gine-gine, kamar ofishi ko wurin kula da yara, duk wuraren da ake amfani da su kamar ofishi, banɗaki, wuraren jama'a, kayan aikin lantarki na kowa kamar su allunan, fuskokin taɓawa, maballan rubutu, iko mai nisa, da kuma na'urar ATM da mai cutar ke amfani da su, ya kamata a yi musu allurar rigakafi.
Ƙungiyoyin lafiya sun ba da shawara cewa a rufe baki da hanci da idon aƙwalle ko kuma a yi amfani da tawul sa'ad da ake yin tari ko kuma a yi hancin, sa'an nan a zubar da tawul nan da nan.
Ana ba da shawarar amfani da abin rufe fuska ga mutanen da suka kamu da cutar saboda sanya abin rufe fuska na iya rage girman da kuma tazarar da ake amfani da shi na saukowar iska a lokacin magana, atishawa, da tari.
WHO ta ba da umarni game da lokacin da za a yi amfani da abin rufe fuska da kuma yadda za a yi amfani da shi.
Stephen Griffin, masanin ƙwayoyin cuta a Jami'ar Leeds ya ce: "Yin amfani da abin rufe fuska zai iya rage haɗarin mutum ya taɓa fuskarsa da hannayen da ba su da tsabta sosai, wanda shi ne tushen kamuwa da cutar". Ƙari ga haka, an ce ya kamata masu kula da wasu da za su iya kamuwa da cutar su riƙa saka abin rufe fuska.
WHO ta bada shawarar sanya abin rufe fuska ne kawai idan mutane masu lafiya ne, kamar waɗanda ke kula da masu cutar COVID-19, kodayake WHO ta yarda cewa sanya abin rufe fuska na iya hana mutane taɓa fuskokinsu.
Wasu ƙasashe sun fara ƙarfafa yin amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar amfani da abin rufe fuska na likitanci wanda aka yi da masana'anta. China musamman ta ba da shawarar amfani da abin rufe fuska na likitanci ga mutanen da ke da lafiya, musamman lokacin da suke kusa da juna (mita 1 (ƙafa 3) ko ƙasa da haka) da wasu.
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko zama a cikin jama'a.
Ma'aikatan kiwon lafiya na Thailand sun shawarci mutane su yi abin rufe fuska a gida kuma su wanke shi kowace rana.
Jamhuriyar Czech da Slovakia sun hana jama'arsu fita a bainar jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta bukaci dukkan 'yan kasar su sanya abin rufe fuska yayin da suke fita a wuraren da jama'a ke don kare kansu da sauran mutane.
Gwamnatin Austriya ta ce duk wanda ya shiga gidan abinci ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar ta su sanya takunkumin fuska a duk lokacin da suke a cikin jama'a.
Taiwan, wadda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta sanya wajibi ga fasinjojin jirgin ƙasa da na bas na wucewa su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta ba da umarnin sanya abin rufe fuska a duk lokacin da ya fita daga gida, tare da ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya siyan abin rufe fuska ba.
Ana kuma amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Taƙaitawar zamantakewa (wanda ake kira ƙuntatawa ta jiki) wani mataki ne na hana kamuwa da cuta wanda aka tsara don rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin da za a iya amfani da su wajen hana jama'a yin hulda da jama'a sun haɗa da keɓewa; hana zirga-zirga; da rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo, ko kuma wuraren kasuwanci.
Mutane na iya yin amfani da hanyoyin da za a yi na nisantar da jama'a ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren da jama'a ke da yawa, yin amfani da sallama ba tare da saduwa ba, da kuma nisantar da kansu daga wasu.
A yanzu haka, gwamnatoci da yawa suna ba da umarnin ko kuma suna ba da shawara a kan takunkumin da za a yi wa jama'a a wuraren da cutar ta fi yaɗuwa.
An rage yawan adadin mutanen da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawara, daga mutane 250 (idan ba a san ko akwai cutar COVID-19 a wani yanki ba) zuwa 50, sannan zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana tarurruka a cikin wuraren jama'a da suka shafi sama da mutane biyu. Tsofaffi da mutanen da ke da yanayin likita irin su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin garkuwar jiki wanda ke da haɗarin kamuwa da cututtuka masu tsanani da kuma ƙarin haɗari CDC ya ba da shawarar a zauna a gida kamar yadda ya kamata a yankunan da ke fama da barkewar cutar a cikin al'umma.
Amfani da kalmar "tsarewar zamantakewa" yana ba da ra'ayi cewa ya kamata mutane su ware kansu gaba ɗaya kuma ba sa ƙarfafa mutane su ci gaba da hulɗa da wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin lafiyar jima'i don amfani da su yayin annobar.
Waɗannan shawarwarin sun haɗa da ƙarfafa yin jima'i da wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓe kai a gida ga mutanen da aka gano suna da COVID-19 da kuma waɗanda ake zargin suna da cutar.
Hukumomin lafiya sun ba da cikakkun umarni don ingantaccen keɓe kai. Yawancin gwamnatoci suna ba da umarnin ko ba da shawarar keɓewa ga duk mutanen da ke zaune a yankunan da abin ya shafa.
An ba da umarnin tsauraran matakan killace kai ga mutanen da ke cikin rukunin haɗari.
Ana ba da shawarar ga mutanen da suka iya fuskantar cutar COVID-19 da kuma mutanen da kwanan nan suka yi tafiya zuwa wata ƙasa ko yanki da ke da yaduwar cutar COVID-19 da su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka yi mu'amala da su.
A cikin dabarun da ake bi wajen dakile cutar, ana amfani da dakilewa ko kuma kawar da cutar, da kuma rage yawan cutar.
Ana yin rigakafin ne a farkon lokacin da cutar ta bulla kuma ana nufin a bi sahu da kuma ware mutanen da suka kamu da cutar tare da aiwatar da wasu matakan hana kamuwa da cuta da kuma allurar rigakafi da nufin dakatar da yaduwar cutar a cikin jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a koma matakin ragewa: ana yin hakan ne don rage yaduwar cutar da kuma rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Haɗin haɗuwa da ragewa na iya faruwa a lokaci ɗaya.
Rashin ƙarfi yana buƙatar ƙarin matakai masu ƙarfi don sauya annobar ta hanyar rage yawan haifuwa zuwa ƙasa da 1. Wani ɓangare na kula da annobar cutar mai saurin yaduwa shine ƙoƙarin rage ƙimar cutar, wanda aka sani da bugun ƙwanƙwasa cutar.
Wannan yana rage hadarin da ke tattare da rashin samun isasshen kayan aikin kiwon lafiya da kuma ba da lokaci don samar da allurar rigakafi da magani.
Matakan da ba na magunguna ba don magance barkewar cutar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da kuma kebe kai; matakan da aka dauka a matakin al'umma don takurawar jiki, kamar rufe makarantu da soke taron jama'a; shigar da jama'a don karfafa yarda da shiga cikin irin wannan aikin; da kuma matakan da aka dauka a matakin muhalli, kamar tsabtace farfajiya.
Sauran kasashen kuma suna da matakan da suke dauka don rage yaduwar cutar.
Koriya ta Kudu ta gabatar da tsauraran matakai da kuma killace mutane a cikin gida, tare da bayar da gargadi game da motsi na masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga mutanen da suka kamu da cutar waɗanda suka keɓe kansu kuma suka ɗora manyan tara ga waɗanda suka ƙi yin hakan.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta masu tara kayan aikin likitanci. Simulation ga Burtaniya da Amurka sun nuna cewa ragewa (ragewa, amma ba a dakatar da yaduwar annoba ba) da kuma kawar da ita (dawo da ci gaban annoba) yana da babban kalubale.
Ingantaccen manufofin ragewa na iya rage yawan bukatar kiwon lafiya da kashi biyu da uku da kuma mutuwar da rabi, amma har yanzu yana haifar da mutuwar dubbai da kuma rashin lafiyar kiwon lafiya.
Za'a iya zaɓar dakilewa, amma ana buƙatar kiyaye shi muddin kwayar cutar tana nan a cikin yawan mutane (ko har sai an sami allurar rigakafi, idan an fara samun wannan), in ba haka ba, yaduwar cutar za ta sake dawowa da sauri yayin da aka sassauta matakan dakilewa.
Matsaloli na dogon lokaci na dakile annobar na da tasirin zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafi da aka amince da shi don COVID-19, amma ana ci gaba da ƙoƙarin ci gaba, wanda ya haɗa da gwajin magunguna na yanzu.
Shan magungunan sanyi da ake sayar wa a kantin magani, da shan isashen ruwa, da kuma hutawa za su iya rage alamun cutar.
Dangane da tsananin cutar, ana iya bukatar maganin oxygen, ruwan jini, da kuma taimakon numfashi.
Yin amfani da steroid zai iya sa yanayin ya yi muni.
Wasu daga cikin abubuwan da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta ana binciken su don amfani da su wajen magance COVID-19.
WHO ta kuma bayyana cewa wasu "magungunan gargajiya da na gida" na iya rage alamun da SARS-CoV-19 ke haifarwa.
WHO ta ce haɓaka iyawa da daidaita ayyukan kiwon lafiya don bukatun marasa lafiya na COVID-19 babban mataki ne na amsa barkewar cutar.
ECDC da ofishin WHO na yankin Turai sun ba da jagorori ga asibitoci da kuma cibiyoyin kiwon lafiya na farko don tura albarkatu a matakai daban-daban, gami da mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, idan zai yiwu soke hanyoyin zaɓuɓɓuka, warewa da keɓe marasa lafiya masu COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin ventilators da gadaje.
Akwai ra'ayoyi da yawa game da asalin wannan shari'ar ta farko (wanda ake kira mai haƙuri na farko).
An gano cewa an samu mutum na farko da cutar korona a ranar 1 ga watan Disambar 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Wadannan shari'o'in galibi suna da alaƙa da Kasuwar Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan K
A ranar 30 ga Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta sanar da abokan aikinta game da "kwayar cutar SARS".
An yi wa takwas daga cikin likitocin gargaɗi, ciki har da Li Wenliang, saboda yaɗa jita-jita na ƙarya, kuma wani, Ai Fen, ya sami horo daga shugabansa saboda gargaɗin da ya yi.
Hukumar lafiya ta Wuhan ta sanar da jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An kai rahoton rahoton wasu lamuran da ba a san su ba ga hukumomin lafiya a Wuhan wanda hakan ya sa aka fara gudanar da bincike a farkon watan Janairu. A farkon barkewar cutar, yawan masu kamuwa da cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan China, wanda ya sami ci gaba ta hanyar ƙaura a lokacin Sabuwar Shekarar Lunar da kuma saboda Wuhan ya kasance cibiyar sufuri da kuma babbar hanyar jirgin ƙasa.
A ranar 20 ga Janairu, China ta ba da rahoton kusan sabbin mutane 140 a rana, ciki har da mutum biyu a Beijing da mutum ɗaya a Shenzhen.
Bayanai na hukuma sun nuna cewa mutane 6,174 sun nuna alamun cutar a ranar 20 ga Janairu 2020.Yana zuwa 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin da aka tabbatar da cutar a duniya.Har zuwa 9 ga Afrilu 2020, an samu fiye da mutane miliyan 1.61 da aka ruwaito a duk duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kasashe da yankuna 200 suna da akalla mutum ɗaya da ya kamu da cutar.
Saboda annobar cutar a Turai, ƙasashe da yawa a Yankin Schengen sun takaita motsi kyauta kuma sun sanya ikon sarrafa kan iyakoki.
Amsar ƙasa ta haɗa da matakan kariya, kamar su keɓewa (wanda aka sani da umarnin zama a gida, umarnin ɓoye a wuri, ko keɓewar yanki) da kuma dokar hana fita da dare. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kuma kusan kashi 90% na yawan jama'a, suna cikin wani nau'i na keɓewar yanki a Amurka, sama da mutane miliyan 50 ke keɓewa a yankin Philippines, kusan mutane miliyan 59 keɓewa a yankin Afirka ta Kudu, kuma mutane biliyan 1.3 ke keɓewa a yankin Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani yanayi na keɓewa na yanki, wanda ya karu zuwa mutane biliyan 2.6 kwana biyu bayan haka, kusan kashi ɗaya cikin uku na yawan mutanen duniya.
Ana iya gano farkon tabbataccen cutar COVID-19 zuwa ranar 1 ga Disamba 2019 a Wuhan; wani rahoton da ba a tabbatar ba ya nuna farkon shari'ar a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan huhu tare da dalilin da ba a san shi ba a ranar 26 ga Disamba; asibitin ya sanar da Jianghan CDC a ranar 27 ga Disamba.
Gwajin kwayar halittar farko da aka yi wa samfurin mai cutar a ranar 27 ga Disamba 2019 ya nuna cewa akwai kwayar cutar ta SARS.
Kwamitin Kiwon Lafiyar Gida na Wuhan ya sanar da sanarwar ga jama'a a ranar 31 ga Disamba.
A ranar ne aka sanar da Hukumar Lafiya ta Duniya.
A lokacin da aka aiwatar da wannan sanarwar, 'yan sanda sun gargadi likitocin Wuhan saboda "yaɗa jita-jita" game da annobar.
Hukumar lafiya ta kasar Sin ta ce babu wani "hujja mai haske" da ke nuna cewa cutar ta yadu daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin China ta kaddamar da wani kamfen na kai hare-hare wanda babban sakatare na jam'iyyar kwaminis ta China Xi Jinping ya bayyana a matsayin "yakin jama'a" don dakile yaduwar cutar.
A cikin abin da ake kira "mafi girma a cikin tarihin ɗan adam", an ba da sanarwar cordon sanitaire ko ƙuntatawa na tsabta a ranar 23 ga Janairu don dakatar da tafiya zuwa da fita daga Wuhan, kuma an faɗaɗa shi zuwa birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
An hana amfani da motoci a cikin gari.
An soke bikin Lunar Sabuwar Shekara (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An kuma gina wani asibiti, asibitin Leishenshan, don karɓar ƙarin marasa lafiya.
A ranar 26 ga Janairu, gwamnati ta tsara ƙarin matakan dakile barkewar cutar COVID-19, gami da fitar da sanarwar lafiya ga masu yawon buɗe ido da kuma tsawaita hutun bikin bazara.
An rufe dukkan jami'o'i da makarantu a cikin kasar.
Yankin Hong Kong da Macau suna aiwatar da wasu matakai, musamman game da makarantu da jami'o'i.
An fara amfani da hanyoyin aiki daga nesa a wasu yankuna na kasar Sin.
An sanya takunkumin hana zirga-zirga a ciki da wajen Hubei.
An dakatar da zirga-zirgar jama'a kuma an rufe gidajen tarihi a duk fadin kasar Sin.
An sanya takunkumin hana zirga-zirgar jama'a a cikin birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu ƙuntatawa a waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana " shigo da " cutar daga wasu ƙasashe.
Misali, Beijing ta sanya dokar keɓewa ta kwanaki 14 ga duk masu yawon buɗe ido na duniya da ke shiga cikin birni.A ranar 23 ga Maris, an watsa cutar ta China ta cikin gida kwanaki biyar da suka gabata, a wannan yanayin ta hanyar wani ɗan yawon buɗe ido da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da yaduwar cutar da aka samu a cikin gida kuma an shawo kan annobar a cikin kasar Sin.
A ranar, an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan an sanya takunkumin yankin. Ma'aikatar Harkokin Waje ta Jamhuriyar Jama'ar Sin ta sanar a ranar 26 ga Maris 2020 cewa za a dakatar da shiga ga masu riƙe da biza ko izinin zama daga ranar 28 ga Maris, ba tare da wani takamaiman bayani game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda ke son shiga China dole ne ya nemi takardar izinin shiga a ofishin jakadancin kasar Sin ko kuma ofishin jakadancin kasar Sin.
A ranar 30 ga Maris, gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa don sake budewa da kuma samar da wani kunshin karfafa kudi ga kamfanoni. Majalisar Jiha ta sanar da yin makoki ta hanyar fara mintuna uku na yin shiru a duk fadin kasar a ranar 4 ga Afrilu da karfe 10:00, wanda ya yi daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta nemi iyalai da su yi bukin girmamawa ta yanar gizo ta hanyar kiyaye takunkumin jiki don kauce wa sabon barkewar cutar COVID-19.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu daga China.
A ranar 20 ga Fabrairu, hukumar lafiya ta jihar ta ba da rahoton gagarumin karuwar a cikin wadanda aka tabbatar da cutar, wanda yawancinsu ya danganci wani sabon addini da aka kafa a Daegu, wanda aka fi sani da Shincheonji Church of Jesus.
Ana zargin mabiyan Shincheonji da ke ziyartar Daegu daga Wuhan da cutar.
A ranar 22 ga Fabrairu, daga cikin mabiya coci 9,336, 1,261 ko kusan kashi 13% sun ba da rahoton alamun.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma sauya jadawalin jiragen sama. Koriya ta Kudu ta gabatar da abin da ake kira mafi girma da kuma mafi kyawun tsari a duniya don tace cutar a cikin jama'a, ware duk wanda ke da cutar, da kuma bin diddigi da kuma killace mutanen da suka sadu da su.
Hanyoyin tacewa sun hada da wajabcin bayar da rahoton alamun cutar da kansu ta hanyar sabbin masu shigowa daga kasashen waje ta hanyar wayar hannu, jerin gwano na kwayar cutar ko kuma gwajin-ta hanyar da za a samu sakamako a rana mai zuwa, da kuma haɓaka damar gwaji zuwa sama da mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu na samun nasarar sarrafa cutar duk da cewa ba a kebe dukkan biranen ba.
'Yan Koriya da dama sun sanya hannu kan takardun neman a tuhumi Shugaba Moon kan zargin da suka yi na cewa gwamnati ta yi kuskure wajen magance annobar, ko kuma a maimakon haka, sun yaba da yadda shugaban ya yi.
A ranar 23 ga Maris, an ba da rahoton Koriya ta Kudu da ke da mafi ƙarancin adadin masu kamuwa da cutar a cikin kwanaki huɗu.
A ranar 29 ga Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu duk mutanen da suka zo daga ƙasashen waje za su yi zaman killace na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimako na gwajin ƙwayoyin cuta daga ƙasashe 121.
Iran ta ba da rahoton farkon cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom kuma, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'amuran al'adu, wasannin motsa jiki, da sallar Juma'a, da rufe jami'o'i, manyan makarantu, da makarantu.
Iran ta ware dala biliyan biyar domin yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na kebe yankunan da cutar ta shafa, za a kebe mutane ne kawai.
An sanar da shirin rage tafiye-tafiye tsakanin biranen a watan Maris, duk da cewa zirga-zirgar manyan biranen da ke gab da sabuwar shekara ta Farisa ta ci gaba.
An dai bude masallacin Shia na Qom ga masu ziyara har zuwa ranar 16 ga watan Maris na 2020. Bayan China, Iran ta zama cibiyar yaduwar cutar a watan Fabrairu.
A cikin ikirarin cewa an rufe adadin cutar a Iran, fiye da kasashe goma sun sake dawo da shari'unsu zuwa Iran a ranar 28 ga Fabrairu, wanda ya nuna cewa adadin cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ba da rahoton cewa 23 daga cikin mambobinta 290 sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga Maris, Human Rights Watch ta bukaci hukumomin gidan yarin Iran da su saki masu kare hakkin bil adama da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba kuma, a wani lokaci, su saki duk fursunonin da suka cancanta.
An ce akwai haɗarin kamuwa da cutar a cikin wuraren da aka rufe kamar gidajen gyaran hali, wanda kuma ba shi da cikakkiyar kulawa ta likita.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar mutum 100 a rana guda, wanda ya kasance mafi yawa a kasar tun lokacin da cutar ta bulla.
A ranar 17 ga Maris, aƙalla 'yan siyasa 12 ko jami'an gwamnatin Iran da suka gabata ko na yanzu sun mutu daga cutar.
A ranar 23 ga Maris, Iran na fuskantar sabbin mutane 50 a kowace awa da kuma sabon mutuwar mutum guda a kowane minti goma daga coronavirus.
A cewar wani jami'in WHO, akwai yiwuwar akwai mutane sau biyar da suka kamu da cutar a Iran fiye da yadda aka ruwaito.
An kuma ce takunkumin da Amurka ta kakaba wa Iran na iya shafar karfin kasar wajen mayar da martani ga barkewar cutar.
Babban Kwamishinan kare hakkin bil'adama na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki kan kasashen da annobar ta shafa, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da barkewar cutar a Italiya lokacin da matafiya biyu 'yan China suka kamu da SARS-CoV-2 a Rome.
Lamarin ya karu sosai, har ya sa gwamnatin Italiya ta dakatar da duk wani jirgin da ke zuwa da dawowa daga China, kuma ta ayyana dokar ta-baci.
Bayan haka, an gano tarin cututtukan COVID-19 da ba su da alaƙa, wanda ya fara da tabbatar da mutane 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabbin dokoki don dakile cutar, wanda ya haɗa da keɓewar mutane sama da 50,000 daga garuruwa 11 daban-daban a arewacin Italiya.
Firaminista Giuseppe Conte ya ce, "A yankin da cutar ta bulla, ba a yarda mutane su fita ko shiga ba.
An umarci dakatar da ayyukan aiki da wasanni a yankin. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a Italiya baki daya idan aka sami mutuwar mutane 100.
Duk manyan wasannin motsa jiki, gami da wasannin Serie A, za a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin motsa jiki na akalla wata guda.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci, ban da manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Italiya ta Anesthesia, Analgesia, Resuscitation, da kuma Kulawa Mai tsanani (SIAARTI) ta ba da shawarar da ya dace game da ka'idojin likita game da yarjejeniyar triase da za a yi amfani da ita.
A ranar 19 ga Maris, Italiya ta ɗauki matsayin China a matsayin ƙasar da ta fi kowacce yawan mace-mace da suka shafi coronavirus a duniya bayan da ta ba da rahoton mutuwar mutum 3,405 sakamakon cutar.
A ranar 22 ga watan Maris, an ba da rahoton cewa Rasha ta tura jiragen sama tara na soji dauke da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar, 15,887 suka mutu, kuma 21,815 sun warke a Italiya, tare da yawancin waɗannan mutanen a yankin Lombardy.
Wani rahoto na CNN ya ce abin da ya sa yawan mutanen da suka mutu ya haɗu da yawan tsofaffi a Italiya da kuma rashin iya yin gwajin ga duk waɗanda suka kamu da cutar.
Da farko, mayar da martani na Burtaniya ga cutar ya kasance ɗaya daga cikin ƙasashe masu rauni a cikin ƙasashe masu rauni, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta aiwatar da duk wani ƙuntatawa na zamantakewa ko kuma keɓewa ga jama'arta.
A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke kira ga dakatar da duk balaguro da hulɗar zamantakewa da ba na asali ba kuma ya ba da shawarar cewa mutane su yi aiki daga gida idan ya yiwu, da kuma guje wa wurare kamar mashaya, gidajen abinci, da gidajen kallo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren nishaɗi, kamar su mashaya da wuraren motsa jiki, dole ne a rufe su da wuri-wuri, kuma ta yi alƙawarin biyan kashi 80% na albashin ma'aikata har zuwa £2,500 a wata don hana rashin aikin yi a cikin rikicin.
Ba kamar matakan da suka gabata ba, 'yan sanda sun tilasta wannan ƙuntatawa ta hanyar biyan kuɗi da kuma rarraba ƙungiyoyi.
An umarci yawancin kasuwancin da za su rufe, sai dai kasuwancin da ake ganin "yana da mahimmanci", wanda ya haɗa da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin gas, da kuma wuraren gyare-gyare.
A ranar 20 ga Janairu, an gano mutum na farko da aka tabbatar da shi yana da cutar COVID-19 a jihar Washington, a wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga Janairu, an kafa Hukumar Kula da Cututtukan Coronavirus ta Fadar White House.
A ranar 31 ga Janairu, gwamnatin Trump ta ba da sanarwar dokar ta baci ta kiwon lafiyar jama'a kuma ta sanya takunkumin shiga ga mutanen da ke zuwa daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta kirkiro nata na'urar gwajin.
Duk da haka, Amurka ta yi jinkirin fara gwajin don haka ya ɓoye ainihin cutar a lokacin.
Gwajin ya kasance yana da matsala ta hanyar kayan gwaji na tarayya da aka samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwaji na wadanda ba na gwamnati ba (na masana kimiyya, kamfanoni, da asibitoci) har zuwa karshen Fabrairu, da kuma ka'idojin da suka dace don mutane su cancanci gwaji har zuwa farkon Maris (dokta na likita ya zama dole bayan haka).
Har zuwa 27 ga watan Fabrairu, The Washington Post ta ba da rahoton cewa an yi gwajin kasa da 4,000 a Amurka.
Har zuwa ranar 13 ga Maris, The Atlantic ta ba da rahoton cewa an yi gwaji ƙasa da 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ba da rahoto cewa: "Mutane da yawa da ke da alamun cutar da kuma umarnin likita suna jira na tsawon sa'o'i ko kwanaki don a gwada su". Bayan da aka samu mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da sanarwar gaggawa, wasu jihohi kuma suka bi sahun.
Makarantun da ke yankin Seattle sun soke karatun a ranar 3 ga Maris, kuma a tsakiyar Maris, an rufe makarantu a duk faɗin ƙasar.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Shirye-shiryen Cutar Coronavirus da kuma Karin Bayar da Karin Bayar da Kudin, wanda ya samar da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don amsawa ga cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikata, sun soke taro, kuma sun karfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga Maris, Trump ya ba da sanarwar hana zirga-zirga zuwa ga yawancin Turai, ban da Burtaniya, na tsawon kwanaki 30, wanda ya fara aiki a ranar 13 ga Maris.
Washegari, ya faɗaɗa takunkumin da ya saka wa Britaniya da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa don haka akwai kudaden tarayya don amsa rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko kuma rage lokacin aiki a fadin Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da barkewar cutar a cikin jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton New York City da ke da adadin mutane 10,700 da suka kamu da cutar coronavirus, wanda ya fi adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan New York ya ce dokar hana fita ta yi nasara saboda an yi jinkirin yin amfani da kwanaki biyu a kan yawan mutanen da suka kamu da cutar daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an tabbatar da mutum 32,308 da suka kamu da cutar a New York City, kuma mutum 672 suka mutu. A ranar 26 ga watan Maris, an ba da rahoton cewa Amurka ta sami karin mutane da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya.
A cewar rahotannin kafofin watsa labarai na ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin hana jama'a shiga har zuwa 30 ga Afrilu.
A wannan ranar, USNS Comfort, wani jirgin ruwa mai asibiti mai ɗakuna 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta sami adadi mafi girma na mutuwar coronavirus 884 a cikin awanni 24.
A jihar New York, adadin wadanda suka kamu da cutar ya zarce dubu 100 a ranar 3 ga Afrilu. An soki fadar White House da yin watsi da barazanar da kuma sarrafa sakonni ta hanyar umurnin jami'an kiwon lafiya da masana kimiyya da su hada kai da sanarwar jama'a da kuma wallafe-wallafen da suka shafi cutar a ofishin mataimakin shugaban Mike Pence.
A takaice dai, amincewa da tsarin gudanar da rikicin Trump ya kasu kashi biyu a tsakanin bangarorin biyu.
Wasu jami'an Amurka da masu sharhi sun soki Amurka kan dogaro da shigo da kayayyaki daga China, wadanda suka hada da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin yanayin tafiye-tafiye don tsarawa da kuma hasashen yanayin yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan da Kungiyar sufurin jiragen sama ta kasa da kasa ta bayar a shekarar 2018, mutane da suka fi tashi daga Wuhan sun fi yawa a Bangkok, Hong Kong, Tokyo, da Taipei.
Dubai, Sydney, da Melbourne suma an bayar da rahoton a matsayin shahararrun wuraren da mutane ke tafiya daga Wuhan.
Bali an bayar da rahoton mafi ƙarancin ƙarfi a cikin yanayin shiri tsakanin manyan biranen da aka fi so 20, yayin da biranen Ostiraliya suka fi ƙarfin.
An ce akwai sauran abubuwa da yawa da ba a gano ba game da COVID-19, kuma Ostiraliya za ta ƙara ƙarfafa kan iyakokin ƙasa da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, Ostareliya ta sanar da cewa tana cikin bala'i.
Saboda dokar hana zirga-zirgar ababen hawa a Wuhan da Hubei, wasu ƙasashe suna shirin kwashe 'yan ƙasa da ma'aikatan diflomasiyyarsu daga yankin, musamman ta hanyar jirgin haya daga ƙasar da suka fito, tare da izinin hukumomin China.
Ƙasashen da suka fara shirin kwashe 'yan ƙasarsu sun haɗa da Kanada, Amirka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da kuma Thailand.
Pakistan ta ce ba za ta kwashe 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma danginsu, tare da wasu 'yan Poland guda hudu, da 'yan China guda daya da kuma dan Indiya daya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, inda jirgin Brazil ya tsaya kafin ya ci gaba da tafiyarsa zuwa Brazil.
'Yan Brazil da suka je Wuhan an killace su a wani sansanin soji da ke kusa da Brasília.
A wannan ranar, Canadians 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi hayar) an kwashe su daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama dauke da 'yan Canada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan kasar 277 a ranar 3 da 4 ga Fabrairu zuwa cibiyar tsare mutanen tsibirin Christmas, wanda aka mayar da shi cibiyar killacewa, inda za su zauna na tsawon kwanaki 14.
Wani jirgin kwashe mutane daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojin (ciki har da wasu daga Ostiraliya da Pacific) an tsare su a sansanin sojan ruwa na Whangaparoa, a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawan da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin da ke dauke da fasinjojin Kanada 129 da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin saman South African Airways wanda gwamnatin Afirka ta Kudu ta yi hayar sa ya dawo da 'yan kasarta 112.
An yi gwajin likita kafin a tashi kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun kwayar cutar don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka gwada kuma suka nuna cewa ba su da ƙwayoyin cutar an sake dawo da su.
Dangane da sakamakon gwajin, an ba da izini ga duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin, matukan jirgin sama, ma'aikatan otal,' yan sanda, da sojoji waɗanda ke cikin aikin agaji; a matsayin kariya, duk an sanya su a cikin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar cutar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako zuwa China.
Wasu daliban kasar Sin a jami'o'i daban-daban na Amurka sun hada kai don aika da kayan agaji zuwa yankunan da cutar ta shafa na kasar Sin, tare da rukunin da suka hada kai daga yankin birni na Chicago; sun yi nasarar aikawa da abin rufe fuska na N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken rigakafi da kokarin magance cutar, da kuma kare "mutane masu haɗari a Afirka da Kudancin Asiya".
Kamfanin Interaction ya ruwaito cewa gwamnatin China ta ba da kyautar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa China.
Japan ta ba da abin rufe fuska miliyan daya zuwa Wuhan, Turkiyya ta aika kayan aikin likita, Rasha ta aika tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da bayar da kayan aikin likita miliyan 18 zuwa China, Jamus ta aika da kayan aikin likita da suka hada da rigunan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita zuwa China tare da yin alkawarin karin dala miliyan 100 a matsayin tallafin kudi ga kasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan kiwon lafiya da kwararru don taimakawa Italiya wajen magance cutar coronavirus.
Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 zuwa Addis Ababa, Habasha, don Tarayyar Afirka ta rarraba.
Bayan haka, ya aika wa Panama kayan gwaji 5,000, abin rufe fuska 100,000, da kuma na'urorin ba da iska guda biyar.
Ma ya kuma ba da gudummawar kayan kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwa game da ingancin abin rufe fuska da kayan gwaji na kasar Sin.
Misali, Spain ta janye kayan gwajin cutar coronavirus na kasar Sin 58,000 tare da daidaito na 30% kawai; a halin da ake ciki, Netherlands ta janye 600,000 na fuskokin fuska na kasar Sin da ke da lahani.
Belgium ta kuma janye wasu abin rufe fuska 100,000 da ba za a iya amfani da su ba, da ake zargin sun fito ne daga China, amma a zahiri daga Colombia ne.
A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani shirin ba da agaji na gaggawa ga kasashe masu tasowa.
Hukumar ta WHO ta yaba wa gwamnatin kasar Sin kan kokarin da ta yi na dakile cutar.
WHO ta lura da bambancin da ke tsakanin barkewar cutar SARS a 2002-2004 lokacin da aka zargi hukumomin kasar Sin da yin rufa-rufa da kuma hana ayyukan hanawa da dakilewa da kuma rikicin na yanzu tare da gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa fargaba a lokacin hutun Sabuwar Shekarar Sinanci".
A ranar 23 ga Janairu, a matsayin martani ga matakin da gwamnatin tarayya ta dauka na hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya ce duk da cewa matakin "ba shawarwarin WHO ba ne a fili", amma matakin "yana da matukar muhimmanci ga alƙawarin da za a iya shawo kan cutar a wuraren da cutar ta fi yawa" kuma ya kira shi "ba a taɓa faruwa ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da mutum zuwa mutum a waje da China da kuma karuwar adadin masu cutar a wasu ƙasashe, WHO ta ayyana cutar a matsayin Babban Rashin Lafiyar Jama'a na Duniya (PHEIC), matakin PHEIC na shida tun lokacin da aka fara aiwatar da shi a lokacin cutar swine flu ta 2009.
Babban Daraktan WHO Tedros Adhanom ya ce an bayyana PHEIC ne saboda "hadarin yaɗuwa a duniya, musamman ga ƙasashe masu ƙarancin kuɗi da matsakaici waɗanda ba su da ingantattun tsarin kiwon lafiya.
Da yake mayar da martani kan aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a aiwatar da matakan da za su hana tafiye-tafiye da cinikayya ta duniya ba tare da dalili ba" kuma "WHO ba ta ba da shawarar takunkumin kasuwanci da motsi ba".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya su ba da gudummawar dala miliyan 675 da za a yi amfani da su don tallafawa shirye-shiryen dabaru a cikin ƙasashe masu ƙarancin kuɗi, yayin da ta ambaci gaggawa don tallafawa ƙasashe waɗanda "ba su da tsarin gano mutanen da suka kamu da cutar idan cutar ta ɓarke".
Tedros ya kara da cewa " iyakar ƙarfinmu yana kan mafi rauni" kuma ya bukaci kasashen duniya su " zuba jari a yau ko kuma su biya ƙarin a nan gaba. " A taron manema labarai na ranar 11 ga Fabrairu, WHO ta ba da sunan COVID-19 a matsayin sunan cutar.
A ranar Litinin, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da "amsawa da ya ƙunshi yin amfani da dukkan ƙarfin tsarin Majalisar Dinkin Duniya".
Daga nan, Majalisar Dinkin Duniya ta kunna Tawagar Gudanar da Rikicin don ba da damar daidaita duk matakan Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan martani na kiwon lafiya, yayin da sauran hukumomin za su iya amfani da ƙwarewar su don magance tasirin cutar a cikin zamantakewar jama'a, tattalin arziki, da ci gaban ƙasa".
A ranar 14 ga Fabrairu, an kunna wani tawagar hadin gwiwa na China wanda WHO ke jagoranta; wannan tawagar tana da nufin samar da kwararrun masana na duniya da WHO a China don taimakawa gudanar da gida da kuma kimanta "matsanancin cututtuka da yaduwar cutar" ta hanyar gudanar da bita da tarurruka tare da hukumomin ƙasa masu alaƙa da kuma yin ziyarar ƙasa don tantance "tasirin ayyukan magance lardin da gundumar, wanda ya haɗa da birane da yankuna". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya dole ne ta yi ƙarin don shirya don yiwuwar cutar ta coronavirus" kuma ta ce, duk da cewa yana da wuri a kira shi da cutar, ya kamata ƙasashe su kasance "a cikin shirin shirye-shiryen lokaci".
A sakamakon barkewar cutar a Iran, WHO ta tura tawagar hadin gwiwa zuwa kasar don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga darajar barazanar coronavirus a duniya daga "babba" zuwa "babba", matakin da ya fi dacewa da matakin tsaro da kuma haɗarin haɗari.
A wata sanarwa, Mike Ryan, darektan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin cewa, "Lokaci ya yi da kowace gwamnati a duniya za ta fuskanci gaskiya: Ku farka.
Wannan kwayar cutar za ta iya zuwa wurinka kuma dole ne ka kasance a shirye", kuma ya nace cewa matakan da suka dace na iya taimaka wa duniya ta kauce wa "mafi munin".
Bugu da ƙari, Ryan ya bayyana cewa bayanan yanzu ba ya ba da damar jami'an kiwon lafiyar jama'a su bayyana cutar ta duniya, ya kuma ce irin wannan sanarwar na nufin "ainihin mun yarda cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga Maris, WHO ta ayyana annobar coronavirus a matsayin annoba.
Babban darektan WHO ya ce WHO "ta damu matuka game da yaduwar cutar da kuma tsananin ta, da kuma jinkirin da ake yi wajen daukar matakin da ya kamata". WHO ta fuskanci suka mai tsanani kan rashin iya magance cutar, wanda ya hada da jinkirin ayyana dokar ta-baci na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annoba.
Daya daga cikin halayen da aka nuna ya hada da takardar neman sa hannu da aka yi wa 733,000 a ranar 6 ga Afrilu, wanda aka aika wa Babban Daraktan WHO Tedros Adhanom don ya nemi ya yi murabus.
A ranar 26 ga Maris, 2020, dubun dubatar da kwararru na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun taimakon ceton rai kuma gwamnati tana da alhakin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba za a yi amfani da shi azaman hujja don nuna bambanci ga wasu ƙungiyoyi ba.
Masana sun jaddada cewa kowane mutum na da hakkin ya sami lafiya, wanda ya hada da nakasassu, kungiyoyin tsiraru, tsofaffi, 'yan gudun hijirar cikin gida, marasa gida, mutanen da ke rayuwa cikin matsanancin talauci, mutanen da ke cikin kurkuku, 'yan gudun hijira, da sauran kungiyoyin da ke bukatar tallafin gwamnati.
Hukumomin duniya suna kokarin magance tasirin zamantakewa da tattalin arziki na rikicin COVID-19.
Kungiyar Hadin Gwiwar Tattalin Arziki da Ci Gaban ta kaddamar da wani shiri na samar da bayanai na kan lokaci da kuma cikakkun bayanai kan martani na manufofi a kasashe a duk fadin duniya, tare da ra'ayoyi da shawarwari.
Daga manufofin da za a karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin keɓewar yanki da takunkumin tafiye-tafiye, cibiyar dijital ta ƙunshi Tracker na Manufofin Kasashe, kuma yana da nufin taimakawa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen martani na duniya don fuskantar ƙalubalen coronavirus.
Gwamnatin China ta fuskanci zargi daga Amurka, Ministan ofishin ministocin Burtaniya Michael Gove, da dan Shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda aka magance cutar da ta fara a lardin Hubei na kasar Sin.
An dakatar da wasu masu gudanarwa na jam'iyyar kwaminis ta kasar Sin (CPC) a matakin lardin dangane da gudanar da aikin killacewa a tsakiyar kasar Sin, wanda ke nuna rashin jin daɗi game da martanin da hukumomin siyasa ke bayarwa game da barkewar cutar a yankin.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da cutar ta coronavirus.
Wasu jami'an China, kamar Zhao Lijian, sun yi watsi da amincewar da suka yi a baya cewa annobar ta fara ne a Wuhan, kuma sun goyi bayan ka'idar da'awar cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta kira coronavirus da "kwayar cutar China" ko "kwayar cutar Wuhan" kuma ta ce "aikin China na rufe fuska ya ba da ƙarfi ga cutar da ke zama cutar ta duniya". Wannan furucin daga baya ya zama abin zargi daga wasu masu sukar da ke nuna wariyar launin fata da kuma "juya hankali daga gazawar gwamnatinsa wajen magance cutar korona".
Daily Beast ta sami sakon gwamnatin Amurka wanda ke bayyana dabarun sadarwa kuma a bayyane yake ya fito ne daga Kwamitin Tsaro na Kasa, tare da dabarun da aka nakalto a matsayin "Dukkanin China.
An gaya mana mu yi kokarin isar da wannan sakon ta kowace hanya da za mu iya, ta hanyar hada taron manema labarai da kuma nunawa a talabijin". Kafofin yada labarai kamar su Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin China na aikawa da taimako ga kasashen da cutar ta shafa wani bangare ne na farfagandar neman yin tasiri a duniya.
Shugaban harkokin waje na Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani bangaren siyasa na kasa, wanda ya hada da yin fada don samun iko ta hanyar karkatar da gaskiya da kuma 'siyasa na jin kai.'"
Borrell ya kuma ce, "China tana tura sakon cewa, ba kamar Amurka ba, tana da abokin tarayya mai dogaro da gaskiya".
China ta kuma yi kira ga Amurka da ta janye takunkumin da ta sanyawa Syria da Venezuela da Iran, kuma an ba da rahoton cewa ta aika da taimako ga kasashen biyu na baya.
An dakatar da kyautar da Jack Ma ya bayar na kayan rufe fuska 100,000 ga Cuba saboda takunkumin da Amurka ta sanya a kan sa a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka bai wa wasu kasashe zuwa kasashensu.
Akwai kuma rikice-rikice game da abin rufe fuska da aka ruwaito tsakanin wasu ƙasashe, kamar Jamus, Austria, da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kwato daruruwan na'urorin sanyaya iska da aka yi niyya don Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai ga Italiya da cutar ta coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce "China ce kawai ke amsawa a kan iyakokin biyu.
Hakika, wannan ba alama ce mai kyau na haɗin kan Turai ba".
A ranar 22 ga Maris, bayan karbar kiran waya daga Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya tura sojojin Rasha don aika da ma'aikatan lafiya na soja, motocin kashe cututtuka na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar Italiya La Stampa ta yi kaulin wani "babban jami'in siyasa" da ba a bayyana sunansa ba, wanda ya ce kashi 80 bisa ɗari na taimakon da Rasha ta ba Italiya "ba su da amfani ko kuma ba su da amfani sosai".
Majiyar ta zargi Rasha da kai hare-hare na "geopolitical da diplomatic".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kuma sun nuna godiyarsu.
Ƙari ga haka, Rasha ta tura jiragen sama masu ɗauke da kayan agaji zuwa Amirka.
Kakakin Kremlin Dmitry Peskov ya ce "a lokacin da muke ba da taimako ga abokan aikinmu na Amurka, [Putin] ya ɗauka cewa idan masu samar da kayan aikin likitancin Amurka da kayan aikin likita suka sami dama, za su iya mayar da martani idan ya cancanta".
An shirya gudanar da atisayen sojan NATO na "Defender 2020" a Jamus, Poland, da kuma kasashen Baltic, wanda shine mafi girman atisayen sojan NATO tun karshen Yakin Cold War, za a gudanar da shi a kan karamin sikelin.
Sakatare Janar na Kamfen na Ƙirƙirar Makamai na Nukiliya Kate Hudson ta soki atisayen Defender 2020: "A cikin halin da ake ciki na matsalar lafiyar jama'a, wannan atisaye ba kawai yana jefa rayukan sojojin Amurka da na ƙasashen Turai da ke halartar ba, har ma da na mutanen ƙasashen da suke aiki. "Gwamnatin Iran ta yi fama da cutar ta wannan kwayar cutar, tare da kusan 'yan majalisa goma sha biyu da suka kamu da cutar da kuma manyan' yan siyasa goma sha biyar na yanzu ko na baya.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya don neman taimako kuma ya ce kasarsa tana fama da yaƙi da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran.
Masu sharhi kan siyasa sun yi hasashen cewa hakan na iya yin illa ga damar da Donald Trump ke da ita na sake samun nasarar lashe zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "kokarin kebewa da rashin aiki na Japan" bayan da Japan ta sanar cewa duk wanda ya zo daga Koriya ta Kudu za a kebe shi na sati biyu a wani wuri da gwamnati ta tsara.
Da farko, ra'ayoyin jama'ar Koriya ta Kudu sun rarrabu dangane da yadda Shugaba Moon Jae-in ya yi game da wannan rikicin.
'Yan Koriya da dama sun rattaba hannu kan takardar neman a tsige Moon, bisa zargin da suke yi cewa gwamnati ta yi kuskure wajen magance annobar, da kuma jin dadin yadda aka yi amfani da ita.
Wasu masu sharhi sun nuna damuwa cewa hakan zai ba gwamnati damar ƙarfafa ikonta.
A Hungary, majalisar ta zabi ta baiwa Firaminista Viktor Orbán damar yin mulki ta hanyar zartarwa ba tare da wani wa'adi ba, ta dakatar da majalisar da zaɓe, da kuma hukunta mutanen da ake ganin suna yada labaran karya game da cutar da yadda gwamnati ke magance matsalar.
An zargi barkewar cutar coronavirus da karancin kayayyaki, wanda ya samo asali daga karuwar amfani da kayan aiki a duniya don magance cutar, sayen hanzari, da kuma katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amirka ta yi gargadin rashin isashen magunguna da kayayyakin kiwon lafiya saboda ƙaruwar bukatar da masu sayarwa ke yi.
Wasu yankuna kuma sun shiga cikin wani hali na sayen kayayyaki wanda ya haifar da karancin abubuwan da ake bukata, kamar abinci, kayan wanka, da ruwan kwalba, wanda ya haifar da karancin kayayyaki.
Musamman, masana'antar fasaha sun yi gargadi game da jinkirin isar da kayayyakin lantarki.
A cewar darektan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ta ƙaru sau 100 a shekara.
Wannan bukatar ta sa farashin ya haura ninki 20 na na yau da kullum kuma hakan ya sa aka jinkirta samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan kuma ya haifar da karancin kayan kariya a duniya, kuma WHO ta yi gargadin cewa wannan zai haifar da hadarin ga ma'aikatan kiwon lafiya.
A Ostiraliya, cutar ta ba da sabuwar dama ga masu sayen daigou don sayar da kayayyakin Australiya a cikin China.
Wannan aikin ya haifar da karancin madara mai dabara a wasu manyan kantuna kuma a karshe gwamnatin Ostiraliya ta hana shi. Duk da yawan cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma yawan bukatar kayayyakin abinci, wadannan yankuna biyu sun kauce wa karancin abinci.
Matakan da China da Italiya suka dauka na yaki da haramtacciyar ajiyar da kuma cinikin kayayyaki masu muhimmanci sun yi nasara, kuma hakan ya hana ƙarancin abinci da ake sa ran zai faru a Turai da Amirka ta Arewa.
Arewacin Italiya, tare da yawan amfanin gona, ba ta sami raguwa mai yawa ba, amma farashin zai iya tashi bisa ga wakilan masana'antu.
An gano shinge na abinci a cikin lokaci, har ma a cikin birnin Wuhan, yayin da jami'an gwamnatin kasar Sin ke kawar da ajiyar naman alade don tabbatar da wadatar abinci ga jama'a.
A Italiya ma akwai irin wannan dokar, wadda ta wajabta wa masu ƙera abinci su ajiye abinci don irin wannan gaggawa.
An ji koma bayan tattalin arzikin duniya a China: a cewar rahotannin kafofin yada labarai na ranar 16 ga Maris, an yi wa tattalin arzikin kasar Sin mummunan rauni a farkon watanni biyu na shekarar 2020 sakamakon matakan da gwamnati ta dauka don dakile yaduwar cutar, kuma tallace-tallace na kasuwa ya ragu da kashi 20.5%.
Saboda babban yankin China babban cibiyar tattalin arziki da masana'antu ne, ana ganin barkewar cutar na haifar da babbar barazanar lalata tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwannin za su ci gaba da yin taurin kai har sai an sami cikakken bayani game da yiwuwar sakamakon karshe.
A cikin Janairu 2020, wasu manazarta sun yi hasashen cewa tasirin koma bayan tattalin arziki na barkewar cutar a kan ci gaban duniya na iya wuce barkewar SARS na 2002-2004.
Wani ƙiyasi daga masanan jami'ar Washington a St. Louis ya ce cutar ta jawo wa sarƙoƙin samar da kayayyaki na duniya fiye da dala biliyan 300, wanda zai iya kai wa shekara biyu.
Kungiyar Kasashen da ke Fitar da Man Fetur ta OPEC ta ce tana cikin rudani bayan da farashin man fetur ya fadi sakamakon raguwar bukatar da ake samu daga China.
A ranar 24 ga watan Fabrairu, kasuwannin hannayen jari na duniya sun fadi saboda karuwar adadin masu cutar COVID-19 a waje da kasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da cutar coronavirus, yawancin alamun hannun jari na Amurka, wanda ya haɗa da NASDAQ-100, S&P 500 Index, da Dow Jones Industrial Average, sun yi rikodin raguwa mafi girma tun daga 2008, tare da Dow ya faɗi maki 1,191, mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi na 2007-2008.
Ƙididdigar jari uku sun ƙare makon da suka gabata da raguwa fiye da kashi 10.
A ranar 28 ga watan Fabrairu, Kamfanin Scope Ratings GmbH ya tabbatar da kimar darajar gwamnatin kasar Sin, amma ya ci gaba da kasancewa a cikin mummunan hangen nesa.
Hannun jari sun sake yin kasa saboda fargabar cutar korona, inda suka yi kasa mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya yin sanyi.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa matakin gaggawa na banki da kuma na jihohi.
Bankunan tsakiya sun yi saurin amsawa fiye da yadda suka yi a lokacin matsalar kuɗi ta shekara ta 2008.
Yawon shakatawa na daga cikin bangarorin da suka fi fama da takunkumin tafiye-tafiye, rufe wuraren taruwar jama'a da suka hada da wuraren yawon shakatawa, da kuma matakan da gwamnatoci ke dauka na takaita tafiye-tafiye a duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke tashin jirage saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na Burtaniya na Flybe ya rushe.
Tasirin da ke kan masana'antar jirgin ruwa ya kai irin wanda ba a taɓa gani ba.
An kuma rufe wasu tashoshin jiragen kasa da kuma tashoshin jiragen ruwa.
Annobar ta zo daidai da lokacin hutu na Chunyun, lokacin da ake yawan yin balaguro wanda ya danganta da hutun Sabuwar Shekara ta Sin.
Gwamnatocin tsakiya da na kananan hukumomi sun soke wasu abubuwan da suka shafi jama'a, ciki har da bikin sabuwar shekarar Lunar da ake yi a shekara, kuma kamfanoni masu zaman kansu sun rufe shaguna da wuraren shakatawa, kamar su Hong Kong Disneyland da Shanghai Disneyland.
An rufe yawancin bukukuwan Sabuwar Shekara ta Hauwa'u da wuraren shakatawa don hana taro, gami da Forbidden City a Beijing da kuma baje kolin gidan ibada na gargajiya.
A larduna 24, birane da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa 10 ga Fabrairu kuma sun umarci yawancin wuraren aiki da kada su sake buɗewa har zuwa wannan ranar.
Wadannan yankuna suna da kashi 80% na GDP na kasar da kuma kashi 90% na fitarwa.
Hong Kong ta ƙara matakan hana yaduwar cututtuka zuwa matakin da ya dace kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris, da kuma soke bukukuwan Sabuwar Shekara.
Ziyarar masu sayar da kayayyaki a Turai da Latin Amurka ta ragu da kashi 40 cikin ɗari.
Kasashen Arewacin Amurka da Gabas ta Tsakiya sun yi asarar kashi 50 zuwa 60 cikin dari.
Wannan kuma ya haifar da raguwar kashi 33-43% na zirga-zirgar masu tafiya zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da na Fabrairu.
Masu amfani da manyan kantuna a duk duniya sun aiwatar da ƙarin matakai, kamar ingantaccen tsaftacewa, shigar da na'urar daukar hoton zafi don bincika zafin jiki na masu siye, da kuma soke abubuwan da suka faru.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta afku a Wuhan, kimanin mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin daga cikin miliyan 300 na ma'aikatan baƙi na ƙauyukan China sun bar gidajensu a lardunan da ke cikin gida ko kuma suka makale a lardin Hubei.A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar wani kimantawa na Bankin Tsaro na Tarayya na St. Louis, cutar ta kwayar cutar kwayar cutar na iya haifar da asarar ayyukan yi miliyan 47 a Amurka kuma rashin aikin yi zai iya kaiwa 32%.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi a ba su tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 a Ingila sun nemi a ba su tallafin.
Tsarin biyan diyya na gajeren lokaci na Jamus ya karɓi Faransa da Ingila.
A duk faɗin duniya, fagen nuna fasaha da al'adun gargajiya sun sha wahala sosai a sakamakon annobar, wanda ya shafi ayyukan ƙungiyoyi da mutane, masu aiki da masu zaman kansu.
Kungiyoyin al'adu da al'adu suna ƙoƙari su riƙe aikinsu (wanda galibi ana samun kuɗin jama'a) don ba da damar samun al'adun al'adu ga jama'a, kiyaye ma'aikata da jama'a, da tallafawa masu fasaha idan ya yiwu.
A watan Maris na 2020, a duk faɗin duniya kuma a matakan da suka bambanta, gidajen tarihi, dakunan karatu, wuraren nunawa, da sauran cibiyoyin al'adu sun rufe har abada, tare da nune-nunen, abubuwan da suka faru, da kuma nunawa an soke ko an jinkirta su.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sabon sakamako na cutar da ke ci gaba da sauri shine soke ayyukan addini, manyan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide-kide, taron fasaha, da kuma kayan ado.
A cikin watan Afrilu, an yi bikin Easter a Roma, wanda ya zo a cikin makon ƙarshe na lokacin tuba na Kirista na Lent.
Yawancin bishopo suna ƙarfafa tsofaffin Kiristoci su zauna a gida kuma kada su halarci Mass a ranar Lahadi; wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen bidiyo ko talabijin, yayin da wasu ke ba da sabis na drive-in ko kuma na gida.
Tare da rufe coci-coci da majami'u da Bishop na Roman Katolika ya yi da kuma kwashe San Peter's Square daga masu yawon bude ido na Krista, sauran kungiyoyin addinai sun soke ayyuka da kuma iyakance taron jama'a a majami'u, masallatai, majami'u, temples, da gurdwaras.
Ma'aikatar lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta bulla kuma an rufe wuraren ibada, yayin da Saudiyya ta hana shiga wuraren bautar baƙi da mazaunanta a wuraren bautar Allah a Makka da Madina.
Wannan annoba ta haifar da babbar matsala ga kalandar wasanni na duniya tun bayan yakin duniya na biyu.
An soke ko jinkirta yawancin manyan wasanni, ciki har da gasar zakarun Turai ta 2019-2020, gasar Premier ta 2019-2020, UEFA Euro 2020, NBA na 2019-2020, da NHL na 2019-2020.
Cutar ta lalata shirin gasar wasannin Olympics ta 2020, wanda aka shirya za a fara a ƙarshen Yuli; Kwamitin wasannin Olympics na Duniya ya sanar a ranar 24 ga Maris cewa za a sake shirya taron har zuwa bayan 2020, amma ba zai wuce lokacin bazara na 2021 ba. "A duk faɗin duniya, gidajen caca da sauran wuraren wasan suna rufe kuma an jinkirta ko soke wasannin poker kai tsaye.
Wannan ya sa yawancin yan caca suka koma yanar gizo, yawancin rukunin caca na yanar gizo suna ba da rahoton ƙaruwar sabbin rajista.
Yawancin manyan gidajen wasan kwaikwayo na Broadway sun dakatar da wasan kwaikwayo.
Masu zane-zane suna bincika hanyoyi daban-daban don ci gaba da samarwa da raba ayyukan su ta hanyar Intanet azaman madadin ga wasan kwaikwayo na gargajiya, kamar su watsa shirye-shiryen raye-raye na kan layi ko ƙirƙirar "bikin biki" na yanar gizo don masu zane su nuna, watsawa, da kuma buga ayyukansu.
An yada labaran yanar gizo masu yawa game da cutar coronavirus a yanar gizo tare da mutane da yawa suna juyawa zuwa nishaɗi da shagala a cikin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an ga karuwar nuna bambanci, kin jinin baki, da kuma nuna wariyar launin fata ga mutanen China da Asiya ta Gabas, da kuma mutanen da ke cikin yankuna da cutar ta shafa a Turai, Amurka, da sauran ƙasashe.
Ana jin tsoro, da kuma nuna rashin amincewa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Amirka ta Arewa, da kuma yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin al'amuran keɓaɓɓu a cikin China) sun ba da labarin ra'ayoyin wariyar launin fata da aka bayyana a cikin ƙungiyoyi a duk duniya cewa Sinawa sun cancanci samun kwayar cutar ko karɓar abin da suke da'awar cewa sakamakon sakamako ne.
Kasashen Afirka da dama na fuskantar tashin hankali kan China.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin yankin.
Akwai tallafi ga Sinawa, a kan layi da kuma a waje, da kuma ga mutanen da ke cikin yankunan da cutar ta shafa.
Bayan ci gaba da barkewar cutar zuwa sabbin kasashe masu tasowa, mutane daga Italiya, kasar farko a Turai da ta fara fuskantar mummunar barkewar COVID-19, na iya zama abin zargi da kuma ƙiyayya. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu da farko sun sa hannu kan takardar neman hana Sinawa shiga ƙasashensu a ƙoƙarin dakatar da cutar.
A Japan, #ChineseDontComeToJapan ya zama abin da ake amfani da shi a Twitter.
'Yan China da sauran mutanen Asiya a Birtaniya da Amurka sun ba da rahoton karuwar yawan cin zarafin kabilanci da kuma hare-hare.
An soki Shugaba Donald Trump na Amurka saboda kiran da ya yi wa coronavirus da "kwayar cutar China", kalmar da masu sukar suka yi da cewa tana nuna wariyar launin fata da kuma adawa da China.
Masu zanga-zangar a Ukraine sun kai hari kan motocin da ke daukar 'yan Ukraine da wasu kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Dalibai daga Arewa maso Gabashin Indiya, waɗanda ke da iyaka da China, da kuma waɗanda ke karatu a manyan biranen Indiya an ba da rahoton cewa sun sami matsala dangane da barkewar cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata Party a jihar Bengal ta yamma Dilip Ghosh ya bayyana cewa China ta lalata yanayi kuma "wannan shine dalilin da ya sa Allah ya yi musu ramuwar gayya".
Daga baya ofishin jakadancin China da ke Kolkata ya soki wannan bayanin, yana mai cewa "rashin gaskiya ne". A China, nuna kyamar baki da wariyar launin fata ga mutanen da ba 'yan China ba sun tashi saboda cutar, tare da bayyana baƙi a matsayin "kayan baƙi" kuma ana nufin "kwana".
Yawancin jaridu da ke amfani da biyan kuɗi sun cire shi don wasu ko duk abin da suka shafi coronavirus.
Yawancin masu wallafawa na kimiyya suna ba da damar samun damar samun takardun kimiyya game da annoba.
Wasu masana kimiyya sun zaɓi su raba sakamakon da sauri a kan sabobin pre-print, kamar bioRxiv.
Sabon cutar mai yaduwa  Cutar da ke kamuwa da cutar da ke tasowa, sau da yawa sabo ne a cikin yanayin annoba ko hanyar watsawa
Duniya da cututtuka - Binciken duniya da cututtuka
Jerin cututtuka da annoba - Jerin wadanda suka mutu saboda cututtukan cututtuka
Satar namun daji da kuma zoonosis - Hadarin kiwon lafiya da ke tattare da cinikin namun daji na ban mamaki
Gwajin dakin gwaje-gwaje na cutar coronavirus na 2019 (COVID-19) da kwayar SARS-CoV-2 sun hada da hanyoyin da ke gano kasancewar kwayar cutar da kuma gano kwayoyin cutar da aka samar a matsayin martani ga kamuwa da cuta.
An tabbatar da kasancewar kwayar cutar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA na kwayar cutar.
An yi amfani da wannan gwajin ne don gano RNA na kwayar cutar SARS-CoV-2 kawai.
Ana amfani da wannan gwajin don tabbatar da sabon kamuwa da cuta ko kuma ci gaba da cutar.
Ana iya amfani da ganowar antibody (serology) don ganewar asali da kuma kula da yawan jama'a.
Gwajin antibody ya nuna yawan mutanen da suka kamu, ya haɗa da waɗanda suke da ƙanƙan da ba a nuna alamun cutar ba ko kuma waɗanda ba su da wata alama.
Ana iya ƙayyade ainihin mutuwar cututtuka da kuma rigakafin ƙwayoyin cuta a cikin yawan jama'a daga sakamakon wannan gwajin.
Saboda karancin gwaji, har zuwa watan Maris na 2020, babu wata ƙasa da ke da ingantaccen bayanai game da yaduwar cutar a cikin yawan jama'ar ta.
A ranar 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi uku cikin ɗari na yawan jama'arta, kuma akwai bambancin ra'ayi a kan yawan gwajin da ƙasashe suka yi.
Wannan bambancin na iya yin tasiri sosai a kan adadin mutuwar da aka ruwaito, wanda wataƙila an ƙididdige shi sosai a wasu ƙasashe.
Ta amfani da ainihin lokacin-lokacin-lokacin-lokaci-lokaci-lokaci-lokaci-lokaci-lokaci (rRT-PCR), wannan gwajin za a iya yi a kan samfurin numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharyngeal swab ko samfurin sputum.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i kadan zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi a kan makogwaro na makogwaro yana da aminci ne kawai a cikin makon farko na cutar.
Daga baya, ƙwayoyin cuta za su iya ɓacewa a cikin makogwaro yayin da suke ci gaba da yawaitawa a cikin huhu.
A madadin haka, ga wanda ya kamu da cutar da aka gwada a mako na biyu, za a iya ɗaukar samfurin daga cikin zurfin numfashi ta amfani da katet na inhalation ko kuma za a iya amfani da kayan da aka fitar ta hanyar tari (sputum).
An kirkiro daya daga cikin gwaje-gwajen PCR na farko a Charité, Berlin, a watan Janairun 2020 ta amfani da ainihin lokacin da ake amfani da shi na rikodin polymerase chain reaction (rRT-PCR), kuma ya samar da akalla 250,000 na gwajin don rarraba ta Hukumar Lafiya ta Duniya (WHO).
United Kingdom ta kuma ci gaba da gwaji a ranar 23 ga Janairu, 2020.Kungiyar Koriya ta Kudu Kogenebiotech ta haɓaka PCR-tushen SARS-CoV-2 (PowerChek Coronavirus) mai ƙwarewa a kan 28 ga Janairu, 2020.
A cikin China, BGI Group yana ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayan Magunguna ta China don kayan aikin SARS-CoV-2 na PCR. A cikin Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta rarraba 2019 New Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel ga dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwajen uku na kwayar halitta a cikin tsohuwar na'urar gwajin ya ba da sakamako mara gamsarwa saboda kuskuren reagent, kuma ƙarancin gwaji a CDC a Atlanta ya ƙare; wannan ya haifar da matsakaicin ƙasa da samfuran 100 kowace rana da aka sarrafa cikin watan Fabrairu na 2020.
An yi la'akari da gwajin yin amfani da abubuwa biyu ba abin dogaro ba har zuwa 28 ga Fabrairu, 2020, kuma bayan haka ne aka ba da izinin gwajin a cikin ɗakunan gwaje-gwaje na jihohi da na gida.
An ba da izinin gwajin ta Hukumar Abinci da Magunguna ta Amurka a ƙarƙashin izinin Amfani da Gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ya sanar da samuwar gwajin COVID-19 na RT-PCR a duk fadin kasar.
Hakanan, Quest Diagnostics ya sanya gwajin COVID-19 don wadatar da ƙasa a ranar 9 ga Maris 2020.
Babu iyakancewar adadi da aka sanar; dole ne a yi tattara da sarrafa samfuran daidai da bukatun CDC.
A Rasha, an kirkiro kuma an samar da gwajin COVID-19 ta Cibiyar Bincike ta Jihar a kan Kwayar cuta da Fasaha ta VECTOR.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kula da Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin.A ranar 12 ga Maris, 2020, Mayo Clinic ya ba da rahoton cewa yana haɓaka gwajin don gano cutar COVID-19.A ranar 13 ga Maris, 2020, Roche Diagnostics ya sami amincewar FDA don gwaji wanda za a iya yi a cikin awanni 3.5 a babban girma wanda zai ba da damar yin gwaji kusan 4,128 a cikin awanni 24 a kan na'ura ɗaya.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji a kan tsarin Abbott m2000; FDA ta ba da izini iri ɗaya a baya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya kuma karbi EUA daga FDA don gwaji wanda ya ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar haɓaka kwayar nucleic acid mai isothermal wanda ba PCR ba.
Ba tare da buƙatar jerin hawan hawan zafi ba, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar da kuma mummunan sakamako a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a cikin Amurka kuma Abbott yana tsammanin haɓaka samarwa zuwa samar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwajin da ke amfani da ƙwayoyin cuta na monoclonal waɗanda ke ɗaure musamman ga furotin nucleocapsid (furotin N) na sabon kwayar cutar corona a Taiwan, da fatan za a iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin hanzarin influenza.
Wani bita na littattafai da aka buga a watan Maris na 2020 ya kammala cewa "hoto na thoracic yana da ƙarancin ƙimar bincike a farkon matakan, kamar yadda binciken CT [computed tomography] na iya kasancewa kafin bayyanar cututtuka".
Halin halayen CT sun haɗa da rashin ƙarfi na ƙasa-gilashin multilobar bilateral tare da rarrabawar kewaye, asymmetry, da baya.
Dominance subpleural, crazy paving, da kuma karfafawa aka kafa a matsayin ci gaba da cutar.
A Wuhan, wani bincike da ya kwatanta PCR da CT a lokacin da cutar ta bullo da cutar ya nuna cewa CT ya fi PCR iyawa, duk da cewa ba shi da takamaiman bayani, tare da fasalin hoton da ya yi daidai da na pneumonia da sauran cututtukan da ke faruwa.
A watan Maris na 2020, Kwalejin Ilimin Radiology ta Amurka ta ba da shawarar "Kada a yi amfani da CT don tantancewa ko a matsayin gwajin farko don gano COVID-19".A watan Maris na 2020, CDC ta ba da shawarar PCR don tantancewa na farko.
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da ƙwayoyin cuta wanda ya haɗa da IgM da IgG.
Ana iya amfani da shi don gano cutar a cikin mutane tun daga kimanin kwanaki 7 bayan kamuwa da cutar, don tantance rigakafin cutar, da kuma a cikin sa ido kan yawan jama'a. Ana iya yin gwajin a cikin cibiyar bincike (CLT) ko kuma ta hanyar gwajin kulawa (PoCT).
Tsarin atomatik mai inganci a yawancin dakunan gwaje-gwaje na asibiti zai iya yin wannan binciken, amma wadatarsa zai dogara ne akan matakin samarwa ga kowane tsarin.
Don CLT, ana amfani da samfurin jini guda ɗaya na ƙarancin jini, kodayake ana iya amfani da jerin samfuran don bin amsawar rigakafi.
Don PoCT, ana amfani da samfurin jini ɗaya wanda aka samo ta hanyar allurar fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin cirewa kafin dubawa. A ranar 26 ga Maris, 2020, FDA ta ambaci hukumomi 29 da ke ba da sanarwar ga hukumomin kamar yadda ake buƙata kuma saboda haka yanzu za su iya rarraba gwajin kwayoyin cutar.
A ranar 7 ga Afrilu 2020, FDA ta amince da gwaji guda ɗaya kawai bisa ga izinin amfani da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan aikin gwajin su wanda zai iya gano IgG da IgA antibodies ga kwayar cutar a cikin samfurin jini.
Yana iya gwada daruruwan samfuran cikin sa'o'i kaɗan, ya fi saurin gwajin PCR na yau da kullum na RNA na kwayar cutar.
A farkon watan Afrilu, Birtaniya ta gano cewa babu wani daga cikin kayan gwajin da ta saya da ya isa a yi amfani da shi.
Hong Kong ta tsara wani tsari don marasa lafiya da ake zargi da cutar su zauna a gida, "sashen kula da gaggawa zai ba marasa lafiya samfurin samfurin, "suka yi taho a ciki, su aika da shi, kuma su sami sakamakon gwajin a wani lokaci daga baya. NHS ta Ingila ta sanar da cewa NHS tana ƙaddamar da tsarin gwajin cutar a gida don kawar da haɗarin kamuwa da cutar idan suka zo asibiti ko kuma yin amfani da rigakafin asibiti idan an yi amfani da shi.
Cibiyar gwajin ta taimaka wa Koriya ta Kudu ta gudanar da gwaji mafi sauri da kuma mafi girma fiye da kowace ƙasa. A ranar 2 ga Maris, Ƙungiyar Ƙungiyar Inshorar Kiwon Lafiya ta Jamus ta ce Jamus tana da damar yin gwaji kusan 12,000 a kowace rana a cikin asibiti kuma an yi gwaji 10,700 a makon da ya gabata.
Inshorar lafiya ce za ta biya kuɗin idan likita ya ce a gwada maka.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar yin gwajin 160,000 a mako.
A ranar 19 ga Maris, an ba da gwaji a manyan birane.
A ranar 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba saboda an ba da rahoton sakamako mai kyau kawai.
Wani binciken farko na dakin gwaje-gwaje ya bayyana cewa, a cikin duka, an gwada aƙalla samfura 483,295 har zuwa kuma har zuwa makon 12/2020 kuma an gwada samfura 33,491 (6.9%) don SARS-CoV-2.A cikin Isra'ila, masu bincike a asibitin Technion da Rambam sun haɓaka da kuma gwada hanyar gwada samfuran marasa lafiya 64 a lokaci ɗaya, ta hanyar haɗa samfuran da kuma kawai gwada ƙarin idan an sami samfuran haɗin gwiwa.
Tare da gina shi wanda wanda ya kafa BGI Wang Jian ya kula da kuma ɗaukar kwanaki 5, samfurin ya nuna cewa adadin masu cutar a Hubei zai iya zama 47% mafi girma kuma farashin da ke tattare da kula da keɓewa zai iya ninka idan ba tare da wannan damar gwajin ba.
Laboratory Wuhan ya biyo bayan Huo-Yan's lab a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk ƙasar Sin.
A ranar 4 ga Maris, 2020, jimlar yawan gwajin yau da kullun ya kai 50,000 a kowace rana. Tsarin zane-zane mai buɗewa wanda Origami Assays ya fitar zai iya gwada samfuran marasa lafiya 1,222 don COVID-19 ta amfani da gwaje-gwaje 93 kawai. Wannan daidaitaccen zane zai iya gudana a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar mai ɗaukar robotic ba.
A watan Maris, karancin reagents da rashin isasshen adadin reagents ya zama cikas ga gwaji a cikin Tarayyar Turai, Burtaniya, da Amurka.
Saboda haka, wasu masu bincike suna kokarin gano hanyoyin da za a shirya samfurin da ke kunshe da dumama samfurin a 98 °C (208 °F) na tsawon minti 5 don sakin kwayar RNA don ƙarin gwaji.
An cimma wannan ne ta hanyar hada gwaje-gwajen ƙasa da sayen ɗakunan gwaje-gwaje masu yawa daga Group 42 da BGI (wanda aka gina a kan dakin gwaje-gwaje na gaggawa na "Huo-Yan" a China).
An gina shi cikin kwanaki 14, yana iya yin dubun dubatar gwajin RT-PCR a kowace rana kuma shi ne na farko da aka gina a wannan sikelin a wajen kasar Sin.
An kirkiro wasu nau'ikan gwajin da ke yin amfani da wasu nau'ikan kwayoyin halittar kwayar cutar a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Ƙungiyar Lafiya ta Duniya ta ɗauki girke-girke na Jamus don samar da na'urar da za a tura wa ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun da za su iya yin amfani da su.
An wallafa girke-girke na Jamus a ranar 17 ga Janairu 2020; ba a samar da ladabi da Cibiyar Kula da Cututtuka ta Amurka ta samar ba har zuwa 28 ga Janairu don rage jinkirin gwajin da ake samu a Amurka.
Akasin haka, masana sun ce kasancewar wadataccen gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina ɗakunan gwaje-gwaje masu yawa, yawancinsu a dakunan gwaje-gwaje masu zaman kansu, a cikin 'yan shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga inganta shirye-shiryen gwaji a matsayin hanya mafi kyau don rage yaduwar cutar ta COVID-19. Babban bukatar gwaji saboda yaduwar cutar ya sa dubban daruruwan gwaje-gwaje suna jiran aiki a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma kayan aikin tsabtace kayan aiki da sinadarai sun zama masu haɗari.
A watan Maris na 2020, China ta ba da rahoton matsalolin daidaito a cikin kayan aikin gwajin su.
A Amurka, na'urar gwajin da CDC ta kirkira tana da "lafiyar" ne; gwamnati ta cire shingen da ke hana gwaji ta hanyar masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon gazawar tattara samfurin ko yin amfani da kayan gwajin daidai.
Ma'aikatar ta Spain ta ce za ta janye kayan aikin da suka ba da sakamakon da ba daidai ba, kuma ta maye gurbin su da wasu kayan gwajin da Shenzhen Bioeasy ta bayar. 80% na kayan gwajin da Czech Republic ta saya daga China sun ba da sakamakon da ba daidai ba. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firaminista Matovič ya ba da shawarar a jefa na'urar gwajin a cikin kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ta ce na'urar gwajin da Turkiyya ta saya daga China tana da "babban kuskure" kuma ba su "amfani da ita".
Gwajin, wanda ya biyo bayan keɓewar mutanen da aka gwada da kuma bin diddigin mutanen da suka yi hulɗa da mutanen da ke da SARS-CoV-2 masu inganci, ya ba da kyakkyawan sakamako.
Masu bincike da ke aiki a garin Vò na Italiya, wurin da mutum na farko ya mutu a Italiya saboda COVID-19, sun yi zagaye biyu na gwaji a kan mutane 3,400, waɗanda suka yi kwana 10 a waje.
Kimanin rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an kebe duk waɗanda aka samu.
Ta hanyar hana mutane zuwa wannan unguwa, an kawar da sabon kamuwa da cuta gaba ɗaya.
Tare da bin diddigin masu hulda, ƙuntatawa na tafiya, gwaji, da keɓewa, annobar cutar korona ta 2020 a Singapore ta yi jinkiri sosai fiye da sauran ƙasashe masu tasowa duk da rashin tsauraran matakai, kamar tilasta rufe gidajen abinci da wuraren kasuwanci.
An soke abubuwa da yawa, kuma Singapore ta shawarci mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Wasu ƙasashe kuma suna magance cutar ta hanyar bin diddigin mutane, ƙuntata tafiye-tafiye, gwaji, da kuma keɓewa, amma ba tare da keɓe yankuna ba, kamar Iceland da Koriya ta Kudu.
Wani bincike ya gano cewa ƙasashen da suka fi gwada yawan mutane, idan aka kwatanta da yawan mutuwarsu, suna da ƙarancin adadin mutuwarsu, wataƙila saboda ƙasashen sun fi iya gano mutanen da ke da alamun rashin lafiya ko kuma waɗanda ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashen da ba su da ƙarfin gwaji, da kuma dakunan gwaje-gwaje na ƙasa da ke da ƙarancin gogewa game da COVID-19, su aika da samfuran farko na COVID-19 guda biyar da kuma samfuran farko na goma zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 na WHO don tabbatarwa.
Daga cikin 16 da aka ba da, 7 a Asiya ne, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, 1 kuma a Ostareliya.
A cikin jadawalin da ke ƙasa, an nuna cewa "% na gwajin da aka yi na gwaji" ya dogara da manufofin gwajin na ƙasa.
Kasashen da ke gwada mutanen da ke asibiti kawai za su sami kashi mafi yawa na sakamako mai kyau fiye da ƙasashen da ke gwada dukkan mutanen da ke cikin su, ko suna da alamun cutar ko a'a, tare da sauran abubuwan da suka dace.
Wanke hannu, wanda ake kira tsabtace hannu, shine aikin tsabtace hannuwan mutum wanda ke da niyyar kawar da datti, mai, ƙwayoyin cuta, ko wasu abubuwa da ba'a so.
Wanke hannu da sabulu a kai a kai a wasu "lokaci" na rana yana hana yaduwar cututtuka da yawa, kamar su cututtukan gudawa da kwalara, waɗanda ake yaɗuwa ta hanyar hanyar sauro-bakin-ka.
Mutane suna iya kamuwa da cuta ta hanyar numfashi, kamar su mura ko kuma mura, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hancinsu, ko kuma bakinsu (wato, mucous membranes).
Sau biyar masu muhimmanci a cikin yini da ya kamata a wanke hannuwanka da sabulu su ne: kafin da bayan an yi fitsari, bayan an wanke bayan yaro ko an canja shi, kafin a ciyar da yaro, kafin a ci abinci da kuma kafin da bayan an shirya abinci ko a sarrafa nama, kifi, ko kaji.
Idan babu sabulu da ruwa, za a iya wanke hannu da toka.
Kafin, lokacin, da kuma bayan an shirya abinci.
Kafin ka kula da marasa lafiya da kuma bayan ka gama da su.
Bayan an canja diaper ko kuma bayan an wanke yaron da ya yi amfani da bayan gida.
Bayan an share hanci, an yi cough, ko kuma an yi atishawa.
Bayan taɓa dabbobi, abincin dabbobi, ko kuma najasa.
Tsabtace hannu na likita yana nufin ayyukan tsabtace hannu da suka shafi hanyoyin likita.
Wanke hannu kafin a ba da magani ko kuma magani zai iya hana ko rage yaduwar cuta.
Babban manufar kiwon lafiya na wanke hannu shine don wanke hannaye daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke haifar da cuta) da kuma sunadarai waɗanda zasu iya haifar da cutar ko cuta.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko aiki a fannin likita, amma kuma yana da mahimmanci ga al'umma gaba ɗaya.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus, da sauran cututtukan da ke yaɗuwa; hana cututtukan da ke haifar da zazzabi; rage kamuwa da cuta ta numfashi;
Kuma hakan ya rage yawan mutuwar da ake samu a gidajen haihuwa.
Nazarin da aka gudanar a 2013 ya nuna cewa ƙara yawan wanke hannu zai iya ƙara ƙarancin ci gaban yara.
A kasashe masu tasowa, ana iya rage yawan mutuwar yara daga cututtukan numfashi da kuma zawo ta hanyar sauƙaƙa wasu canje-canje na ɗabi'a, kamar wanke hannu da sabulu.
Wannan ƙaramin mataki zai iya rage mutuwar da ake samu daga wannan cuta da kusan kashi hamsin.
Ayyukan da ke karfafa wanke hannu na iya rage yawan cututtukan guda ɗaya cikin uku; ana iya yin wannan aikin ta hanyar samar da tsaftataccen ruwa a yankuna masu ƙarancin kuɗi.
48% na ragewa a cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuttuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cut cututtuka na cututtuka na cututtuttuka na cut cut cut cut cut cututtuka na cut cututtuka na cututtut
Cutar huhu, wacce ita ce babbar cuta mai suna ISPA, ita ce ke kan gaba wajen kashe yara ƙanana; cutar tana kashe yara miliyan 1.8 a shekara.
Ciwon guda biyu, wato, na zawo da na huhu suna kashe yara kusan miliyan ɗaya da miliyan uku a kowace shekara.
UNICEF ta ce, wanke hannu da sabulu kafin cin abinci da bayan an yi amfani da bayan gida zai iya ceton rayuka fiye da kowace rigakafi ko magani, kuma ya rage mutuwar da ake samu daga cututtukan guda biyu da rabi kuma ya rage mutuwar da ake samu daga cututtukan numfashi da kashi ɗaya bisa huɗu.
Wanke hannu ana yawan hada shi da sauran ayyukan tsafta a matsayin wani bangare na shirin ruwa, tsafta da tsabta (WASH).
Wanke hannu yana kuma kare mutum daga cutar impetigo da ake iya samu ta hanyar saduwa kai tsaye.
Wani sakamako mai illa na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike da aka yi a 2012 a Denmark ya gano cewa yawan wanke hannu yana iya haifar da yanayin fata mai ɗorewa da ƙaiƙayi, wanda aka fi sani da eczema ko dermatitis na hannu, wanda ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu da yawa ana ganin alama ce ta rashin nutsuwa.
Akwai lokuta masu mahimmanci guda biyar a cikin rana lokacin da wanke hannu da sabulu yana da mahimmanci don rage yaduwar cutar ta hanci-da-bakin-baki, wato: kafin da kuma bayan amfani da bayan gida (washe, babban kwance), bayan wanke bayan yara (canja diapers), kafin ciyar da yara, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa nama, kifi, ko kaji.
Wasu lokatai da suke da muhimmanci wajen kiyaye yaduwar cuta su ne kafin da kuma bayan an yi jinyar rauni; bayan an yi atishawa, an yi cough, ko an busa hanci; bayan an taɓa najasa ko kuma dabbobi; da kuma bayan an yi amfani da shara.
A ƙasashe da yawa, har yanzu akwai ƙarancin wanke hannu da sabulu.
Binciken wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita kashi 38.7% na gidaje suna wanke hannu da sabulu. Wani binciken na 2014 ya nuna cewa Saudi Arabia tana da mafi girma da kashi 97%; Amurka kusan a tsakiya da kashi 77%; da China a mafi ƙasƙanci da kashi 23%. Yanzu akwai wasu hanyoyin canza halaye don haɓaka tallafi na wanke hannu da sabulu a lokutan wahala.
Shirin Kula da Lafiya na Farko wanda Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na matakin da ya dace don tallafawa lafiyar yara da ilimantarwa.
Yin maganin tsutsotsi sau biyu a shekara, tare da wanke hannu kullum da sabulu da kuma goge haƙori kullum da ruwa mai ɗauke da sinadarin fluoride, sune ainihin abin da ake yi a wannan ƙasa.
An kuma yi nasarar aiwatar da wannan shirin a Indonesia.
Ana iya tsaftace fata daga ƙwayoyin cuta ta hanyar ƙara sabulu ko kuma maganin wanke ruwa.
Babban aikin sabulu da na'urar wanke-wanke shi ne rage shinge da ke hana ruwa narkewa da kuma ƙara yawan narkewar ruwa.
Ruwa ba shi da kyau wajen wanke fata domin kitse da furotin, waɗanda suke cikin ƙwayoyin cuta, ba sa narkewa cikin ruwa.
Duk da haka, ana samun isashen ruwa don a tsabtace kitse da furotin.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, zai iya ƙunsar ƙwayoyin ƙwayoyin cuta da aka samu daga amfani da shi a baya.
Ƙananan nazarin da aka yi a kan ƙwayoyin ƙwayoyin cuta da ke cikin sabulu ya nuna cewa ba za a iya samun irin wannan ƙwayar cuta ba domin ƙwayoyin cuta sun shaƙu da kumfa.
Amma, CDC ta ce "sabon ruwa da ake amfani da shi ba tare da an taɓa hannunsa ba ya fi dacewa".
Ana ba da shawarar sabulu mai hana ƙwayoyin cuta sosai ga mutanen da suke da hankali ga lafiyarsu.
Har zuwa yanzu, babu wata shaida da ke nuna cewa amfani da maganin antiseptic ko maganin rigakafi ya fi dacewa ga kwayoyin da ke da juriya a cikin yanayi.
Duk da haka, sabulu na antibacterial yana dauke da magungunan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin kwayoyin da ke da ƙarfin ƙwayoyin cuta.
Saboda haka, ko da yake sabulu mai hana ƙwayoyin cuta ba ya cutar da ƙwayoyin cuta, ba zai iya zama mai tasiri kamar yadda ake yi a kasuwa ba.
Bayan sunadarai da abubuwan da ke kare fata, ƙwararrun maganganu na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid a matsayin mai maganin antimicrobial mai aiki, da ƙarin kayan aikin fata (harshen alligator, bitamin, menthol, abubuwan tsiro).Binciken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun yana da tasiri kamar sabulu na masu amfani da kwayoyin cutar da ke dauke da triclosan a cikin rigakafin cututtuka da kuma tsabtace kwayoyin daga hannu.
Ruwa mai ɗumi da za ka iya wanke hannunka da shi ba zai kashe ƙwayoyin cuta ba.
Kwayoyin suna girma da sauri a zafin jiki (37 °C).
Ruwa mai ɗumi da sabulu ya fi ruwan sanyi da aka yi da sabulu kyau wajen cire duk wani abu kamar mai da ke hana ƙazanta da ƙwayoyin cuta shiga jikin mutum.
Amma, akasin abin da mutane da yawa suka gaskata, binciken kimiyya ya nuna cewa ruwan ɗumi ba ya rage ƙwayoyin cuta da ke hannu.
Mai tsabtace hannu ko mai maganin antiseptic na hannu shine mai tsabtace ruwa wanda ba na ruwa ba.
A ƙarshen 1990s da farkon karni na 21, masu tsabtace hannu ba masu amfani da ruwa ba (wanda ake kira masu amfani da giya, masu amfani da maganin antiseptic, ko masu tsabtace hannu) sun zama sananne.
Yawancin magungunan tsaftace-tsaftace suna da isopropyl alcohol ko ethanol wanda aka tsara tare da kayan ƙanshi kamar Carbomer (polymer na acrylic acid) zuwa gel ko tare da humektan kamar glycerin zuwa ruwa ko kumfa don sauƙin amfani da kuma rage tasirin bushewa na barasa.
Ƙara hydrogen peroxide mai laushi yana ƙara ƙarin aikin antimicrobial. Yin cyanitic na hannu wanda ya ƙunshi aƙalla 60-95% na barasa yana da inganci mai kashe ƙwayoyin cuta.
Alcohol nitration yana kashe kwayoyin cuta, kwayoyin cuta masu tsayayya da magunguna (MRSA da VRE), kwayoyin tuberculosis, wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza, da hepatitis), da fungi.
Ruwan shan giya mai dauke da kashi 70% na barasa yana kashe kashi 99.97% (rage log na 3.5, kwatankwacin rage decibel 35) na kwayoyin cuta a hannu 30 seconds bayan amfani da shi kuma 99.99% zuwa 99.999% (rage log 4 zuwa 5) na kwayoyin cuta a hannu 1 minti bayan amfani da shi. Ruwan shan giya na hannu yana da tasiri sosai ga ƙwayoyin cuta kuma ba shi da tasiri ga wasu ƙwayoyin cuta.
Alcohol-based hand sanitizers kusan ba su da tasiri a kan norovirus (ko Norwalk) -type, wanda shine mafi yawan abin da ke haifar da cututtukan gastroenteritis.
A gaba da bayan hannaye biyu da kuma a gefen hannu da kuma a saman dukkan yatsunsu ana shafawa na kimanin dakika 30 har sai ruwa, kumfa, ko gel ya bushe.
A cikin wannan yanayin, an ba da shawarar yin wanka da hannu maimakon yin wanka da hannu, musamman ma lokacin da hannu ya kasance mai datti.
Ƙara yawan amfani da kayan aikin cyanidation saboda sauƙin amfani da saurin kashewa na microorganisms; duk da haka, ba za a yi amfani da kayan aikin cyanidation a matsayin madadin wanke hannu na gaskiya ba, sai dai idan sabulu da ruwa ba su da sauƙi.
Yin amfani da maganin shafawa na giya na yau da kullun na iya haifar da bushewar fata, sai dai idan an ƙara emolien da/ko mai laushi na fata a cikin ƙirar.
Za'a iya rage ko kawar da tasirin bushewar barasa ta hanyar ƙara glycerin da / ko wasu emollients a cikin tsari.
A cikin gwajin asibiti, emollient-based hand sanitizers sun haifar da ƙarancin irritation da bushewar fata fiye da sabulu da kayan wanke-wanke na antimicrobial.
Allergic contact dermatitis, ciwo na urticaria, ko rashin jin daɗi ga barasa ko abubuwan da ke cikin abin da ke shafawa na hannu ba safai ba.
Ƙananan haɗarin haifar da cututtukan fata na tuntuɓar da ke damuwa da wannan samfurin ya fi dacewa da wanke hannu da ruwa da sabulu.
Duk da cewa suna da tasiri, masu maganin ba sa wanke hannu daga kwayoyin halitta, amma suna wanke su ne kawai.
Saboda wannan dalili, wankin hannu ba shi da inganci kamar sabulu da ruwa wajen hana yaduwar cututtuka masu yawa domin suna nan a hannu.
Ingancin wankin hannu na alcohol-free ya dogara sosai da kayan da aka yi da kuma yadda aka tsara shi, kuma a tarihi, ya yi ƙasa da na masu amfani da barasa da kuma masu yin amfani da giya.
Kwanan nan, an tabbatar da cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da kuma aikin antimicrobial bayan amfani, ba kamar na barasa ba, wanda aka nuna yana da rauni bayan amfani da shi, mai yiwuwa saboda sakamakon sakamako na sakamako mai illa.
Mutane da yawa a cikin ƙananan al'ummomin da ba su da kuɗin sayen sabulu suna amfani da toka ko ƙasa a maimakon.
Ash ko ƙasa za su iya yin aiki fiye da ruwa kawai, amma ba za su iya yin aiki kamar sabulu ba.
Ɗaya daga cikin damuwar da ake da ita ita ce, idan ƙwayoyin cuta suka ƙazantu a ƙasa ko kuma a turɓaya, za su iya sa cutar ta yaɗu maimakon ta rage.
Kamar sabulu, toka ma wakili ne na maganin kashe cututtuka saboda, idan ta yi hulɗa da ruwa, toka za ta samar da wani bayani mai ma'ana.
WHO ta ba da shawarar ash da sand a matsayin madadin sabulu lokacin da sabulu ba ya samuwa.
Hanyoyin wanke hannu daidai bisa ga shawarar Cibiyar Kula da Cututtuka ta Amurka don hana yaduwar cututtuka sun haɗa da waɗannan matakan:
A wanke hannuwanku da ruwan dumi ko ruwan sanyi mai gudana.
Ana bada shawarar ruwa mai gudana saboda kwalbar da aka dafa tana iya zama gurbatacciya, yayin da zazzabi na ruwa ba ya da tasiri.
A wanke hannuwanku ta hanyar shafa su da sabulu mai yawa, har da bayan hannu, a tsakanin yatsunsu, da ƙarƙashin ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai sa'ad da suka yi amfani da sabulu fiye da yadda suke yi sa'ad da suka yi amfani da ruwa kawai.
Ka yi wanka a kan dutsen na tsawon aƙalla daƙiƙa 20.
Shafa yana sa a samu ƙanshin cuta, wanda zai taimaka wajen cire ƙwayoyin cuta daga fata, kuma idan aka shafa tsawon lokaci, ƙanshin cuta zai fi yawa.
Ka yi tunanin yadda ruwa yake gudana a hankali.
Wanke hannu a cikin bokiti zai iya sake gurɓata hannuwan.
Ka bushe da tsintsiya ko kuma ka bar shi ya bushe a iska.
Hannun da ke cikin ruwa da kuma danshi suna da saukin kamuwa da cutar, kuma wuraren da ake yawan mantawa da su su ne manyan yatsun hannu, wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa.
Ƙusa da kuma ƙwanƙolin da aka cire daga farfajiyar ƙusa na iya zama wurin da ƙwayoyin cuta suke zama.
Sau da yawa ana ba da shawarar yin amfani da kayan shafawa don hana hannaye bushewa; bushewa na fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za'a iya yin zaɓuɓɓuka masu arha don sauƙaƙe wanke hannu lokacin da ruwan famfo da/ko sabulu ba su da sauƙi, misali, zubar da ruwa daga matattarar ruwa ko kwalban da aka rataye da ɓoyewa da/ko amfani da toka, idan ya cancanta, a cikin ƙasashe masu tasowa.
Tukunyar ruwa fasaha ce mai sauƙi da take amfani da kwalban ruwa da aka rataye da igiya, levers da ake amfani da su a kafa don zuba ruwa kaɗan a hannu, da kuma sabulu.
Ingantaccen bushewar hannu yana da muhimmiyar bangare na tsabtace hannu, amma akwai muhawara game da yadda za a iya samun ingantattun hanyoyin bushewar hannu a cikin gidajen wanka na jama'a.
Ƙarin bincike ya nuna cewa tawul ɗin hannu yana da tsabta fiye da busassun hannu na lantarki da ake samu a yawancin banɗaki.
A shekara ta 2008, wani bincike da jami'ar Westminster ta London ta gudanar, kuma wanda masana'antar kayan kwalliya ta Turai Tissue Symposium ta bayar, ya gwada ingancin tsabtace kayan kwalliya, bushewar hannu mai iska mai zafi, da kuma na zamani na jet.
Bayan wanka da bushewa da bushewar iska mai dumi, an gano cewa adadin kwayoyin cutar ya karu da kashi 194 bisa dari a kan yatsun hannu da kuma kashi 254 bisa dari a kan hannuwan hannu.
Drying da jet na'urar bushewa yana haifar da ƙaruwa a yawan kwayoyin cuta a matsakaicin kashi 42% a cikin yatsun hannu da kashi 15% a cikin tafin hannu.
Bayan wanka da bushe hannaye da takarda, an rage adadin kwayoyin cuta da kashi 76% a kan yatsun hannu da kashi 77% a kan tafin hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tantance yuwuwar gurɓatar da sauran masu amfani da bayan gida da kuma yanayin bayan gida daga kowane nau'in bushewa.
Jirgin iska mai iska, wanda ke fitar da iska daga cikin naúrar a saurin da aka yi iƙirari 180 m/s (650 km/h; 400 mph), yana da ikon busa kwayoyin cuta daga hannaye da naúrar kuma yana iya gurɓata sauran masu amfani da bayan gida da kuma bayan gida har zuwa mita 2.
Yin amfani da na'urar busar da hannu da iska mai zafi yana iya watsa ƙwayoyin cuta zuwa mita 0.25 daga na'urar busar da hannu.
A shekara ta 2005, a cikin binciken da TÜV Produkt und Umwelt ya yi, an kimanta hanyoyin bushewar hannu daban-daban.
Bayan bushewar hannu, an lura da canje-canje a cikin adadin kwayoyin cuta kamar haka:
Akwai masana'antun busar hannu da yawa, kuma an kwatanta busar hannu da busar hannu da amfani da takarda.
Wanke hannu da sabulu na wanka hannu wani zaɓi ne a lokacin tafiya idan babu sabulu da ruwa.
Ana amfani da maganin shafawa na hannu don yin maganin shafawa na giya wanda ya ƙunshi aƙalla kashi 60% na giya.
An fara amfani da wanke hannu a asibiti bayan da Ignaz Semmelweis, masanin ilimin likitanci na Hungary ya gano yana da tasiri wajen hana kamuwa da cuta a asibiti.
Akwai na'urar lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cuta ya ragu da amfani da na'urar.
Ana yin wanka na hannu na likita na aƙalla dakika 15, ana amfani da sabulu da ruwa mai yawa ko gel don yin ado da goge kowane ɓangaren hannu.
Hannunsu ya kamata su kasance tare da juna tare da yatsunsu.
Idan akwai datti a ƙarƙashin ƙusa, za a iya yin amfani da goge goge don cire shi.
Tun da yake ƙwayoyin cuta za su iya tsira a cikin ruwa da ke hannuwa, ya kamata a wanke hannayen da kyau kuma a bushe su da tsabta.
Bayan an bushe, ana amfani da takarda don kashe bututun ruwa (kuma buɗe ƙofar idan ya cancanta).
Wannan yana hana sake gurɓata hannu daga wannan farfajiyar.
Manufar wanke hannu a cikin tsarin kiwon lafiya shine kawar da kwayoyin cuta ("bacteria") da kuma guje wa watsawa.
The New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu har yanzu yana da ƙarancin karɓa a yawancin wuraren kiwon lafiya, tare da adadi mai yawa na likitoci da ma'aikatan jinya da ke ci gaba da manta da wanke hannayensu kafin su taɓa marasa lafiya kuma suna ba da kwayar cutar.
Wani bincike ya nuna cewa wanke hannu daidai da sauran hanyoyin da suka dace na iya rage yawan kamuwa da cututtukan jini da ke hade da kateters har zuwa kashi 66 bisa dari.Kungiyar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda ake wanke hannu da kuma shafa hannu a bangaren kiwon lafiya.
Hakanan ana iya ganin jagororin WHO na tsabtace hannu a shafin yanar gizon don ra'ayoyin jama'a.
Whitby et al ne suka yi binciken da ya dace.
Na'urar sayar da kayayyaki na iya auna da kuma tabbatar da tsabtace hannu idan an bukaci a nuna cewa an bi ka'idodi.
Hukumar Lafiya ta Duniya tana da "Lokaci biyar" don wanke hannu:
bayan an yi amfani da shi a cikin jini/ruwan jiki
kafin aikin aseptic, da kuma
Bayan an gama da mai jinya, sai a saka masa sinadarai masu kashe ƙwayoyin cuta.
Don 'rubbing' hannaye kafin aikin tiyata, ana buƙatar famfo wanda za'a iya kunnawa da kashewa ba tare da taɓawa ba, chlorhexidine ko yodium washer, sterile goge don bushe hannaye bayan wanka, da goge buroshi mai tsabta don gogewa da sauran kayan aikin da ba su da ƙazanta don tsabtace ƙusa.
Dole ne a cire duk kayan adon.
Wannan aikin yana buƙatar wanke hannuwanku da ƙwanƙwasawa har zuwa idon sawun, yawanci 26 minti.
Ba a buƙatar tsawan lokacin shafawa (minti 10).
Idan kana wanke hannuwanka, ka guji ruwan da ke hannunka ya koma hannunka.
Bayan an gama wanke hannu, sai a wanke hannu da rigar da ba ta da ƙazanta, sa'an nan a saka mayafi.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da na'urar wanke hannu kafin da kuma bayan an gama kula da marasa lafiya.
Don kula da kamuwa da cutar staphylococcus a asibitoci, an gano cewa mafi girman fa'idar wanke hannu ya zo ne daga kashi 20 cikin ɗari na farko na wankewa, kuma cewa ƙarin fa'idar da aka samu kaɗan ne lokacin da aka ƙara yawan yawan wanke hannu sama da kashi 35%.
A kwatanta tsakanin shafawa hannu da maganin da aka yi da giya da kuma wanke hannu da sabulun da aka yi da giya da kuma wanke hannu da sabulun da aka yi da giya da matsakaicin lokaci na 30 seconds kowannensu ya nuna cewa wankin hannu da aka yi da giya ya rage gurbatacciyar cuta ta 26% fiye da sabulun da aka yi da maganin da aka yi da giya.
Duk da haka, sabulu da ruwa sun fi tasiri fiye da masu tsabtace hannu na barasa don rage ƙwayar cutar ta H1N1 da Clostridium difficile daga hannaye.
Ana bukatar ƙarin bincike don a san irin taimakon da ya fi kyau a wurare dabam-dabam a tsarin kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu an yarda da cewa hanya ce mai tsada da kuma muhimmiyar hanya don samun koshin lafiya da kuma abinci mai gina jiki.
Duk da haka, rashin ingantaccen ruwa, sabulu, ko wanke hannu a gidajen jama'a, makarantu, da wuraren aiki ya sa cimma burin wanke hannu a duniya ya zama ƙalubale.
Alal misali, a yawancin yankunan karkara na Afirka, ruwan wanke hannu kusa da ban daki na sirri ko na jama'a ba ya yawan kasancewa, duk da cewa akwai zaɓuɓɓuka don yin wanka a hannu a farashi mai sauƙi.
Koyaya, ƙarancin wanke hannu na iya faruwa saboda al'ada da aka gina kuma ba saboda rashin sabulu ko ruwa ba.
Ƙarfafawa da kuma ƙarfafa wanke hannu da sabulu na iya yin tasiri a kan yanke shawara kan manufofi, da ƙara wayar da kan jama'a game da amfanin wanke hannu, da kuma kawo canji na dogon lokaci a cikin halayyar jama'a.
Don yin aiki yadda ya kamata, ana bukatar a riƙa lura da kuma bincika ayyukan.
Wani nazari na yau da kullun na nazarin 70 ya gano cewa hanyoyin al'umma sun kasance masu tasiri wajen inganta wanke hannu a cikin LMICs, yayin da kamfen ɗin tallan zamantakewa ba shi da tasiri.
Idan aka cika wannan bukata, makarantun za su iya samun ci gaba daga tauraro ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na wanke hannu da aka yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wata alama ce ta wayar da kan jama'a da ke ƙoƙarin cimma burin canza hali.
Wasu bincike sun duba tasirin tsaftace hannu gaba ɗaya a ƙasashe masu tasowa dangane da rage shekarun rayuwa da aka daidaita ta nakasa (DALYs) ko kuma shekarun da aka rasa saboda rashin lafiya.
Wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi yawa a farashin ruwa da sauran ayyukan tsaftacewa.
Muhimmancin wanke hannu ga lafiyar mutum, musamman ga mutane masu rauni, kamar uwaye da suka haihu ko sojoji da suka ji rauni a asibiti, an fara gane su a tsakiyar karni na 19 ta biyu masu tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria, da Florence Nightingale, "mahaifiyar aikin jinya na zamani" a Ingila.
A lokacin, mutane da yawa sun gaskata cewa ƙamshin ƙanshi da ake kira miasma ko kuma iska mai ƙazanta ne ke jawo cutar.
A cikin shekarun 1980s, annobar da ke tattare da abinci da cututtukan da ke da alaƙa da kiwon lafiya ya sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta fi himma wajen ƙarfafa tsabtace hannu a matsayin muhimmiyar hanya don hana yaduwar kamuwa da cuta.
Bala'in annobar mura a 2009 da annobar COVID-19 a 2020 sun sa mutane a ƙasashe da yawa su san muhimmancin wanke hannu da sabulu don kare kansu daga wannan cuta mai yaduwa.
Alal misali, a Jamus, an saka hotuna "dabaru masu kyau na wanke hannu" kusa da wajen wanke hannu a bayan gidajen jama'a da kuma bayan gidajen ofisoshin gwamnati da na filayen jiragen sama.
"Washe hannu" yana nufin mutum ya ƙi ya ɗauki alhakin wani abu ko kuma ya ƙi yin wani abu da ya shafi kansa.
Wannan kalmar ta samo asali ne daga littafin Matta inda Bilatus Babba ya wanke hannayensa bayan ya yanke shawarar gicciye Yesu Kristi, amma an yi amfani da ita a cikin harshen Turanci.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a kai a kai don tsabtace ƙazantar tunanin; wani aiki wanda ke nuna laifin laifin da ta aikata da kuma cewa ta rinjayi mijinta ya aikata shi.
An kuma gano cewa, bayan an tuna ko an yi tunani a kan wani abu mara kyau, mutane sukan wanke hannayensu sau da yawa kuma su fi daraja kayan wanke hannu.
Bugu da ƙari, mutanen da aka bari su wanke hannayensu bayan wannan wanka suna da ƙananan damar shiga cikin ayyukan "tsabtace" na gyara, kamar su ba da kai.
Addini yana ba da umarnin wanke hannu don tsabtace jiki da kuma alamomi. wanke hannu na alama, wanda ke amfani da ruwa, amma ba tare da sabulu don wanke hannu ba, wani ɓangare ne na al'adar wanke hannu a cikin addinai da yawa, gami da Baha'i, Hindu, Tevlila da Netilat Yadayim a cikin Yahudanci, Lavabo a cikin Kiristanci, da Wudhu a cikin Islama. Addini kuma yana ba da umarnin wanke hannu don tsabta, musamman bayan wasu ayyuka.
Addinan Hindu, Yahudawa, da Islama sun bukaci a wanke hannu bayan an yi amfani da bayan gida.
Bugu da ƙari, addinan Hindu, Buddha, Sikh, Yahudanci, da Musulunci sun bukaci a wanke hannu kafin a ci abinci da kuma bayan hakan.
Kula da haɗarin COVID-19 a wurin aiki
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin lafiya da lafiya na aiki don kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Ingantaccen kula da haɗarin a wurin aiki ya dogara da wurin aiki da aikin, wanda ya dogara da kimanta haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da kuma haɗarin kowane ma'aikaci na iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin hulɗar aiki tare da jama'a da sauran abokan aiki; don waɗannan ayyukan, ana ba da shawarar matakan rigakafin kamuwa da cuta, wanda ya haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna cikin asibiti, da kuma yin tsabtace gida da kuma tsabtace wuraren aiki akai-akai.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ayyukan da ke buƙatar kusanci ko hulɗa da mutane da ba a san ko an yi tsammanin suna da COVID-19 ba, amma ana iya kamuwa da cutar saboda ci gaba da yaduwar jama'a ko tafiye-tafiye na ƙasa da ƙasa.
Wannan rukunin ya haɗa da ma'aikata waɗanda ke da hulɗa da jama'a kamar a makarantu, wuraren aiki tare da yawan jama'a, da kuma manyan ɗakunan sayar da kayayyaki.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta, sun haɗa da yin amfani da iska mai kyau, rigakafin hanci, da kuma samar da kayan kariya na mutum idan ya sadu da masu COVID-19.
OSHA ta yi la'akari da ma'aikatan kiwon lafiya da kuma masu kula da gawawwaki da ke hulɗa da mutanen da aka sani ko ake zargin suna da COVID-19 a matsayin masu haɗarin haɗari, wanda ya ƙaru zuwa haɗarin haɗari mai yawa idan ma'aikata suna gudanar da hanyoyin samar da aerosol a kan, ko karɓar ko sarrafa samfura daga, mutanen da aka sani ko ake zargin suna da COVID-19.
Wannan hadarin ya shafi ma'aikata, wanda ya haɗa da sarrafa kayan aiki, kamar su ɗakin iska mai ƙarancin ƙarfi, da kayan kariya da suka dace da aikin.
COVID-19 ya iya haifar da wasu matsaloli a wuraren aiki.
Ma'aikaci zai iya ƙin zuwa aiki domin yana rashin lafiya, yana bukatar ya kula da wasu, ko kuma don yana tsoron kada a kama shi.
Tsarin kasuwanci na iya canzawa, a cikin nau'ikan abubuwan da ake nema da kuma yadda ake samun waɗannan abubuwan (kamar sayayya a cikin lokutan da ba su dace ba, ta hanyar aikawa, ko kuma ta hanyar layi).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ke shafar yanki na iya zama mai wahala.
Shirin ya yi la'akari da matakan hadarin da ke tattare da wurare daban-daban da kuma ayyukan aiki, ya hada da tushen fallasa, abubuwan hadarin da ke tattare da tsarin gida da al'umma, da kuma abubuwan hadarin ma'aikaci, kamar tsufa ko kuma yanayin rashin lafiya na yau da kullum.
Tsarin ya kuma bayyana irin matakan da ake bukata don magance hadarin da kuma shirin gaggawa don yanayin da zai iya tashi sakamakon barkewar cutar.
Shirye-shiryen rigakafin cututtuka da shirye-shiryen rigakafin cututtuka na iya zama batun shawarwarin ƙasa ko ƙasa.
Manufofin magance barkewar cutar sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan rashin lafiya, kula da ayyukan kasuwanci, da rage tasirin cutar a kan sauran ƙungiyoyi a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'ummar da kasuwancin ke zaune yana tasiri kan matakan da aka ɗauka.
Tsarin kula da haɗari shine tsarin da aka yi amfani dashi a cikin lafiyar aiki da lafiyar aiki don rarraba sarrafa haɗari bisa ga tasirinsa.
Idan ba za a iya kawar da haɗarin COVID-19 ba, mafi kyawun maganin shine sarrafa fasaha, sannan gudanarwa, da na ƙarshe kayan aikin kariya.
Kulawa ta fasaha ya ƙunshi keɓe ma'aikaci daga haɗarin da ke tattare da aikin ba tare da dogaro da halayen ma'aikaci ba kuma yana iya zama mafi kyawun mafita don aiwatarwa.
Gudanarwa na gudanarwa shine canji a cikin manufofin aiki ko hanyoyin da ke buƙatar aikin ma'aikaci ko mai aiki.
Kayan kariya na mutum (APD) ba shi da tasiri kamar na kulawar fasaha da na gudanarwa, amma yana iya taimakawa wajen hana wasu daga cikin bayyanuwa.
Duk nau'ikan APD dole ne a zaɓa bisa ga haɗarin ma'aikaci, a sanya su yadda ya kamata (misali, na'urar numfashi), a saka su daidai kuma daidai, a duba su, a kula da su, kuma a sauya su a kai a kai, idan ya zama dole, kuma a cire su, a tsabtace su, kuma a adana su yadda ya kamata ko kuma a zubar da su don guje wa gurɓata su.
A cewar Hukumar Kula da Lafiya da Tsaro ta Amurka (OSHA), ayyukan da ke da ƙarancin haɗarin haɗari suna da ƙarancin hulɗar aiki tare da jama'a da sauran abokan aiki.
Abubuwan da aka ba da shawarar don kiyaye cututtukan cututtukan da ke faruwa a duk wuraren aiki sun haɗa da wanke hannaye sosai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, halayyar numfashi sun haɗa da rufe tari da hancin, samar da kayan aiki da kwantena, shirya aiki ta nesa ko kuma aiki tare da lokacin isowa/fita, idan ya cancanta, sanar da ma'aikata kada su yi amfani da kayan aiki da kayan aikin wasu, da kuma tsabtace da kuma gurɓata yanayin aiki akai-akai.
Gano mutum da sauri da kuma ware shi daga masu cutarwa yana da muhimmanci wajen kare ma'aikata, abokan ciniki, masu ziyara, da sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun cutar numfashi na gaggawa su zauna a gida har sai sun sami zazzabi, alamun zazzabi, da sauran alamun aƙalla awanni 24 ba tare da amfani da maganin zazzabi ko wasu magungunan da ke sauya alamun ba, kuma cewa manufofin hutun rashin lafiya suna da sassauƙa don ba da damar ma'aikata su zauna a gida don kula da dangin da ke rashin lafiya, kuma cewa ma'aikata su san wannan manufar.
A cewar OSHA, ayyukan da ke da haɗarin haɗari sun haɗa da ayyukan da ke buƙatar kusanci ko kusanci a cikin ƙafa shida (1,8 mita) tare da mutanen da ba a san ko an yi zargin suna da COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar a cikin al'umma kusa da wurin kasuwanci, ko kuma saboda wani ya yi tafiya ta ƙasa da ƙasa zuwa wani wuri da ke da yaduwar COVID-19.
Wannan rukunin ya hada da ma'aikatan da ke da hulda da jama'a kamar a makarantu, wuraren aiki da ke da yawan jama'a, da kuma manyan manyan kantunan sayar da kayayyaki. Ka'idojin sarrafawa ga wannan rukunin da kuma rukunin haɗarin haɗari sun haɗa da sanya matattarar iska mai inganci, haɓaka matakan yin iska, sanya shingen jiki kamar filastik mai haske mai hana yin tsutsa, da kuma sanya windows na drive-thru ko windows na latsawa don sabis na abokin ciniki.
Ma'aikata a cikin rukunin haɗarin ba sa bukatar na'urar ta numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware marasa lafiya daga wasu mutane da nisan kafa 6, sanya ma'aikatan jirgin sama guda ɗaya don kula da marasa lafiya, da kuma ba da abin rufe fuska ga marasa lafiya ko kuma sanya musu tawul don rufe baki da hanci lokacin da suke yin tari ko tari.
Ma'aikatan jirgin ya kamata su sa safofin hannu na likita da za a iya amfani da su a lokaci guda yayin kula da fasinjoji marasa lafiya ko kuma taɓa ruwan jiki ko saman da zai iya gurbatawa kuma wataƙila wasu kayan kariya idan fasinjoji marasa lafiya suna da zazzaɓi, tari mai ɗorewa, ko wahalar numfashi.
Ga jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa, kula da haɗari ya haɗa da jinkirta tafiya idan akwai rashin lafiya, ware kai, da kuma sanar da cibiyar likitancin jirgin ruwa nan da nan idan mutum ya kamu da zazzabi ko wata alama yayin da yake kan jirgin.
Idan akwai yiwuwar kamuwa da cutar a cikin al'umma, don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsabtace ko kuma kashe ƙwayoyin cuta idan wani wanda ya kamu da cutar ya kasance a cikin makarantar.
Idan akwai ƙananan cututtukan cututtukan jama'a, ana iya amfani da dabarun iyakancewar jama'a, wanda ya haɗa da: soke ziyarar filin, tarurruka, da sauran manyan taron jama'a, kamar su ilimin motsa jiki, azuzuwan mawaƙa, ko cin abinci a cikin cafeteria, ƙara nesa tsakanin tebur, lokaci zuwa zuwa da dawowa, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓun wuraren kula da lafiya don yara masu alamun cututtukan cututtukan cututtukan.
Idan akwai babban kamuwa da cutar a cikin al'ummomin gida, a cikin dabarun nesantawa da jama'a, za a iya yin la'akari da tsawaita rufe makarantu. Ga jami'an tilasta bin doka da ke gudanar da ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiya na gaggawa a matsayin mara kyau.
An ba da shawarar cewa jami'an tilasta yin doka da suka yi hulɗa da mutanen da aka tabbatar ko aka yi zargin suna da COVID-19 su bi ƙa'idodi iri ɗaya da na likitocin gaggawa, gami da amfani da kayan kariya na mutum.
Idan kusanci ya faru yayin kamawa, ma'aikata ya kamata su tsaftace da kuma tsabtace belts da kayan aiki kafin sake amfani da su ta amfani da tsabtace gida ko tsabtace gida da kuma bin ka'idodin aiki don sarrafawa da kuma kawar da APD da aka yi amfani da shi da kuma sarrafawa da kuma wanke tufafi masu tsabta.
OSHA ta ɗauki wasu ma'aikatan lafiya da kuma gawawwakin da ke cikin rukunin haɗarin haɗari mai ƙarfi ko mai ƙarfi.
Ayyukan da ke da haɗarin haɗari sun haɗa da samar da kiwon lafiya, tallafi, dakunan gwaje-gwaje, da ma'aikatan jigilar likitoci waɗanda ke fuskantar haɗari tare da waɗanda aka sani ko waɗanda ake zargi da COVID-19.
Wannan aikin yana da haɗarin haɗari mai yawa idan ma'aikata suna gudanar da ayyukan samar da aerosol a kan, ko karɓar ko sarrafa samfur daga, mai cutarwa da aka sani ko wanda ake zargi da COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin shigar da tari, bronchoscopy, wasu hanyoyin da binciken hakori, ko kuma daukar kwayar cutar.
Ayyukan morgue masu haɗarin haɗarin haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da aka sani ko waɗanda ake zargi da cutar COVID-19 a lokacin mutuwa; wannan aikin ya zama haɗarin haɗarin haɗari mai haɗari idan ma'aikaci ya yi aikin bincike.
Ƙarƙashin iska na musamman zai iya zama daidai a wasu wuraren kiwon lafiya da kuma ɗakin gawa.
Dole ne a kula da samfurin tare da matakan tsaro na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware masu shigowa zuwa dakunan jira daban-daban bisa la'akari da ko sun kamu da cutar COVID-19.Bayan sauran APDs, OSHA ta ba da shawarar cewa a sanya masu amfani da na'urar numfashi a kan masu aiki a cikin nisan kafa 6 daga wanda aka sani ko wanda ake zargin yana dauke da SARS-CoV-2, da kuma masu gudanar da ayyukan aerosol.
A Amurka, NIOSH da aka amince da shi ko mafi kyawun masks masu rufe fuska N95 masu rufe fuska dole ne a yi amfani da su a cikin mahallin rubutaccen, cikakken shirin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo, da kuma gwajin likita.
Wasu nau'in na'urar na iya samar da kariya mafi girma da kuma inganta jin daɗin ma'aikata. WHO ba ta bayar da shawarar rufewa ko sutura ba saboda COVID-19 cuta ce ta numfashi ba ta jiki ba.
Hukumar ta WHO ta ba da shawarar sanya abin rufe fuska ne kawai ga jami'an da ke duba masu shigowa kasar.
Ga mutanen da ke ɗaukar samfurin numfashi, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da aiwatar da hanyoyin samar da iska ba, WHO ta ba da shawarar rufe fuska, tabarau mai kare fuska, ko kuma rigar fuska, da kuma safar hannu.
Idan an yi aikin aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin cewa wadatar APDs ba ta isa ba a duk duniya, WHO ta ba da shawarar rage buƙatun APDs ta hanyar sabis na likitancin nesa, ƙuntataccen jiki kamar windows na gani, tare da kawai mutanen da ke cikin kulawa kai tsaye shiga cikin ɗakin da ke ɗauke da marasa lafiya na COVID-19, amfani da APDs kawai waɗanda ake buƙata don takamaiman aiki, ci gaba da amfani da respirator ɗaya ba tare da cirewa ba yayin da yake kula da marasa lafiya da yawa tare da wannan cutar, saka idanu da daidaita sarkar samar da APD, da ƙarfafa kada a yi amfani da abin rufe fuska ga mutanen da ba su da alamun cutar.
Daga Katherine Maher, Shugaba na Gidauniyar Wikimedia
GASKIYA: Duk ma'aikatan Gidauniyar Wikimedia
ABIN DA LITTAFI MAI TSARKI YA CE: Ka sauƙaƙa wa kanka nauyi kuma ka shirya wa kanka nan gaba.
A cikin wannan labarin, za mu ga yadda za a iya amfani da shi don yin amfani da shi don yin amfani da shi don yin amfani da shi.
Ba a ba da izinin amfani da wannan ba.
Mun sami kanmu a cikin wani yanayi mai ban mamaki a wannan wata.
Annobar COVID-19 ta zama wata alama ta haɗin kan duniya da kuma nauyin da muke da shi ga juna.
Ba mu taɓa fuskantar irin wannan ƙalubalen ba, amma mun san cewa mafi kyawun amsa da za mu iya bayarwa ta dogara ne da irin wannan tausayi, haɗin kai, da kuma gina al'umma ta duniya, wanda shi ne zuciyar wannan ƙungiyar.
Abokantaka da kuma kulawa da muka gani tsakanin abokan aikinmu ta hanyar imel, kira, da kuma tattaunawa, sun tabbatar da cewa akwai mutane na musamman, waɗanda muke da sa'ar yin aiki tare da su.
Abin farin ciki ne da kuma abin alfahari a gare ni in kira ku abokan aiki.
A makon da ya gabata, wani ya gaya mini yadda yake godiya da aikin da muke yi.
Sun tunatar da ni yadda samun damar shiga Wikipedia yake da muhimmanci a duniya a yau da kuma yadda yake da muhimmanci a ci gaba da samun wannan muhimmiyar hanya a kan layi ga kowa.
Aikinku na sa wannan ya yiwu, ko dai ta wajen ci gaba da wannan shafin, taimaka wajan biyan abokan aikinmu, ko kuma taimakawa wajen kiyaye lafiyar al'ummarmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, musamman a wannan lokaci.
Wannan shi ne lokacin da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri a duniya.
Saboda muhimmancin wannan aikin da kuma matsayin ku a ciki, za mu yi wasu canje-canje masu muhimmanci ga yadda muke aiki tare, wanda za mu fara a mako mai zuwa.
Yin gyara ga aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata, ƙungiyar C ta haɗu a daren jiya don tattauna hanyoyin da za a bi da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna abin da muka ga ya fi dacewa don magance ƙalubalen da muke fuskanta da kuma yadda za mu iya taimaka wa ƙungiyarmu ta ci gaba da yin nasara a wannan mawuyacin lokaci.
Muna son mu rage matsin da muke fuskanta kuma mu sa aikinmu ya yi nasara.
Idan kuna bukatar ku rage ayyukanku, ba matsala.
Ga ma'aikata, yan kwangila, da kuma ma'aikatan kwangila:
Aikinmu na yau da kullum zai kasance awa 4 a rana, ko 20 a mako, har sai an ba da sanarwa.
Ba mu da ranar hutu, idan za ku iya yin aiki fiye da yadda ya kamata, wannan aikin na bukatar ku.
Duk da haka, duniya ba za a iya tantance ta ba a yau, kuma ko kana bukatar ka kula da ƙaunatattunka, ka je sayayya, ko kuma ka je ganin likita, lafiyarka ita ce fifikonmu.
Ba ma sa ido a lokacin aikinka.
Idan kun yi rashin lafiya, kada ku yi aiki.
Bai kamata a ce ba, amma mun ce.
Ba a bukatar hutun rashin lafiya ko PTO, kawai ka sanar da manajanka kuma ka taimaka wa ƙungiyarka wajen gyara kalanda da jadawalin don tabbatar da cewa za a iya kammala muhimman fannoni na aiki.
(Idan an gano ka da COVID-19, don Allah ka sanar da Bryan a cikin T&C Ops domin T&C ta taimaka da tallafi da kuma tabbatar da cewa yanayin ka ya sami kulawa mai kyau daga gudanarwa).
Abokan aikin da suke aiki da sa'o'i za a biya su cikakken albashi.
Mun riga mun faɗi haka, kuma za mu sake faɗin hakan, don mu cika alƙawarin da muka yi wa abokan aikinmu da kuma ma'aikatanmu.
Za a biya kowa bisa sa'o'in da ya yi a lokacin da al'amura suka yi daidai.
Hakan ya haɗa da rashin lafiya da kuma rashin aiki.
Idan kana son ka yi aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su ba da damuwa ga duniya da ke kewaye da mu.
Aiki da muke yi yana iya zama mai gamsarwa, musamman a irin wannan lokaci.
Kuma, abin da ya fi muhimmanci shi ne ka mai da hankali ga kanka.
Abin da muke so shi ne ku tattauna da shugabanku don mu san abin da za mu yi tsammani kuma mu yi abin da ya dace.
Wasu ayyuka suna da muhimmanci.
Akwai wasu ayyuka da za a ci gaba da yi.
SRE, HR Operations, Trust & Safety, da kuma Fundraising teams, a tsakanin sauran, suna yin mahimman ayyuka waɗanda na iya buƙatar ƙarin tallafi.
Za mu fara da tsari tare da dukkan sassanmu don tantance manufofinmu na yanzu kuma mu mai da hankalinmu ga tallafawa abubuwan da ke da mahimmanci ga aikinmu.
Da yake akwai abubuwa da yawa da za mu yi, za mu mai da hankali ga ayyuka masu muhimmanci.
Rashin sauri a yanzu ba zai taimaka ba a nan gaba.
Ba mu da shirin "cin zarafin aiki" bayan wannan annoba ta wuce.
Ba za a bukaci ka yi aiki fiye da lokacin da aka ba ka ba don ka cika wani takamammen aiki ba.
Mun fahimci cewa yanayin ya canza kuma za mu yi ƙoƙari mu saita sabon manufofi da kuma lokacin da ya dace.
APP (shirin shekara-shekara) fa?
Don daidaitawa da sabon gaskiya da tsammanin sa'o'in aiki na yau da kullun, muna da niyyar daidaita lokacin aiki don aiwatar da Shirin Shekara na 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita tsarin 2019-2020 wanda zai ba da ƙarin lokaci don yin kasafin kuɗi don haka ma'aikata za su iya ba da fifiko ga mahimman ayyuka, kula da kansu, da kula da ƙaunatattun su yayin da suke ɗaukar waɗanda suke buƙata ko son yin aiki tare da jadawalin da aka rage don 'yan makonni masu zuwa.
Wannan tsawaita lokacin aiki yana rage yawan aiki da kuma matsin lamba na tsarawa a yanzu a cikin kungiyar.
Za mu gabatar da shawarwarinmu ga majalisar zartarwa a mako mai zuwa kuma za mu sanar da tawagar da kuma yadda za a yi nan gaba da zarar mun samu tabbaci.
Godiya ga tawagar APP don jagorancinku a wannan.
Matsayi, bayyanar, da kuma tsabtace ofishin
A makon da ya gabata, mun samu labari cewa wani abokin aikinmu da ke SF na iya kamuwa da cutar COVID-19.
Amma, saboda damuwarmu, mun yi hayar ma'aikatan tsabtace muhalli don su tsabtace dukkan saman da ke ofishinmu a San Francisco.
Suna amfani da maganin rigakafin asibiti don su kashe duk wani abu, ko kuma ɗaki, da kuma duk wani abin hawa da zai shiga bene.
Masu ginin suna amfani da nasu tsarin don tabbatar da tsaro ta amfani da kayayyakin da ke inganta lafiyar masu amfani da su.
Mun yi farin ciki cewa ofishinmu zai kasance a shirye don lokacin da za mu koma.
Ofishin DC ɗinmu yana cikin WeWork, wanda ya ba mu ladabi na COVID-19 da kuma dukkan ma'aikatan DC.
Farawa daga makon da ya gabata, ofishinmu na DC ya koma cikakken tsari na aiki na nesa, daidai da jagorar da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu da ke birnin New York suka sani, muna tattaunawa game da hayar wani wuri a Brooklyn.
Wannan tattaunawar ta ci gaba, amma za a iya jinkirta ta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki daga nesa sun fahimci cewa za a iya yin gyare-gyare kuma suna son ba ku shawara:
Ka ƙyale taron ya ɗauki tsawon sa'o'i ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi tunanin yadda za ka iya raba shi zuwa kwanaki da yawa.
Ka tsara taron da za ka yi da kuma abin da za ka karanta kafin lokacin.
Ka sanya bidiyo a matsayin tsoho, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai kai tsaye.
Sanya shugaba don sauƙaƙe kowane taro, wani don saka idanu kan tattaunawa don tambayoyi da kuma lura da jerin masu magana, da kuma wani don taimakawa wajen yin bayanin taron (ko yin haɗin gwiwar yin bayanin kula).
Aika imel zuwa tallafin fasaha idan kuna buƙatar kayan ji mai kyau.
Ku ciyar da kuɗin da kuke samu don ku sayi abinci.
Ka shiga cikin #remoties a Slack domin tattaunawa da abokan aiki game da aikin da aka raba
Kungiyar Ayyukan HR tana neman jagorar ergonomics na yanar gizo don tallafawa haɓaka ayyukan da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma su soke duk wani taron jama'a da Wikimedia ke tallafawa, kamar Edit-a-thon, har sai WHO ta ayyana cewa cutar ta ƙare.
Mun gaya musu cewa mun fahimci cewa bukatarmu ta sokewa da kuma wasu takunkumi na iya sanya musu rashin yiwuwar kammala ayyukan da aka amince da su da kuma cewa babu wanda za a hukunta saboda jinkirta ko canzawa.
A mako mai zuwa za mu ci gaba da karin bayani game da Wikimania da sauran taron al'umma na yanki da na al'ada.
Gabaɗaya, jin daɗin duka al'ummar duniya ya kasance kamar baƙin ciki ne saboda wannan rikici, amma kuma a lokaci guda, jin daɗi ne saboda tsabta da ikon mayar da hankali ga al'ummar Wikimedia da sauran su.
A gaba, CRT na kokarin kafa wani shafi a Meta-Wiki don samar da wani wuri ga al'umma don sa ido kan tasirin da kuma bin diddigin hanyoyin sadarwa da muke yi da su.
Kasancewa a haɗe a yayin COVID-19
Za mu aika muku da wasiƙa a cikin kalandarku don ranar Alhamis mai zuwa, a ƙarfe 2:00 na yamma UTC/07:00 na yamma PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma samun lokaci don yin hulɗa da juna.
Dukanmu muna cikin wannan yanayin kuma muna son mu taimaka yadda za mu iya.
A halin yanzu, zaku iya ci gaba da samun bayanai daga wannan imel da kuma duk wasu mahimman bayanai game da COVID-19 a cikin Office Wiki.
CRT za su ci gaba da sabunta wannan shafin kuma su tabbata cewa duk bayanan suna wuri guda.
Muna kuma kokarin ci gaba da tattaunawa da ma'aikatanmu da ke zaune a kasashen da ke fama da cutar.
Idan kuna da wata tambaya game da tafiye-tafiye, abubuwan da suka faru, hanyoyin aiki, ko matsalolin da suka shafi labarai, ko wani abu da zai buƙaci taimako, kada ku yi jinkirin sanar da CRT kuma ku yi aiki tare da shi.
Mu ne ke da alhakin tallafawa da kuma yin aiki a matsayin masu shiga tsakani a duk lokacin da ake bukata.
Idan kuna da wata matsala ko damuwa, don Allah a aika da imel zuwa Bryan Judan, Daraktan Ayyuka na Duniya na HR International.
Kada a ɗauki kowanne irin canji a matsayin yin watsi da aikinmu da kuma hakkinmu.
Maimakon haka, wannan canji ya nuna cewa, a yanzu, ayyukanmu da kuma hakkokinmu na iya bukatar a daidaita su a hanyoyin da ba mu taɓa yi ba.
Waɗannan canje-canje matakai ne da muke ganin suna da mahimmanci don tallafawa juna a cikin wannan halin don mu ci gaba da aiki, samar da tallafi da ake buƙata don motsinmu, da kuma samar da duniya da sabis ɗin da suke dogaro da shi.
Aikin da muka tsara a baya zai kasance a can yana jiranmu idan lokacin ya yi.
A yanzu, lokaci ne da za mu goyi bayan juna da kuma samar da sarari ga muhimmin aikin da zai zo a cikin makonni masu zuwa da watakila watanni masu zuwa.
Muna bukatar ku duka don mu yi hakan, don haka, muna son ku kula da kanku da kuma iyalanku don ku yi iya ƙoƙarinku a lokacin da ake bukata.
A ƙarshe, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
A cikin wannan labarin, an ba da labarin labarin da aka ba da labarin da aka ba da labarin da aka ba da labarin game da wasu daga cikin 'yan wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo
b'Enzyme angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda yake a haɗe zuwa ƙwayoyin waje na waje (cells) a cikin huhu, jijiyoyi, zuciya, kodan, da kuma hanji.
ACE2 tana da ayyukan da suka saba wa angiotensin-converting enzyme (ACE), ta hanyar rage adadin angiotensin-II da haɓaka Angiotensin (1-7), wanda ya sa ya zama kyakkyawan manufa na magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin wurin shiga cikin sel don wasu coronaviruses.
ACE2 na mutum ana kiransa da hACE2.
Angiotensin-converting enzyme 2 shine zinc-containing metalloenzyme wanda yake a saman ƙwayoyin endothelial da sauran ƙwayoyin.
Sunadaran ACE2 suna da M2 peptidase na N-terminal da kuma C-terminal renal collectrin amino acid transporter.
ACE2 shine furotin mai kulawa na membrane na irin I, tare da yankin da ke aiki da enzymatically wanda aka fallasa a kan sel a cikin huhu da sauran kwayoyin.
Rukunin ACE2 na waje an cire shi daga yankin transmembrane ta wani enzyme, wanda aka sani da sheddase, kuma ana fitar da sunadarin da aka samar a cikin jini kuma a ƙarshe an fitar da shi cikin fitsari.
ACE2 yana cikin mafi yawan kwayoyin halitta: ACE2 yana haɗe da ƙwayoyin cuta musamman ƙwayoyin alveolar na huhu na II, ƙananan ƙwayoyin ƙwayoyin cuta, ƙwayoyin endothelial na jijiyoyi da jijiyoyin jini, da ƙwayoyin tsoka na jijiyoyin jini a cikin mafi yawan kwayoyin halitta.
Hakanan an sami bayyanar ACE2 mRNA a cikin cortex na kwakwalwa, striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine a matsayin mai daidaita ACE.
ACE tana rushe angiotensin I hormone zuwa angiotensin II na vasoconstrictor.
A ƙarshe, ACE2 ta yanke amino acid na karboxyl na phenylalanine na angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ta yi amfani da shi don zama angiotensin (1-7) vasodilator (H-Asp-Arg -Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya karya wasu peptides da suka hada da [des-Arg9] -bradikinin, apelin, neurotensin, dinorfin A, da ghrelin.
ACE2 kuma yana tsara zirga-zirgar membrane na aminogin amino acid mai tsaka-tsaki SLC6A19 kuma yana da hannu a cikin cututtukan Hartnup.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin babbar hanyar shiga cikin sel don wasu coronaviruses, wanda ya haɗa da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, ɗaurewar furotin S1 a kan SARS-CoV da SARS-CoV2 spike da enzyme ACE2 a kan farfajiyar sel yana haifar da endocytosis da kuma fassarar ƙwayoyin cuta da enzymes zuwa cikin endosomes da ke cikin sel.
Wannan shigarwar kwayar cutar kuma tana buƙatar samar da furotin S ta TMPRSS2 mai hana serin protease, wanda aka hana shi a halin yanzu ana bincika shi azaman magani mai yuwuwa.
Duk da haka, yawancin al'ummomin ƙwararru da ƙungiyoyin tsarawa sun ba da shawarar ci gaba da maganin ACE da kuma magungunan ARB na yau da kullun.
Binciken da aka yi na yau da kullun da kuma nazarin meta, wanda aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "amfani da ACE inhibitors ya haifar da raguwar 34% a cikin haɗarin cutar huhu idan aka kwatanta da iko".
Bugu da ƙari, "amfani da ACE inhibitors kuma yana rage haɗarin cutar huhu a cikin marasa lafiya waɗanda ke da haɗarin haɗarin cutar huhu, musamman marasa lafiya da ke fama da bugun jini da rashin cin nasara na zuciya.
Amfani da ACE inhibitors kuma yana da alaƙa da raguwar mutuwar cututtukan huhu, kodayake sakamakon ba shi da ƙarfi idan aka kwatanta da haɗarin huhu gaba ɗaya".
Ana sa ran sake haɗuwa da ACE2 na ɗan adam (rhACE2) ya zama sabon magani don raunin huhu mai tsanani, kuma ya bayyana yana haɓaka haemodynamics na huhu da iskar oxygen a cikin aladu tare da cutar cututtukan cututtukan huhu mai tsanani wanda lipopolysaccharides ke haifar.
Rayuwar rhACE2 a cikin mutum yana da kimanin sa'o'i 10 tare da tsawon aiki na minti 30 ban da tsawon sakamako (tsawon) sa'o'i 24.
Wasu binciken sun nuna cewa rhACE2 na iya zama magani mai alƙawarin marasa lafiya tare da rashin haƙuri ga magungunan tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko a cikin cututtuka tare da angiotensin II a cikin hawan jini.
b'Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu wanda aka tsara don taimakawa bin diddigin lamba don magance cutar coronavirus ta 2019-2020, wanda shine tsarin gano mutane ("lambar sadarwa") waɗanda ƙila sun yi hulɗa da waɗanda suka kamu da cutar.
An kirkiro ko kuma an gabatar da aikace-aikace da yawa, waɗanda ke da goyan bayan hukuma a wasu yankuna da yankuna.
An riga an tsara tsarin da za a bi don gina aikace-aikacen sa ido na tuntuɓar.
An yi tambayoyi game da al'amuran sirri, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da aikace-aikacen suke.
Alternatives cewa ba sosai intrusive hada da yin amfani da sigina na Bluetooth don rikodin mai amfani ta kusa da wani waya.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar cewa za su haɗa aikin don tallafawa aikace-aikacen da aka kafa ta Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnatin China, tare da Alipay, sun fitar da wata manhajar da ke bai wa jama'a damar duba ko sun yi mu'amala da wanda ke da cutar COVID-19.
An yi amfani da wannan manhajar a birane fiye da 200 a China.
Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen Bluetooth don bin diddigin haɗarin mutanen da ke iya kamuwa da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
An kirkiro shi ne a karkashin ma'aikatar sadarwa da fasaha da ma'aikatar kiwon lafiya.
Har zuwa 14 ga Afrilu 2020, har yanzu ana jiran amincewar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen sa ido na tuntuɓar yana cikin ci gaba na ci gaba kuma zai kasance don rarraba a cikin makonni.
Australia da New Zealand suna la'akari da aikace-aikacen da aka gina akan TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow; an tsara wannan app ɗin don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya ambaci wasu matsaloli da za su iya faruwa a tsarin da ke amfani da manhajar, da suka hada da rashin ingancin bayanan da aka samu da kuma rashin ingancin bayanan da aka samu a cikin wani yanki na jama'a.
Don magance damuwa game da yaɗuwar aikace-aikacen "coronavirus" masu ɓatarwa ko haɗari, Apple ya sanya iyakance ga nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance ga ƙungiyoyi "na hukuma" ko waɗanda suke da suna.
Google da Amazon suna da irin wannan takunkumin.
Masu ba da shawara kan tsare sirri sun nuna damuwa game da tasirin sa ido kan jama'a ta amfani da aikace-aikacen coronavirus, musamman game da ko za a dakatar da tsarin sa ido da aka tsara don magance cutar coronavirus bayan barazanar ta wuce.
Ƙungiyar Amnesty International da kuma wasu ƙungiyoyi fiye da 100 sun yi kira cewa a daina irin wannan sa ido.
Kungiyar ta bayyana sharudda guda takwas ga duk wani aikin gwamnati:
surveilans dole ne "doka, dole ne, kuma daidai gwargwado";
Ƙarin kulawa da kuma kula da su dole ne su kasance da tsarin kula da rana;
yin amfani da bayanai dole ne a iyakance ga COVID-19 dalilai;
Tsaron bayanai da kuma rashin suna ya kamata a kare kuma a tabbatar da karewa bisa ga shaida;
Digital Surveillance ya kamata ya kauce wa nuna bambanci da kuma yin watsi da shi;
kowane raba bayanai tare da ɓangare na uku dole ne a ayyana a cikin doka;
dole ne a sami kariya daga cin zarafi da kuma 'yancin jama'a na amsawa ga cin zarafi;
Ana buƙatar sa hannu mai ma'ana na duk "masu ruwa da tsaki masu dacewa", waɗanda suka haɗa da ƙwararrun ƙwararrun lafiyar jama'a da ƙungiyoyin da aka yi wa katanga.
Tsarin da Google da Apple suka gabatar na nufin magance matsalar sa ido ta hanyar cire hanyoyin sa ido daga tsarin aiki na na'urar da ba a bukatarsu.
Wasu ƙasashe suna amfani da hanyar sadarwar da ke amfani da hanyar sadarwa, maimakon aikace-aikace, don haka cire buƙatar saukar da aikace-aikacen da ikon kauce wa sa ido.
A Isra'ila, an yarda da tsarin bin diddigin hanyar sadarwa.
Hanyoyin sadarwa da ke da damar yin amfani da bayanan wuri mai mahimmanci suna da babbar matsala ta sirri.
Duk da haka, ba duk tsarin da ke da uwar garken tsakiya yana buƙatar samun damar bayanan wuri na sirri; an ƙirƙiri wasu tsare-tsaren tsare-tsaren tsare-tsare da kuma amfani da uwar garken tsakiya kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba ya amfani da manhajar don bin diddigin lamba.
Madadin amfani da aikace-aikacen da aka keɓance, tsarin yana tattara bayanan sa ido daga tushe daban-daban, ya haɗa da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa wannan bayanin don samar da sanarwa ta saƙon rubutu ga mutanen da ke da cutar.
Baya ga amfani da wannan bayanin don gargadi ga yiwuwar tuntuɓar, gwamnati ta kuma sanya wannan bayanin wuri a bainar jama'a, wanda aka ba da izini ta hanyar canje-canje masu yawa ga dokokin tsare sirri na bayanan bayan barkewar MERS a cikin ƙasar.
Kasashen da suka haɗa da Jamus suna tunanin yin amfani da tsarin da aka tsara ta hanyar da ta dace da kuma tsarin da ke kare sirri.
Har zuwa 6 ga Afrilu, 2020 ba a ba da cikakken bayani ba.
Abun lura da lamba wanda ke kare sirri abu ne mai inganci, tare da ɗimbin yawa na wallafe-wallafen bincike wanda ya fara aƙalla 2013. A ranar 7 ga Afrilu 2020, sama da ƙungiyoyi goma sha biyu na ƙwararru suna aiki kan mafita mai aminci, kamar amfani da Bluetooth Low Energy (BLE), don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT wani ƙoƙari ne na haɗin kai wanda ya ƙunshi tsarin da aka tsara da kuma rarraba, kuma ba wani tsari ba ne. Tsarin da aka tsara ya ƙunshi Tsarancin Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambar Lambar Lamba (TCN, wanda ake kira Lambar Lambar Lamba, CEN), da kuma Tsarin Sirri na Sirri don Kula da Sadarwar Sadarwar Sadarwa (PACT), da sauransu.
A cikin wannan yarjejeniya, bayanan sirri da aka gano ba ya barin na'urar, kuma duk abubuwan da aka dace suna faruwa ne a na'urar.
Ƙungiyar Sirri a MIT Media Lab ta haɓaka SafePaths, wani dandamali don amfani da dabarun da ke kare sirri yayin tattarawa da amfani da wuri ko bayanan haɗin raƙuman ruwa don bin sawun yaduwar COVID-19.
Wannan ya dogara ne akan binciken daga takarda mai suna "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" wanda aka fitar a watan Maris 2020. Wani irin wannan kokarin shi ne na SafeTrace ta Enigma MPC, wani kamfani ne da ke bunkasa fasahar sirri kuma an kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasaha na kayan aiki don ba da damar masu amfani su raba wurare da kuma bayanan kiwon lafiya mai mahimmanci tare da sauran masu amfani da masu kula ba tare da yin watsi da sirrin bayanan ba.
A ranar 5 ga Afrilu 2020, an kafa TCN Coalition na duniya ta ƙungiyoyi waɗanda suke da kusan iri ɗaya kuma sun kasance yarjejeniya mai yawa, tare da manufar rage rarrabuwa da ba da damar haɗin kai a duniya don aikace-aikacen sa ido da faɗakarwa, wanda shine babban bangare don cimma babban karɓa.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar BlueTrace da hukuma ta yi amfani da ita a cikin aikace-aikacen hukuma.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke sarrafa Android da iOS na wayar hannu, sun sanar da wani shiri na bin diddigin lamba, wanda suka ce zai kare sirrin mutum, bisa ga haɗin fasahar Bluetooth Low Energy da kuma kare sirrin sirri.
Sun kuma buga ainihin ƙayyadaddun fasahar da aka yi amfani da ita a cikin tsarin.
A cewar Apple da Google, an tsara wannan tsarin ne a matakai uku:
An kaddamar da kayan aiki don ba da damar gwamnati ta yi amfani da aikace-aikacen da ke bin diddigin coronavirus wanda ke kare sirrin mutum
Haɗuwa da wannan aiki kai tsaye zuwa iOS da Android Google da Apple suna shirin magance matsalar tattara bayanai da kuma ci gaba da sanya ido ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan kuma cire shi ta hanyar wannan hanyar bayan barazanar ta wuce.
b'Repositioning magani (wanda ake kira da sabon makirci, sabon profile, ko sabon aiki a kan wani magani ko wani magani sauya) ne da amfani da wani magani da aka amince da sabon magani dalilai, wato, ga wani cuta ko likita yanayin da cewa shi ne daban-daban daga na farko manufar da magani ci gaba.
Wannan wata hanya ce ta binciken kimiyya da ake gudanarwa a halin yanzu don samar da ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar COVID-19 da kuma ƙarin jini na plasma. SARS-CoV-2 yana da furotin kusan 66 waɗanda za su iya zama maƙasudin magani, kowane furotin yana da wasu wuraren da aka haɗa ligand.
Nazarin wuraren haɗin ligand na iya zama tushen aikin don ƙirƙirar maganin rigakafi mai tasiri ga furotin na COVID-19.
Wasu daga cikin mahimman sunadarai masu kama da SARS-CoV-2 sune papain-like proteases, RNA-dependent polymerase-RNA, helicase, protein S, da ADP ribofosfatase.
Hussein A A, et al sun bincika wasu magungunan da aka tsara kuma sun yi nazarin kamannin da suka yi aiki da magungunan da aka amince da su kuma suna da mafi girman kamannin don hanzarta haɓaka magungunan anti-SARS-CoV-2 a cikin binciken da aka yi na farko don ba da shawarar a cikin ƙirar binciken asibiti.
Chlorine wani magani ne na antimalarial wanda kuma ake amfani da shi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydrochloroquine masu alaƙa biyu ne daga cikin magunguna huɗu da za a bincika a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamna New York Andrew Cuomo ya sanar da cewa gwajin chloroquine da hydrochloroquine a New York za su fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate bisa ga Amfani da Amfani da Gaggawa (EUA).
Ba a yarda da maganin ba ta hanyar gwajin asibiti na FDA kuma an ba da izini ta hanyar EUA kawai azaman magani na gwaji don amfani da gaggawa a cikin marasa lafiya da aka kwantar da su, amma ba za su iya karɓar maganin a cikin gwaji ba.
CDC ta ce "ba a tantance amfani da hydroxychloroquine ba, ko kuma yawan amfani da shi, ko kuma tsawon lokacin da za a yi amfani da shi wajen hana ko kuma magance cutar SARS-CoV-2".
Likitoci sun ce suna amfani da shi ne kawai sa'ad da "babu wani zaɓi".
Wata ƙungiyar masu bincike a ƙasar Turkiya da ke birnin Istanbul suna yin bincike a kan yin amfani da chlorokuin da aka haɗa da zinc, bitamin A, bitamin C, da kuma bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar NYU Langone Medical School tana gudanar da gwajin kare lafiya da kuma ingancin maganin hydroxychloroquine.
Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa fapiravivir ya tabbatar da "tasiri a fili".
Mutum talatin da biyar a Shenzhen sun yi gwajin cutar cikin kwanaki hudu, yayin da tsawon cutar ya kasance kwanaki 11 ga marasa lafiya 45 da ba su karbi maganin ba.
A wani bincike da aka yi a Wuhan a kan mutane 240 da suka kamu da cutar nimoniya, an ba rabin mutanen favipiravir, an ba sauran rabin mutanen kuma umifenovir.
Hukumar Kula da Magunguna ta Italiya ta gargadi jama'a cewa shaidar da ke goyan bayan maganin ba ta da yawa kuma ba ta isa ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don yin ajiyar kaya da amfani da sojoji don aika da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump tayin sayen maganin.
Wannan magani ba zai zama lafiya ba idan ana amfani da shi ga mata masu juna biyu ko mutanen da suke ƙoƙarin yin ciki.
Wani bincike da aka yi a kan maganin rigakafi na lopinavir/ritonavir (Kaletra) ya ce: "Babu wani amfani da aka samu".
An tsara maganin don hana kwayar cutar HIV ta hanyar ɗaurewa ga protease.
A tawagar masu bincike a Jami'ar Colorado suna kokarin gyara maganin don gano wani fili da zai iya ɗaure ga SARS-CoV-2 protease. Akwai suka a cikin al'ummar kimiyya kan tura albarkatu don sake sanya maganin da aka kirkira musamman don cutar HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity ta duniya.
Gilead Sciences ta kirkiro Remdesivir don maganin Ebola da cutar Marburg. Daga baya, Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafi a cikin in vitro akan wasu filo-, pneumo-, paramico-, da coronaviruses.
Ɗaya daga cikin matsalolin maganin ƙwayoyin cuta shi ne, ƙila za a iya samun ƙin maganin ta hanyar ƙwayoyin cuta da suka kamu da ita, kuma hakan zai iya sa cutar ta yaɗu sosai.
Wasu binciken farko sun nuna cewa remdesivir na iya haifar da babban cikas ga juriya. Akwai gwaji na asibiti da ke gudana, ciki har da asibitocin asibiti biyu da Cleveland University Hospital ke gudanarwa, ɗaya ga mutanen da ke da matsakaiciyar cuta da kuma na marasa lafiya.
Akwai gwaji uku na asibiti da ake gudanarwa na Vitamin C na jini ga mutanen da ke cikin asibiti da kuma masu cutar COVID-19, biyu na placebo (China, Kanada) da kuma wanda ba a sarrafawa (Italiya).
Jihar New York ta fara gwajin gwajin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Kiwon Lafiya ta Duniya ta Japan (NCGM) tana shirin gwajin gwaji na Alvesco (ciclesonide) Teijin, inhalation corticosteroid don asma, don kula da marasa lafiya masu cutar coronavirus.
Ga wani nau'i na angiotensin-converting enzyme 2, wani gwaji na Phase II yana gudana wanda zai dauki marasa lafiya 200 daga masu ciwo masu tsanani a asibiti a Denmark, Jamus, da Austria don a tantance tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19 masu laushi.
Binciken, wanda aka yi wa lakabi da COLCORONA, ya yi amfani da mutane 6000 masu shekaru 40 zuwa sama da su da aka gano suna da COVID-19 kuma suna da alamun rashin lafiya wanda bai buƙaci a kwantar da su a asibiti ba.
Mata masu juna biyu ko masu shayar da jariri ko kuma ba sa amfani da maganin hana haihuwa ba sun cancanci a yi amfani da su.
Ana gwada wasu magungunan da ke hana jini taɓarɓare a ƙasar Italiya.
Ana amfani da heparin mai nauyin ƙananan ƙwayoyin cuta don magance marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta buga jagororin amfani da shi.
An sanar da wani bincike na asibiti mai yawa a cikin marasa lafiya 300 da ke nazarin amfani da enoxaparin sodium a cikin maganin rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga binciken kimiyya don ba da sababbin magunguna ga magungunan da aka amince da su da kuma waɗanda aka haɓaka don barkewar cutar, kamar MERS, SARS, da kwayar cutar West Nile.
Ribavirin: ribavirin an ba da shawarar don maganin COVID-19 bisa ga ka'idodin kasar Sin na 7
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagororin China na 7
Wasu kwayoyin da aka gano suna da damar zama sabbin magunguna don maganin COVID-19:
Tocilizumab (Anti-IL-6 mai karɓar): An amince da shi ta China.
Bugu da ƙari, an gudanar da gwaje-gwaje a Italiya da China, duba Tocilizumab # COVID-19.
b'Allurar rigakafin COVID-19 allurar rigakafi ce da aka yi tunanin za a iya yi wa cutar coronavirus ta 2019 (COVID-19).
Duk da cewa babu wani maganin da ya kammala gwajin asibiti, ana kokarin samar da maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce, a cewar WHO, ba za a samu rigakafin SARS-CoV-2 ba, cutar da ke haifar da cutar, a cikin kasa da watanni 18.
Masu neman allurar rigakafin guda biyar suna cikin binciken lafiya na Mataki na I a watan Afrilu.
An gano COVID-19 a cikin Disamba 2019.
Babban annoba ya bazu a duniya a cikin 2020, wanda ya haifar da babban saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Kungiyoyin da yawa suna amfani da wannan kwayar halittar don samar da allurar rigakafin da za ta iya magance SARS-CoV-2.
A watan Afrilu CEPI ta ce abin da ya kamata a yi la'akari da shi a cikin samar da allurar rigakafi shi ne saurin, ƙarfin samarwa, rarrabawar da ake buƙata, da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa dandamali 10 na fasaha daban-daban suna cikin bincike da ci gaba a farkon 2020 don yin allurar rigakafin COVID-19.
Babban dandamali na farko da aka ci gaba zuwa binciken binciken tsaro na Phase I, sun haɗa da:
nucleic acid (DNA da RNA) (mai haɓaka Phase I da kuma mai neman allurar rigakafi: Moderna, mRNA-1273)
kwayar cutar kwayar cuta (mai haɓaka Phase I da kuma mai neman allurar rigakafi: CanSino Biologics, adenovirus mai nau'in 5 mai ɗaukar hoto)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, jimillar allurar rigakafin 115 na cikin matakan farko na ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma tare da karancin bayanan jama'a (ana zaton suna cikin shiri ko kuma ana tsara su).
Matakan gwaji na I-II na gwada aminci da kuma rigakafin farko, yawanci ana yin su ne a bazuwar, ana sarrafa su da placebo, kuma a wurare da yawa, yayin da ake tantance mafi kyawun tasiri.
Gwaje-gwajen Phase III yawanci suna haɗawa da ƙarin mutane, sun haɗa da rukunin kulawa, kuma suna gwada ingancin allurar don hana cutar, yayin da suke lura da illa a mafi kyawun kashi.
Daga cikin alluran rigakafin rigakafi 79 da ake aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 daga cikinsu ba su riga sun kasance cikin kimantawa na ɗan adam ba (har yanzu suna cikin binciken "preclinical").
A ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar cuta wacce za ta iya canza sunadarin sunadarin kwayar cutar don haifar da halayen rigakafi.
A ranar 24 ga Janairu 2020 a Kanada, Cibiyar Alurar rigakafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa sun fara haɓaka allurar rigakafi, tare da manufa don gwaji a cikin mutane a cikin 2021.
An sanar da shirin samar da allurar rigakafin a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairu 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanin Janssen na Magunguna, wanda Hanneke Schuitemaker ke jagoranta, ya sanar da cewa sun fara haɓaka allurar rigakafi.
Janssen ya yi aiki tare da abokin aikinsa na biotech, Vaxart, don haɓaka allurar rigakafin baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa wata takarda game da ƙirar allurar rigakafi tare da fasahar kama da fasahar da aka yi amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugabannin cibiyoyin bincike sun sanar da cewa sun kammala aikin samar da allurar rigakafin kuma za su fara gwaji.
A ranar 27 ga Fabrairu, 2020, reshen Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin allurar rigakafi don yin allurar ƙwayoyin cuta na Ii-Key akan COVID-19.
Suna son samar da wani maganin da za a iya gwadawa a cikin mutane "cikin kwana 90".
A ranar 5 ga Maris 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Bincike da Kula da Lafiya ta Rundunar Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, dukansu a yammacin Maryland, sun sanar da cewa suna haɓaka allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa suna aiki tare da Novavax Inc.
A cikin samar da allurar rigakafi da kuma samar da shi.
Bugu da ƙari, haɗin gwiwar ya sanar da shirye-shiryen gwajin gwaji da gwajin gwaji na Phase I a watan Yuli 2020.
A ranar 12 ga Maris 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki a kan abubuwa 11, kuma har ma a kan hanya mai sauri, ci gaban allurar rigakafi na iya ɗaukar akalla shekara ɗaya da rabi zuwa biyu.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere-kere na kere-kere a Quebec City, Quebec, ya ba da rahoton kirkirar kwayar cutar da ke kama da kwayar cutar coronavirus tare da wani kudaden tallafi daga Cibiyoyin Nazarin Kiwon Lafiya na Kanada.
Wannan maganin na cikin binciken dakunan gwaje-gwaje, tare da gwajin mutum da aka shirya a watan Yuli ko Agusta 2020.
A farkon makon, The Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba da "'babban kuɗi' don samun damar yin amfani da allurar rigakafin COVID-19" ga CureVac, wanda gwamnatin Jamus ta yi tir da shi.
A ranar 17 ga Maris, 2020, kamfanin hada magunguna na Amurka Pfizer ya sanar da yin hadin gwiwa tare da kamfanin Jamus, BioNTech, don samar da allurar rigakafin mRNA.
A halin yanzu, ana gudanar da gwajin rigakafin cutar mRNA mai suna BNT162 a cikin gwaji kafin a fara gwajin asibiti a watan Afrilu 2020.
A ranar 17 ga Maris 2020 a Italiya, kamfanin Takis Biotech na Italiya ya ba da sanarwar cewa za su sami sakamakon gwajin gwaji a watan Afrilu 2020 kuma ana iya fara gwajin allurar rigakafin a cikin mutane a cikin kaka.
A ranar 19 ga Maris 2020 a Faransa, Epidemic Preparedness Innovation Coalition (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19 wanda ya haɗa da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, tare da jimlar saka hannun jari na CEPI a cikin ci gaban allurar COVID-19 da ya kai dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don ci gaban allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da kuma Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin alluran rigakafi shida a cikin dabbobi.
Masu bincike na Kwalejin Imperial na London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka allurar rigakafin RNA mai iya haɓaka kansa don COVID-19.
An samar da allurar rigakafin ne cikin kwanaki 14 bayan an karɓi jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da tallafin C$275 miliyan don ayyukan bincike na likita na 96 don COVID-19, wanda ya haɗa da wasu takaddun allurar rigakafi a kamfanonin Kanada da jami'o'i, kamar shirin Medicago da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta ba da sanarwar C$192 miliyan na musamman don samar da allurar rigakafin COVID-19, tare da shirin kafa "bankin allurar rigakafi" na ƙasa da ke ɗauke da sabbin alluran rigakafi da za a iya amfani da su idan wani annobar coronavirus ta sake faruwa.
A ranar 2 ga Afrilu 2020, masu bincike a Kwalejin Likita na Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, wani rigakafin COVID-19 mai neman a cikin beraye; sun bayyana cewa "MNA da ke ba da rigakafin SARS-CoV-2 na S1 yana haifar da martani na musamman na antigen mai ƙarfi [a cikin beraye] wanda ya fara bayyana makonni 2 bayan alurar rigakafi".
A ranar 16 ga Afrilu 2020 a Kanada, Jami'ar Pharmacy ta Jami'ar Waterloo ta sanar da wani zane na rigakafin rigakafin DNA a matsayin mai yuwuwar fesa hanci.
Ta amfani da bacteriophages, an tsara DNA don yin kwafi a cikin kwayoyin halittar mutum don samar da ƙwayoyin cuta masu kama da ƙwayoyin cuta marasa cutarwa, wanda zai iya ƙarfafa tsarin rigakafi don samar da ƙwayoyin cuta ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tattara albarkatun don samun damar yin amfani da kwamfuta mai sarrafa kwamfuta daga IBM, tare da hada albarkatun girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda kuma ake kira sakamako na musamman.
Hakan yana nufin cewa alluran rigakafin za su iya ba da amfani fiye da cutar da suke hanawa.
Wani gwaji na musamman a Australia ya yi ƙoƙarin bin 4,170 da suka yi aikin kiwon lafiya.
Akwai yiwuwar cewa maganin da ake samarwa ba zai zama mai inganci ba ko kuma mai aminci.
Nazarin farko don tantance ingancin allurar rigakafi ta amfani da ƙayyadaddun ƙirar COVID-19, kamar ƙirar ƙirar ACE2-transgenic, sauran dabbobi na gwaji, da dabbobi masu ƙarancin rai, sun nuna buƙatar matakan dakilewa don cimma matakin aminci na 3 na biosafety a cikin magance kwayar cutar, da haɗin gwiwar duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
Har zuwa 2020, babu wani magani ko rigakafin rigakafin SARS da aka tabbatar da aminci da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka sabon allurar rigakafi da magunguna don magance SARS shine babban fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya.
Lokacin da MERS ya zama ruwan dare, ana ganin binciken SARS na yanzu zai iya zama abin koyi mai amfani don haɓaka allurar rigakafi da magani ga kamuwa da MERS-CoV.
A watan Maris na 2020, akwai allurar rigakafin MERS guda daya (wanda aka tsara ta DNA) wacce ta kammala gwajin gwaji na farko a cikin mutane, kuma akwai wasu alluran rigakafi guda uku a cikin tsari, dukkansu sune allurar rigakafin kwayar cuta, biyu na kwayar adenovirus (ChAdOx1-MERS, BVRS-GamVac), da kuma kwayar MVA (MVA-MERS-S).
Sakon kafofin sada zumunta ya yi tsokaci kan ka'idar makirci da ke cewa an riga an gano cutar COVID-19 kuma an riga an sami maganin.
Abubuwan da aka ambata a cikin kafofin watsa labarun sun yi magana ne game da haƙƙin mallaka don kwayar halitta da allurar rigakafi don sauran ƙwayoyin coronavirus, kamar SARS coronavirus.
b'Cutar coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa wanda ke haifar da cutar coronavirus na cututtukan cututtukan numfashi mai tsanani na 2 (SARS-CoV-2).
Alamun da ake yawan gani a ciki su ne zazzaɓi, tari, da kuma numfashi na ɗan ciwo.
Sauran alamun na iya zama gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙamshi, da kuma ciwon ciki.
Lokacin bayyanar cututtuka a cikin al'ada kusan kwanaki biyar ne, amma zai iya kaiwa daga kwana biyu zuwa goma sha huɗu.
Ko da yake mafi yawan cututtuka suna da sauƙi, wasu suna iya zama cututtuka na huhu da kuma ciwon gabobin jiki.
Ya zuwa 17 ga Afrilu 2020, an ba da rahoton fiye da mutane miliyan 2.24 a cikin ƙasashe 210 da yankuna, wanda ya haifar da mutuwar sama da 153,000.
An warkar da mutane fiye da 568,000. Cutar ta fi yaduwa tsakanin mutane ta hanyar kusanci, sau da yawa ta hanyar ƙura ko ƙananan ƙwayoyin da aka samu ta hanyar tari, tari, ko magana.
Ko da yake ana yin numfashi ne a lokacin numfashi, yawanci ana samun sa ne a ƙasa ko kuma a saman wani abu, ba a yin nisa ana samun sa.
Mutum zai iya kamuwa da cutar ta wurin taɓa wani abu da ya kamu da cutar, sa'an nan kuma ya taɓa idanunsa, hanci, ko kuma bakinsa.
A saman ƙasa, kwayar cutar za ta iya rayuwa har tsawon sa'o'i 72.
Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya faruwa kafin bayyanar cututtuka da kuma bayan matakan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargin sun kamu da cutar da kuma waɗanda suke kula da su.
Shawarwarin da jama'a ke bayarwa game da amfani da abin rufe fuska sun bambanta; wasu hukumomi suna ba da shawarar kada a yi amfani da abin rufe fuska, wasu suna ba da shawarar yin amfani da shi, wasu kuma suna buƙatar yin amfani da shi.
A halin yanzu, babu wani rigakafi ko maganin rigakafi na musamman don COVID-19.
An samu karuwar cutar a kusan kowace ƙasa a cikin yankuna shida na WHO.
Mutumin da ke da kwayar cutar na iya zama ba tare da wata alama ba ko kuma ya sami alamun cutar kamar zazzabi, tari, gajiya, da kuma numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko ƙuntatawa a cikin kirji, rikicewa, wahalar tashi, da fuska ko layin baki; an ba da shawarar neman likita nan da nan idan waɗannan alamun suka bayyana.
Ana iya samun alamun cututtukan numfashi na sama, kamar gudawa, rashin jin daɗi, ko kuma ciwon makogwaro, amma ba safai ake samun irin wannan ba.
Ana samun alamun gastrointestinal, kamar su tashin zuciya, amai, da kuma zawo, a cikin kashi daban-daban.
Wasu daga cikin waɗannan mutanen da aka gano a ƙasar Sin sun soma da wani ciwo mai tsanani da ake kira palpitations.
A wasu mutane, cutar na iya ci gaba zuwa ciwon huhu, rashin iya aiki na gabobin jiki, da mutuwa.
Wannan lokaci ana kiransa lokaci na shiryawa.
Lokacin shiryawa don COVID-19 yawanci kwanaki biyar zuwa shida, amma yana iya zama daga kwana biyu zuwa 14.
97.5% na mutanen da ke da alamun za su nuna alamun a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk wanda ke da cutar ba ne ke nuna alamun.
Ba a san matsayin waɗannan masu ɗaukar hoto ba a cikin watsawa; duk da haka, alamu na farko sun nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
A halin yanzu, yawan mutanen da suka kamu da cutar ba su da alamun cutar kuma ana binciken su, inda Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20 cikin 100 na duk waɗanda aka tabbatar da cutar ba su da alamun cutar yayin da suke jinya a asibiti.
Hukumar Lafiya ta kasar Sin ta fara hada wadanda ba su da wata alama a cikin wadanda suka kamu da cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) ba su nuna wata alama ba a lokacin gwajin.
Guda da kuma sauro na iya ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana fitar da ƙarin ɗigo ko ɗigo fiye da yadda mutum yake yi a cikin magana.
Wani bincike a Singapore ya gano cewa tari da ba a rufe shi ba zai iya sa ɗigo ya yi tafiyar tsawon kafa 15.
Kodayake ba a yawanci watsa wannan kwayar cutar ta iska, Cibiyar Kimiyya ta Amurka ta nuna cewa yiwuwar watsawa ta hanyar iska tana iya faruwa kuma masu tara iska da aka sanya a cikin wani hallway a waje da ɗakin mutane suna samar da samfuran da suka dace da RNA na kwayar cutar.
Wasu hanyoyin magani, kamar su intubation da resuscitation na zuciya (RJP), suna iya sa abin da mutum ya ɓoye ya zama aerosols da za su iya yaduwa cikin iska.
Ko da yake akwai damuwa cewa kwayar cutar na iya yadawa ta hanyar farji, amma an yi imani cewa wannan ƙananan haɗari ne. Kwayar cutar ta fi yaduwa yayin da mutum ke da alamomi; ko da yake yaduwa na iya faruwa kafin bayyanar cututtuka, haɗarinsa ya yi kadan.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, amma mutum daya yakan kamuwa da mutum biyu zuwa uku.
Musamman, an gano cewa ana iya gano kwayar cutar a cikin kwana ɗaya a kan kwali, har zuwa kwana uku a kan filastik (polypropylene) da karfe mai ƙarancin ƙarfi (AISI 304), kuma har zuwa awanni huɗu a kan 99% jan ƙarfe.
Amma, wannan ya bambanta dangane da yanayin zafi da kuma yanayin zafi.
Sabulu da na'urar wanke wanka suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna lalata layin mai mai mai da ke kare kwayar cutar, yana kashe kwayar cutar, kuma yana kawar da ita daga fata da sauran wurare.
Sauran maganin, kamar su benzalkonium chloride da chlorhexidin gluconate (kayan aikin tiyata), ba su da tasiri sosai.
A cikin biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman kwayar cutar a ranar gwaji ta biyu.
Cutar kwayar cutar coronavirus mai saurin numfashi 2 (SARS-CoV-2) sabuwar cuta ce ta ƙwayar cutar kwayar cutar respiratory syndrome, wacce aka fara warewa daga mutane uku da ke da cutar huhu da ke da alaƙa da rukunin cututtukan cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna cikin kwayar cutar coronaviruses da ke da alaƙa da juna a cikin yanayi.
A wajen jikin mutum, sabulu na gida ne ke kashe kwayar cutar, wanda ke lalata kumfa mai kariya. SARS-CoV-2 dangi ne na kusa da SARS-CoV na farko.
Gwargwadon jini sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar tana shiga cikin sel mai karɓar ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin nau'in ƙwayoyin alveolar na II na huhu.
Kwayar cutar tana amfani da wani irin glycoprotein mai suna "spike" ko kuma "tuft" (peplomer) don haɗawa da ACE2 kuma shiga cikin kwayar mai shi.
An gano cutar zuciya mai tsanani a kashi 12% na masu kamuwa da cutar da aka kwantar a Wuhan, China, kuma ya fi yawa a cikin cututtukan cututtuka.
Babban halayen cututtukan zuciya ya samo asali ne daga tsarin ƙwayoyin cuta da kuma rashin lafiyar tsarin rigakafi a lokacin ci gaba da cutar, amma raunin myocardial na iya kasancewa yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna da yawa a cikin zuciya kuma suna da hannu a cikin aikin zuciya.
An sami babban abin da ya faru na thrombosis (31%) da kuma na venous thromboembolism (25%) a cikin masu cutar COVID-19 a ICU kuma ana iya danganta su da mummunan hangen nesa. Binciken gawa a cikin mutanen da suka mutu daga COVID-19 ya gano lalacewar alveolar difus (DAD) da kuma kumburi mai dauke da lymphocytes a cikin huhu.
Kodayake SARS-COV-2 yana da tropism ga ƙwayoyin epithelial na jijiyoyin numfashi waɗanda ke nuna ACE2, marasa lafiya COVID-19 masu tsanani suna da alamun bayyanar hyperinflammation na tsarin.
Musamman, kwayoyin T masu ɓoye GM-CSF na cututtuka sun tabbatar da alaƙa da ɗaukar kwayar cutar IL-6 mai ɓoyewa da cututtukan huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton kamuwa da cutar lymphocytic a autopsy.
WHO ta wallafa wasu hanyoyin gwajin cutar.
Hanya na yau da kullun na gwaji shine ainihin lokacin da aka sake yin amfani da hanyar haɗin polymerase (rRT-PCR).
Ana yin gwajin ne akan samfurin numfashi da aka samu ta hanyar nasopharyngeal aspiration; duk da haka, ana iya amfani da samfurin nasal aspiration ko sputum.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i kadan zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini sau biyu a kowane mako, saboda haka, sakamakon yana da ɗan lokaci kaɗan.
Masana kimiyya na kasar Sin sun iya ware kwayar cutar ta coronavirus kuma sun buga kwayar halittar kwayoyin halittar ta don haka dakunan gwaje-gwaje a duk duniya na iya haɓaka gwajin gwajin sarkar polymerase (PCR) da kansa don gano kamuwa da cutar ta wannan kwayar.
A ranar 4 ga Afrilu, 2020, gwajin kwayar cutar antibody (wanda zai iya gano cutar da ke aiki da kuma ko mutum ya riga ya kamu da cutar) yana kan ci gaba, amma ba a yi amfani da shi sosai ba.
Gwajin da aka yi a Sin ya nuna cewa an yi daidai ne kawai a kashi 60 zuwa 70 cikin 100 na gwajin.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris 2020 don amfani a ƙarshen wannan watan.
Opasity na ƙasa-glass na bilateral tare da rarrabawar peripheral, asymmetrical, da kuma na baya ana samun su da yawa a farkon kamuwa da cuta.
Dominance na subpleural, crazy paving (ƙullawar lobular septum tare da alveolar filling ya bambanta), da kuma ƙarfafawa na iya bayyana yayin da cutar ta ci gaba.
Akwai karancin bayanai game da cutar ta COVID-19 da kuma yadda take kama da cutar.
Babban binciken binciken autopsy shine:
A cikin ƙwayoyin cuta: pleurisy, pericarditis, ƙarfafawa na huhu, da kuma edema na huhu
Ana iya lura da nau'ikan cutar huhu guda huɗu:
ƙananan ƙwayoyin cuta: edema na huhu, hyperplasia na huhu, pneumocytes na atypical mai girma, kumburi na interstitial tare da infiltration na lymphocytic, da kuma samar da manyan kwayoyin halitta masu yawa
pneumonia mai tsanani: lalacewar alveolar mai yaduwa (DAD) tare da alveolar exudate mai yaduwa.
DAD na haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (ARDS) da kuma mummunan hypoxemia.
pneumonia a cikin matakan warkewa: tsarin exudate a cikin rami na alveolar da fibrosis na interstitial pulmoner
Jinin: raɗaɗin coagulation na intravascular (DIC); halayen leukoeritroblastic
Matakan kariya don rage yiwuwar kamuwa da cuta sun haɗa da zama a gida, guje wa wuraren da mutane da yawa, wanke hannu sau da yawa da sabulu da ruwa na aƙalla naƙiƙa 20, yin tsabtace numfashi mai kyau, da kuma guje wa taɓa idanu, hanci, ko baki da hannaye marasa wanki.
CDC ta ba da shawarar rufe baki da hanci da tawul lokacin yin tari ko hancin kuma ta ba da shawarar amfani da ciki na cinya idan tawul ba ya nan.
Ana bada shawara a yi tsabtace hannu sosai bayan an yi tari ko hancin.
CDC ta ba da shawarar amfani da suturar fuska a wuraren jama'a, a wani ɓangare don iyakance watsawa ta hanyar mutanen da ba su da alamun cutar. Dabarun keɓewa na zamantakewa yana nufin rage hulɗar da mutane da yawa da ke da cutar, ta hanyar rufe makarantu da wuraren aiki, iyakance tafiya, da kuma soke manyan tarurruka a wuraren jama'a.
Sharuɗɗan ƙuntatawa kuma sun haɗa da mutane suna nisantar juna aƙalla ƙafa 6 ko mita 1.8.
Babu wani magani da aka sani da zai iya hana COVID-19.Tun da ba a samu rigakafin cutar ba har zuwa farkon 2021, babban bangare na magance COVID-19 shi ne ƙoƙarin rage yawan cutar, wanda aka sani da "daidaita yanayin".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa a kai a kai na akalla aƙalla sakan 20, musamman bayan sun yi amfani da ban daki ko kuma idan hannayensu sun yi datti, kafin su ci abinci, da kuma bayan sun sha hanci, sun yi tari, ko sun yi aƙida.
CDC ta ba da shawarar amfani da maganin wankin hannu na barasa wanda ya ƙunshi aƙalla kashi 60% na barasa, amma kawai lokacin da sabulu da ruwa ba su da wadata.A yankunan da ba a samun maganin wankin hannu na kasuwanci, WHO ta samar da tsari biyu don samar da gida.
A cikin wannan tsari, antimicrobial aiki ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin ƙwayoyin cuta a cikin giya; wannan abu "ba mai aiki ba ne don maganin antisepsis na hannu".
Ana ƙara glycerol a matsayin mai ba da gudummawa.
Ana kula da mutane da taimakon taimakon da zai iya haɗawa da maganin ruwa, taimakon oxygen, da kuma taimakon wasu gabobin jiki da suka raunana.
CDC ta ba da shawarar cewa duk wanda ke da cutar ya kamata ya sanya abin rufe fuska.
An yi amfani da extracorporeal membrane oxygenation (ECMO) don magance matsalar rashin ƙarfi na numfashi, amma amfanin har yanzu ana la'akari da shi.
Ana bada shawara ga mutum ya kasance da tsabtar jiki da kuma rayuwa mai kyau da kuma abinci mai kyau don inganta rigakafi.
Tallafi na taimako na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon kamuwa da cutar. WHO da Hukumar Lafiya ta China ta ba da shawarwari don kula da mutanen da ke da COVID-19 a asibiti.
Masana da ke kula da cututtuka masu tsanani da kuma masu kula da huhu a Amirka sun haɗa shawarwarin da hukumomi dabam-dabam suka bayar a cikin wani littafi da ba a biyan kuɗi, wanda ake kira IBCC.
Ya zuwa watan Afrilun 2020, babu takamaiman magani ga COVID-19.
Don alamun bayyanar, wasu likitoci sun ba da shawarar paracetamol (acetaminophen) fiye da ibuprofen don amfani da layi na farko.
Dole ne a dauki matakan kariya don rage haɗarin kamuwa da kwayar cutar, musamman a cikin tsarin kiwon lafiya lokacin aiwatar da hanyoyin da za su iya haifar da aerosol, kamar intubation ko iska mai ƙarfi.
Ga ma'aikatan kiwon lafiya da ke kula da masu COVID-19, CDC ta ba da shawarar sanya su a cikin Wurin keɓewa don cututtukan cututtukan cututtukan cututtukan (AIIR) ban da amfani da daidaitattun matakan kariya, matakan kariya na tuntuɓar, da matakan kariya na cutar. CDC ta ba da jagororin amfani da kayan kariya na mutum (APD) yayin annobar.
Abubuwan da aka ba da shawarar sune: mayafin APD, respirator ko abin rufe fuska, mai kare ido, da safar hannu na likita. Idan akwai, respirator (maimakon abin rufe fuska) ya fi kyau.
An yarda da masu aikin N95 don tsari na masana'antu, amma FDA ta ba da izinin wannan abin rufe fuska don amfani da ita bisa ga izinin Amfani da Gaggawa (EUA).
An tsara masu numfashi na N95 don karewa daga ƙwayoyin iska kamar ƙura, amma ba a ba da tabbacin inganci ga takamaiman abubuwan da ke tattare da kwayoyin halitta don amfani da ba a ambata a kan lakabin ba.
Idan ba a samun abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko, a matsayin abin da ya fi dacewa, abin rufe fuska da aka yi da hannu.
Yawancin lokuta na COVID-19 ba su da tsanani sosai har da buƙatar ventilation na inji ko madadin, amma wasu lokuta suna da tsanani.
Ana gudanar da bincike kan hanyoyin samar da taimakon numfashi ga mutanen da ke fama da matsalar numfashi da ke da nasaba da COVID-19 ga mutanen da ke cikin asibiti, kuma akwai tabbaci cewa za a iya kaucewa yin amfani da intubation ta hanyar amfani da hanci mai gudana ko kuma karfin iska mai kyau.
Ba a san ko ko ɗaya daga cikin waɗannan hanyoyin yana ba da fa'idodi iri ɗaya ga waɗanda ke da mummunan rashin lafiya ba.
Wasu likitoci sun fi son ci gaba da amfani da iska mai haɗari, idan akwai, saboda wannan fasaha yana iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da kanula na hanci mai zurfi.
Yawancin ƙasashe masu ci gaba ba su da isassun gadaje na asibiti a kowane mutum, wanda ke iyakance ƙarfin tsarin kiwon lafiya don magance hauhawar kwatsam na COVID-19 wanda ya isa ya zama dole a kwanta asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na masu cutar sun shiga sashen kula da marasa lafiya, kashi 2.3 cikin 100 na bukatar taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30 cikin 100 na masu cutar COVID-19 da aka yi wa asibiti sun shiga ICU.
Ta hanyar iska ta hanyar inji yana ƙara rikitarwa yayin da cutar COVID-19 ta haifar da cututtukan numfashi na gaggawa (ARDS) kuma samun isasshen oxygen ya zama da wahala.
Ana buƙatar masu ba da iska da ke da ikon yin yanayin kula da matsin lamba da kuma PEEP mai ƙarfi don haɓaka isar da iskar oxygen tare da rage haɗarin rauni na huhu da na pneumothorax da ke da alaƙa da masu ba da iska.
Ƙarin PEEP ba zai kasance a kan tsofaffin ventilators ba.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020 kuma wasu magungunan riga-kafi na cikin gwaji na asibiti.
Remdesivir ya fi yin kyau.
Duk da yake samar da sababbin magunguna na iya ɗaukar lokaci har zuwa 2021, wasu magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi a kan mutane da suke da ciwo mai tsanani.
Hukumar ta Amirka ta ba da izini na ɗan lokaci don amfani da jini a matsayin magani na gwaji a lokacin da ake fuskantar haɗari mai tsanani ko kuma na gaggawa ga rayuwar mutum.
Ba a yi nazarin asibiti da ake bukata don tabbatar da aminci da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da wata manhajar wayar hannu don magance barkewar cutar.
Ana tambayar masu amfani su shigar da sunayensu da lambar ID.
Wannan na iya gano 'mafi kusanci' ta amfani da bayanan sa ido don haka gano yiwuwar kamuwa da cuta.
Kowane mai amfani kuma zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano wani hadari, ba wai kawai manhajar za ta ba da shawarar kebewa da kai ba, amma za ta kuma sanar da jami'an kiwon lafiya na gida. Ana amfani da nazarin bayanai na wayar salula, fasahar gane fuska, bin wayar salula, da kuma wucin gadi don gano mutanen da suka kamu da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan, da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izini ga hukumomin tsaro su bi diddigin bayanan wayar salula na mutanen da ake zargi da kamuwa da cutar coronavirus.
An dauki wannan matakin ne domin a killace mutanen da suka kamu da cutar.
Bugu da ƙari, a cikin Maris 2020, Deutsche Telekom ta raba tarin bayanan wurin waya tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don yin bincike da hana yaduwar cutar.
Rasha tana amfani da fasahar gane fuska don gano masu karya dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya, Giulio Gallera, ya ce an gaya wa masu amfani da wayoyin salula cewa "kashi 40 cikin ɗari na 'yan ƙasar suna ta yin kaurace-kaurace".
Gwamnatin Jamus ta gudanar da wani taron hackathon na tsawon sa'o'i 48 da ya yi sama da mutane 42,000.
Bugu da kari, shugaban kasar Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin kirkira don yaki da yaduwar cutar.
Mutane na iya fuskantar matsi daga keɓewa, ƙuntata tafiye-tafiye, sakamakon sakamako masu illa na magani, ko kuma tsoron kamuwa da cutar kanta.
BBC ta ɗauko daga bakin Rory O'Connor wanda ya ce: "Rashin jituwa da mutane, rashin jin daɗi, damuwa da rashin lafiya, damuwa, da kuma matsalar tattalin arziki sune abubuwa da suke sa mutane baƙin ciki".
Wannan cuta tana iya zama mai sauƙi tare da 'yan kaɗan ko babu alamun bayyanar cututtuka, wanda ya yi kama da sauran cututtukan na sama na numfashi, kamar sanyi.
Magunguna masu saukin kamuwa da cuta sukan warke cikin makonni biyu, yayin da wadanda ke da mummunan cuta ko kuma na gaggawa na iya daukar makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya zama a cikin haɗarin kamuwa da COVID-19 mai tsanani bisa ga bayanai daga wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma har yanzu ba a sami bayanai game da COVID-19 ba. A wasu mutane, COVID-19 na iya shafar huhu don haifar da cutar huhu.
A cikin mutanen da suka kamu da cutar COVID-19, za su iya kamuwa da cutar ta ARDS, wadda za ta iya haifar da gazawar numfashi, ciwon shanyewar jiki, ko kuma rashin aiki na gabobin jiki.
Abubuwan da ke tattare da COVID-19 sun haɗa da rashin lafiya, ƙwayoyin jini da ke tattare da cutar, da kuma lalacewar zuciya, koda, da kuma hanta.
Rashin karfin jini, musamman karuwar prothrombin lokaci, an lura da shi a cikin kashi 6% na marasa lafiya na COVID-19 da aka kwantar, yayin da rashin aikin koda ya bayyana a kashi 4% na wannan rukuni.
Kimanin kashi 20 zuwa 30 cikin 100 na mutanen da ke da hoto na COVID-19 sun nuna hawan hawan enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da mutum ya mutu da cutar kwanaki goma ne, tare da kwana biyar a asibiti.
Amma, marasa lafiya da aka kai ICU suna da matsakaicin kwana bakwai tsakanin lokacin da suka mutu.
A wani bincike da aka yi a kan mutanen da suka kamu da cutar, an gano cewa tsawon lokacin da mutum ya mutu daga lokacin da ya fara kamuwa da cutar ya kai kwanaki 14, kuma tsawon lokacin ya kai kwanaki 6 zuwa 41.
A wani bincike da Hukumar Lafiya ta kasar Sin (NHC) ta gudanar, maza sun yi kashi 2.8 cikin dari na mutuwar, yayin da mata suka yi kashi 1.7 cikin dari.
Binciken da aka yi na bayan mutuwarsa ya nuna cewa akwai lalacewar alveolar da ke dauke da kwayar fibromyxoid a cikin huhu biyu.
An lura da canjin kwayar cutar a cikin kwayoyin cuta.
Hoton da aka nuna na huhu ya nuna alamun cutar ƙanƙara na numfashi (ARDS).
A kashi 11.8 na mutuwar da Hukumar Kula da Lafiya ta Kasar Sin ta bayar, an ga lalacewar zuciya, tare da karuwar troponin ko kuma bugun zuciya.
A watan Maris, an ba da rahoton cewa kashi 89 cikin 100 na mutanen da ke asibiti a Amurka suna da cututtukan da suka haifar da rashin lafiya.
An yi hasashen mutuwar da ke faruwa a cikin wannan cuta ya bambanta saboda bambancin yankin, amma kuma saboda matsalolin da suka shafi hanyoyin.
Rashin ƙididdigar ƙididdigar ƙananan ƙididdiga na iya haifar da ƙididdigar yawan adadin mutuwa.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon wani lamari da ya faru a baya yana iya nufin cewa ƙididdigar mutuwar a halin yanzu ta yi ƙasa da kima.
Masu shan sigari sun fi saurin kamuwa da COVID-19 da kusan sau 1.4 kuma sun fi saurin buƙatar kulawa mai tsanani ko mutuwa fiye da marasa shan sigari. Akwai damuwa game da cututtukan da ke tattare da cutar.
Hukumar asibitocin Hong Kong ta gano cewa an rage karfin huhu da kashi 20 zuwa 30 cikin dari a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin.
Hakanan zai iya haifar da ciwon bayan-ciwon-ciwon-ciwon bayan an warke.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da ingantaccen kariya mai dorewa ga mutanen da suka warke daga cutar ba.
Ana iya samun rigakafi ta hanyar lura da halayyar wasu ƙwayoyin cuta, amma an ba da rahoton samun warkewa daga COVID-19 wanda ya biyo bayan gwajin ƙwayoyin cuta na kwanaki da yawa.
An yi amannar cewa cutar ta kasance ne a lokacin da ta yi tsanani, ba a lokacin da ta sake kamuwa ba.
An yi amannar cewa kwayar cutar ta samo asali ne daga dabbobi, kuma ta hanyar kamuwa da cuta ne.
Ba a san ainihin asalinsa ba, amma a watan Disamba na 2019, kusan kusan dukkanin masu kamuwa da cutar sun kamu da cutar daga mutum zuwa mutum.
Nazarin 41 na farko da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a The Lancet, ya bayyana cewa ranar farko da aka fara nuna alamun cutar ita ce ranar 1 ga Disamba 2019.
Wani littafin WHO na hukuma ya ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Yawanci, ana amfani da ma'auni don ƙididdige yawan mutuwar.
Wannan adadi ya bambanta a yankuna da kuma tsawon lokaci, kuma ana shafar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan kulawa, lokacin da aka fara kamuwa da cutar, da yanayin alƙaluma kamar shekaru, jinsi, da kuma lafiyar gaba ɗaya.
A karshen 2019, WHO ta sanya lambar cutar ta gaggawa ta ICD-10 U07.1 don mutuwar da aka tabbatar da cutar SARS-CoV-2 da U07.2 don mutuwar da aka yi daga COVID-19 da aka gano a asibiti ko kuma a fannin annoba ba tare da tabbatar da asibiti ba don kamuwa da SARS-CoV-2.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mutuwar cutar a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Sauran ma'aunin sun hada da adadin mutuwar cutar (CFR), wanda ke nuna yawan mutanen da aka gano da suka mutu daga wata cuta, da kuma adadin mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan adadin mutanen da suka kamu da cutar (wacce aka gano da wanda ba a gano ba) da suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna bin wani ƙayyadadden alƙaluma daga kamuwa da cuta zuwa warwarewar shari'ar.
Ko da yake ba duk mutanen da suka kamu da cutar suke samar da kwayoyin cutar ba, kasancewar kwayoyin cutar na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar Italiya, Castiglione d'Adda, wani ƙauye mai mazauna 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta bazu ta hanyar bikin Carnival, wanda ya bazu tsakanin matasa, ya haifar da ƙananan mutuwar, kuma ba za a iya rarraba dukkan mutuwar COVID-19 a matsayin mutuwar COVID-19 ba.
Bugu da ƙari, tsarin kula da lafiyar Jamus bai cika ba tukuna.
A Netherlands, kusan kashi 3 na yawan mutanen da ke da kwayar cutar za su iya samun kwayoyin cutar, kamar yadda aka gano daga masu ba da jini.
Mutane 69 (0.004% na yawan jama'a) sun mutu sakamakon COVID-19.
Sakamakon cutar da kuma yawan mace-mace ya bambanta tsakanin maza da mata.
Mutuwar ta fi yawa a cikin maza a cikin binciken da aka yi a China da Italiya.
Babban haɗarin ga maza yana cikin shekarunsu na 50, kuma bambancin haɗarin tsakanin maza da mata ba a bayyane yake ba a shekarun 90.
A China, yawan mace-mace ya kai kashi 2.8 cikin dari na maza da kashi 1.7 cikin dari na mata.
Ba a san ainihin dalilin bambancin jinsi ba, amma dalilai na hali da na dabi'a na iya zama dalili.
Bambancin rigakafi ta hanyar jinsi, ƙananan yawan shan sigari a cikin mata, da maza da ke da yanayin da ke da haɗari, kamar hawan jini, a cikin ƙuruciya fiye da mata na iya taimakawa wajen mutuwar maza.
A Turai, 57% na waɗanda suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka danganci jinsi don kamuwa da COVID-19.
Bincike ya nuna cewa cututtuka na ƙwayoyin cuta, kamar su Ebola, HIV, influenza, da kuma SARS, suna shafan maza da mata dabam dabam.
Ma'aikatan kiwon lafiya mata sun fi yawa, musamman ma ma'aikatan jinya, kuma suna da damar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar a hukumance shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na nufin kwayar cutar, D na nufin cuta, da kuma 19 na nufin lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa yin amfani da shi zuwa wani yanki (misali China), nau'in dabba, ko rukuni na mutane, daidai da shawarwarin ƙasashen duniya don suna wanda ke nufin hana ƙazantar da kai.
WHO ta kuma yi amfani da "COVID-19 virus" da "virus da ke da alhakin COVID-19" a cikin sadarwa na jama'a.
Ana kiran cutar da kwayar cutar "coronavirus".
A farkon barkewar cutar a Wuhan, China, ana kiran cutar da cutar "coronavirus" da "coronavirus na Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da cutar numfashi mai saurin 2019-nCov a matsayin sunan wucin gadi na ƙwayoyin cuta da cututtuka daidai da ƙa'idodin 2015 waɗanda ke ba da shawarar kada a yi amfani da sunayen wuri a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen COVID-19 da SARS-CoV-2 a hukumance a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntataccen ƙarfin da ke cikin daidaitattun hanyoyin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da kayan aikin ventilator.
A wani misali, lokacin da wani asibiti a Italiya yake da gagarumar bukatar ƙwararrun masu aikin sanyaya iska, kuma masu ba da kayayyaki ba su iya ba da su a cikin lokaci ba, wani kamfani na gida ya sake yin injiniya kuma ya buga ƙwararrun masu aikin sanyaya iska guda 100 cikin dare.
Bayan barkewar cutar COVID-19, ra'ayoyin makirci, bayanan da ba daidai ba, da kuma rashin fahimta sun bayyana game da asalin cutar, yawanta, rigakafinta, maganin ta, da sauran fannoni na cutar, wanda ya yadu da sauri a kan layi.
Mutane suna iya yada kwayar cutar zuwa wasu dabbobi.
Bincike ya kasa gano shaidar kwayar cutar a cikin aladu, da dabbobin gida, da kuma kaji.
Har ila yau, ba a san da wani magani ko allurar rigakafin da za a yi amfani da shi wajen magance wannan cutar ba.
Bincike na kasa da kasa kan allurar rigakafin COVID-19 da magungunan rigakafi yana gudana ne ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi, da masu binciken masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta gabatar da wani gwaji mai suna "SOLIDARITY Trial" don nazarin maganin da magungunan ƙwayoyin cuta huɗu da ake amfani da su yanzu suke da shi da kuma yadda za su iya magance cutar.
Ba a samu riga-kafin cutar ba, amma kungiyoyi daban-daban na aiki a kan samar da allurar rigakafi.
An yi amfani da binciken SARS-CoV na baya saboda SARS-CoV da SARS-CoV-2 duka suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike a kansu.
Na farko, masu bincike suna son yin allurar rigakafin cutar.
Amfani da irin wannan kwayar, ko dai kwayar da ba ta aiki ko kuma wacce aka kashe, an yi niyyar saurin haifar da martani na rigakafin jikin mutum ga sabon kamuwa da COVID-19.
Hanyar na biyu, wato, allurar rigakafin ƙananan rukuni, tana da nufin ƙirƙirar allurar da za ta sa tsarin garkuwar jiki ya kamu da wasu ƙananan rukuni na kwayar cutar.
A cikin SARS-CoV-2, binciken ya mai da hankali kan S-spike protein wanda ke taimakawa kwayar cutar ta shiga cikin masu karɓar ACE2 masu karɓar enzyme.
Dabara ta uku ita ce allurar rigakafin kwayar nucleic acid (Allurar rigakafin DNA ko RNA, sabuwar hanyar yin allurar rigakafi).
A ranar 16 ga Maris, 2020, an fara gwajin farko na asibiti na allurar rigakafi tare da masu sa kai hudu a Seattle.
Alluran rigakafi suna ƙunshe da lambar ƙwayoyin cuta mara lahani da aka kwafa daga ƙwayoyin cuta da ke haifar da cutar. An ba da shawarar haɓakawar-antibody-dependent a matsayin ƙalubalen ƙalubale don haɓaka allurar rigakafin SARS-COV-2, amma wannan hanyar har yanzu tana da rikici.
Akwai gwaji na asibiti sama da 300 da ke gudana a watan Afrilun 2020.
An yi gwaji bakwai da suka yi nazarin magungunan da aka amince a yi amfani da su don magance zazzabin cizon sauro, kuma sun haɗa da gwaji huɗu da aka yi a kan maganin hydroxychloroquine ko chloroquine.
Sabon maganin da aka ba da izini ya zama babban bincike na kasar Sin, tare da gwajin gwaji na Mataki na III na tara a kan remdesivir a cikin wasu ƙasashe tare da ƙarshen ranar ƙarshe na Afrilu.
A watan Afrilu na 2020, an fara nazarin magungunan rigakafi da magungunan da ke maganin COVID-19. Ana kimanta wasu magungunan rigakafi don maganin COVID-19, wanda ya haɗa da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir, da lopinavir/ritonavir haɗe tare da interferon beta.
A watan Maris na 2020, an sami ɗan gajeren shaida na ingancin remdesivir.
An lura da karuwar asibiti a cikin marasa lafiya da aka yi wa maganin rigakafi a cikin kulawa na gaggawa.
Ana gudanar da gwajin asibiti na Phase III a Amurka, China, da Italiya. Chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, an yi nazari a China a watan Fabrairun 2020, tare da sakamako na farko.
Duk da haka, an yi kira ga a sake duba irin wannan bincike.
Hukumomin kiwon lafiya na Koriya da na China sun ba da shawarar yin amfani da maganin nan.
Koyaya, Cibiyar Nazarin Kwayoyin Cutar Wuhan, duk da shawarar kashi ɗaya na gram a kowace rana, ta lura cewa ninki biyu yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine a kan shawarar likitocin da ke kula da masu cutar COVID-19.Shafukan na 7 na China sun haɗa da amfani da interferon, ribavirin, ko umifenovir don COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don hana SARS-CoV-2 a cikin in vitro.
Nitazoxanide an ba da shawarar don ƙarin nazarin in vivo bayan ya nuna hana SARS-CoV-2 a cikin ƙananan ƙananan.Bincike ya nuna cewa farkon farkon furotin na protin na protin na protin na 2 (TMPRSS2) yana da mahimmanci ga shigarwar SARS-CoV-2 ta hanyar hulɗa tare da masu karɓar ACE2.
Nazarin kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da manyan iyakoki waɗanda suka hana ƙungiyar likitoci amfani da wannan maganin ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a in vitro kuma ba shi da wani sanannen matsayi a cikin maganin COVID-19.
Abubuwan rikitarwa na cytocin za su iya faruwa a cikin COVID-19 mai tsanani.
Tocilizumab an saka shi a cikin jagororin magani ta Hukumar Kiwon Lafiya ta kasar Sin bayan da aka kammala karamin bincike.
Maganin yana cikin gwaji na biyu a matakin kasa a Italiya bayan ya nuna sakamako mai kyau a cikin mutane da ke da mummunan cuta.
Idan aka hada da gwajin jini na serum ferritin don gano cytocin, maganin zai yi maganin cytocin, wanda aka yi zargin ya yi sanadiyar mutuwa a wasu mutanen da aka yi wa allurar.
A cikin 2017, FDA ta amince da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa bisa ga nazarin binciken da aka yi na baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na steroid, wanda aka haifar da wata hanyar daban, wato maganin T-cell CAR.
A halin yanzu, babu wani gwaji na bazuwar da aka gudanar wanda ya nuna cewa tocilizumab magani ne mai tasiri ga CRS.
An yi nazarin canja wurin tsarkakewa da kuma rigakafin da aka samar da tsarin mutanen da suka warke daga COVID-19 zuwa ga mutanen da suke buƙatar shi a matsayin hanyar ba da rigakafin rigakafi.
An gwada wannan dabarar don SARS tare da sakamako mara kyau.
Tsarewar kwayar cutar ita ce hanyar da ake sa ran maganin rigakafin rigakafi zai iya ba da kariya ga SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar su antibody-dogara da kuma / ko phagocytosis-dabbara cellular cytotoxicity, ma zai yiwu.
Wani nau'i na maganin rigakafin rigakafi, alal misali, wanda ke amfani da kwayoyin rigakafin monoclonal, ana ci gaba da bunkasa shi.
Za a iya inganta samar da maganin maganin, wanda shine ruwa daga jinin marasa lafiya da suka warke kuma yana dauke da kwayoyin cutar musamman ga wannan kwayar cutar don amfani da sauri.
Cutar korona, wani rukuni na cututtukan da ke da alaƙa
Li Wenliang, likita ne a asibitin Wuhan, wanda ya kamu da cutar COVID-19 bayan ya sanar da mutane game da yaduwar cutar.
